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Give every individual the right amount of exercise, not too little 
and not too much. 
Hippocrates P 
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Abstract 
Participation in marathons and ultra-endurance races is growing every day, but it is 
worrisome that these types of races are becoming mass events, where many 
runners are not sufficiently prepared. For example, in the 2017 Barcelona marathon 
there were 19.740 runners, whereas in the 2007 marathon there were 7.430 runners 
(Zurich Barcelona Marathon). In the age of social media, everyone wants to put his/
her photo and comment on Instagram, Facebook, Twitter, etc., about the 
achievement reached, without caring if his/her health has been compromised. A 
marathon or longer distance races, require significant exertions and result in an 
impact on our bodies and bring short and long-term consequences for our health. 
Never before has running been so fashionable, but to what extent is it done in a 
healthy manner? 
The motivation and merit of this thesis lie in the fact of finding the impact of a 42km 
run on our body and evaluate the risk of muscle and cardiac damage, inflammation, 
immunological changes, infection, and renal impairment.  
A total of 234 non-elite runners were studied for 4 years (from 2016 to 2019). The 
articles presented in this thesis are based on the runners who participated in the 
marathon of 2016. In the article “The Dynamics of Cardiovascular Biomarkers in non-
Elite Marathon Runners”, 79 runners were analyzed, in the “Salivary immunity and 
lower respiratory tract infections in non-elite marathon runners”, 47 runners were 
analyzed and in the “Effects of a polysaccharide-based multi-ingredient supplement 
on salivary immunity in non-elite marathon runners”, 41 runners were analyzed. 
The changes evaluated in pre-race conditions (baseline), in the end, and 48 h post-
race were through blood and saliva biomarkers. Additionally, other variables were 
assessed before the race, like the nutrition balance and some specific supplement 
intake, and it was proved how the body weight, recovery time, and amount of training 
done can directly affect the runner’s performance and health.  
The highest elevations in biomarkers associated with muscle damage (CK), 
inflammation (CRP), and cardiovascular health (Hs-TnT, NT-proBNP, ST2) were 
seen in the runners with the worse performance time and less training hours pre-
race. 
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Also, the marathon provoked changes in salivary immunity and increased the risk of 
developing a respiratory tract infection. In addition, supplementation actions like 
polysaccharide-based ones, positively affected the immune response initiated during 
a 42 km effort. 
By BIVA methodology, a correlation can be made with a displacement of the vector 
impedance at 24 h and 48 h post-race on the tolerance ellipses of a European 
Caucasian reference population with biomarkers of renal damage. Transient values 
of acute kidney injury (AKI) stage 1, more related to inflammatory factors rather than 
muscle damage, were found in many marathoners which recovered mostly 48 h 
post-race. 
Regarding diet, a correct mono- and poly-unsaturated fatty acid, potassium, and 
magnesium intake before the marathon influenced better performance and better 
cardiovascular health. 
But, what are the negative long-term effects of these acute changes in clinical 
biomarkers and bioimpedance measurements after 42 km? How does it affect an 
inadequate diet and preparation? 
This thesis is based on five original publications, three accepted and two under 
review, separated into three chapters ordered from 2 to 4, starting with 
cardiovascular biomarkers, immunity, and supplements. In Appendix 2, renal function 
and bioimpedance vector displacement, and in Appendix 3, diet effects on 
performance and cardiac health. An introduction in Chapter 1, describes the rationale 
of the published work and its place within the whole topic of this thesis. As an elite 
runner for many years and already a veteran, this thesis is my "grain of sand" in the 
fascinating world of our body’s metabolic responses while running. 
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Resum 
La participació en maratons i curses d'ultra resistència creix cada dia, però és 
preocupant que aquest tipus de curses es converteixin en esdeveniments massius, 
on molts corredors no estan prou preparats. Per exemple, a la marató Barcelona del 
2017 hi havia 19.740 corredors, mentre que a la marató del 2007 hi havia 7.430 
corredors (Zurich Barcelona Marathon). En l'era de les xarxes socials, tots volen 
posar la seva foto i comentar a Instagram, Facebook, Twitter, etc., sobre l'assoliment 
aconseguit, independentment de si la seva salut s'ha vist compromesa. Una marató 
o cursa de llarga distància, requereix esforços significatius i té un impacte en el 
nostre cos amb unes conseqüències a curt i llarg termini per a la nostra salut. Mai 
abans havia estat tan de moda córrer, però fins a quin punt es fa de manera 
saludable? 
La motivació i el mèrit d'aquesta tesi rau en el fet de veure l'impacte d'una carrera de 
42 km en el nostre cos i avaluar el risc de dany muscular, dany cardíac, d’inflamació, 
de canvis immunològics, d’infecció, i d’insuficiència renal.  
Un total de 234 corredors no elit es van estudiar durant 4 anys (del 2016 al 2019). 
Els articles presentats en aquesta tesi es basen en els corredors que van participar 
en la marató del 2016. En l’article “The Dynamics of Cardiovascular Biomarkers in 
non-Elite Marathon Runners” es van analitzar 79 corredors, en el de “Salivary 
immunity and lower respiratory tract infections in non-elite marathon runners” es van 
analitzar 47 corredors i en el de “Effects of a polysaccharide-based multi-ingredient 
supplement on salivary immunity in non-elite marathon runners” es van analitzar 41 
corredors.  
Els canvis avaluats en les condicions prèvies a la cursa (estat basal), al final i 48 
hores després de la cursa, es van realitzar a través de biomarcadors en sang i 
saliva. A més a més, es van avaluar altres variables abans de la cursa, com 
l'equilibri nutricional i una suplementació específica, i es va demostrar com el pes 
corporal, el temps de recuperació i la quantitat d'entrenament realitzat poden afectar 
directament el rendiment i la salut del corredor. 
Les elevacions més altes en els biomarcadors associats amb el dany muscular (CK), 
la inflamació (CRP) i la salut cardiovascular (Hs-TnT, NT-proBNP, ST2) es van 
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observar en els corredors amb pitjor rendiment en cursa i amb menys hores 
d'entrenament abans de la mateixa. 
A més, la marató va provocar canvis en la immunitat salival i va augmentar el risc de 
desenvolupar una infecció del tracte respiratori. Així mateix, les accions de 
suplementació com les basades en polisacàrids van afectar positivament la resposta 
immune iniciada durant l'esforç de córrer 42 km. 
Segons el mètode BIVA, es pot fer una correlació del desplaçament del vector 
impedància a les 24 h i 48 h després de la carrera sobre les el·lipses de tolerància 
d'una població de referència caucàsica europea, amb els biomarcadors de dany 
renal. Els valors transitoris de la lesió renal aguda (AKI) tipus 1, més relacionats 
amb factors inflamatoris que amb el dany muscular, es van trobar en molts 
maratonians que van recuperar a les 48 h després de la cursa. 
Pel que fa a la dieta, una correcta ingesta d'àcids grassos monoinsaturats i 
poliinsaturats, potassi i magnesi abans de la marató va influir en un millor rendiment 
i una millor salut cardiovascular. 
Però quins són els efectes negatius a llarg termini d'aquests canvis aguts en els 
biomarcadors clínics i en les mesures de bioimpedància després de 42 km? Com 
afecta una dieta i una preparació inadequades? 
Aquesta tesi es basa en cinc publicacions originals, 3 acceptades i dos en revisió, 
separades en tres capítols ordenats del 2 al 4, començant amb biomarcadors 
cardiovasculars, infecció, immunitat i suplementació. En l’Annex 2, la funció renal i el 
desplaçament del vector de bioimpedància, i en l'Annex 3, els efectes de la dieta 
sobre el rendiment i la salut cardíaca. Una introducció al Capítol 1 descriu la 
justificació del treball publicat i el seu lloc dins el tema general d'aquesta tesi. Com a 
corredora d'elit durant molts anys i ja veterana, aquesta tesi és el meu "gra de sorra" 
en el fascinant món de les respostes metabòliques que fa el nostre cos mentre 
correm. 
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Resumen 
La participación en maratones y carreras de ultra resistencia crece cada día, pero es 
preocupante que este tipo de carreras se conviertan en eventos masivos, donde 
muchos corredores no están lo suficientemente preparados. Por ejemplo, en la 
maratón Barcelona de 2017 había 19.740 corredores, mientras que en la maratón 
de 2007 había 7.430 corredores (Zurich Barcelona Marathon). En la era de las redes 
sociales, todos quieren subir su foto y comentar en Instagram, Facebook, Twitter, 
etc., sobre el logro alcanzado, sin importar si su salud se ha visto comprometida. 
Una maratón o carrera de larga distancia, requiere esfuerzos significativos y tiene un 
impacto en nuestro cuerpo con unas consecuencias a corto y largo plazo para 
nuestra salud. Nunca antes había estado tan de moda correr, pero ¿hasta qué punto 
se hace de manera saludable? 
La motivación y el mérito de esta tesis radica en el hecho de ver el impacto de una 
carrera de 42 km en nuestro cuerpo y evaluar el riesgo de daño muscular, daño 
cardíaco, inflamación, cambios immunológicos, infección, e insuficiencia renal.  
Un total de 234 corredores no elite se estudiaron durante 4 años (del 2016 al 2019). 
Los artículos presentados en esta tesis se basan en los corredores que participaron 
en la maratón del 2016. En el artículo “The Dynamics of Cardiovascular Biomarkers 
in non-Elite Marathon Runners” se analizaron 79 corredores, en el de “Salivary 
immunity and lower respiratory tract infections in non-elite marathon runners” se 
analizaron 47 corredores y en el de “Effects of a polysaccharide-based multi-
ingredient supplement on salivary immunity in non-elite marathon runners” se 
analizaron 41 corredores. 
Los cambios evaluados en las condiciones previas a la carrera (estado basal), al 
final y 48 horas después de la carrera, se realizaron a través de biomarcadores de 
sangre y saliva. Además, se evaluaron otras variables antes de la carrera, como el 
equilibrio nutricional y una suplementación específica, y se demostró como el peso 
corporal, el tiempo de recuperación y la cantidad de entrenamiento realizado pueden 
afectar directamente el rendimiento y la salud del corredor. 
Las elevaciones más altas en los biomarcadores asociados con el daño muscular 
(CK), la inflamación (CRP) y la salud cardiovascular (Hs-TnT, NT-proBNP, ST2) se 
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observaron en los corredores con peor rendimiento en carrera y con menos horas 
de entrenamiento antes de la misma. 
Además, la maratón provocó cambios en la inmunidad salival y aumentó el riesgo de 
desarrollar una infección del tracto respiratorio. A su vez, las acciones de 
suplementación como las basadas en polisacáridos afectaron positivamente la 
respuesta inmune iniciada durante el esfuerzo de correr 42 km. 
Según el método BIVA, se puede hacer una correlación del desplazamiento del 
vector impedancia a las 24 h y 48 h después de la carrera sobre las elipses de 
tolerancia de una población de referencia caucásica europea, con los 
biomarcadores de daño renal. Los valores transitorios de la lesión renal aguda (AKI) 
tipo 1, más relacionados con factores inflamatorios que con el daño muscular, se 
encontraron en muchos maratonianos que recuperaron a las 48 h después de la 
carrera. 
Con respecto a la dieta, una correcta ingesta de ácidos grasos monoinsaturados y 
poliinsaturados, potasio y magnesio antes de la maratón influyó en un mejor 
rendimiento y una mejor salud cardiovascular. 
¿Pero cuáles son los efectos negativos a largo plazo de estos cambios agudos en 
los biomarcadores clínicos y las mediciones de bioimpedancia después de 42 km? 
¿Cómo afecta una dieta y una preparación inadecuadas? 
Esta tesis se basa en cinco publicaciones originales, tres aceptadas y dos en 
revisión, separadas en tres capítulos ordenados del 2 al 4, comenzando con 
biomarcadores cardiovasculares, infección, inmunidad y suplementación. En el 
Anexo 2, la función renal y el desplazamiento del vector de bioimpedancia, y en el 
Anexo 3, los efectos de la dieta sobre el rendimiento y la salud cardíaca. Una 
introducción en el Capítulo 1 describe la justificación del trabajo publicado y su lugar 
dentro del tema general de esta tesis. Como corredora de élite durante muchos 
años y ya veterana, esta tesis es mi "grano de arena" en el fascinante mundo de las 
respuestas metabólicas que hace nuestro cuerpo mientras corremos. 
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Preface 
Doing more than 100 races (marathons and ultramarathons) during the last 15 years 
has given me a very broad vision of what it means to be a runner (Appendix 6). I 
have seen the importance of good preparation before any challenge, and not only at 
the physical level, but also at a nutritional and medical level.  
Running all this time, suffering injuries, dehydration, muscle damage or injury, 
infection or immunosuppression, has illustrated to me as a biochemist the lack of 
published scientific rigor, and the need to give this knowledge to both non-elite and 
elite runners like myself have accumulated lots of km and races. 
Since 2012 I started a research project to explore the impact of running at a 
muscular, cardiac, physiological, and genetic level. This project denoted SUMMIT 
(Salut en les Ultra Maratons i els seus LíMITs, health in the ultramarathons and their 
limits) has analyzed more than 500 runners in more than 25 different races or events 
(Appendix 5). First I focused on mountain races, both in short and long distances, 
and then in asphalt marathons like the Zurich Barcelona Marathon, which is the 
center of this doctoral thesis. 
Through the discovery of how a mountain race affects the skeletal and cardiac 
muscle, gene expression, heart variability, right ventricle adaptation or pulmonary 
vascular function; I wanted to see what happens in the discipline where there are 
more fans in the whole world, the asphalt marathon.  
Initially, I did not focus on the elite runner, since they are a minority of the total 
number of practitioners and difficult to convince, and I went to find the amateur 
runner, enthusiastic and predisposed, with more or less experience in marathons but 
representing more than 99% of the currently enrolled participants. The main 
objective was to analyze and determine running risk factors and find the tools to 
prevent them. 
During the first stage of the SUMMIT Project, starting in 2012 with the mountain 
races, some articles were published (Appendix 4) before enrolling in the thesis at the 
UPC. The second stage started in 2016 when I enrolled in the UPC doctoral 
program, Biomedical Engineering, analyzing the Barcelona marathon from which I 
have already published 3 articles and 2 more are under submission  
xxi
The races carried out by myself and as a result of all these investigations, provide a 
knowledge that goes far beyond what can be found by a researcher who does not 
run, or by someone who performs only laboratory tests. 
xxii
Justification 
This study is born from the interest to deepen knowledge and future prevention tools 
regarding the impact of running on people, that without being sufficiently prepared, 
exercise challenges that go beyond healthy.  
This thesis can help coaches, sports clinicians, researchers and especially athletes 
to better understand some physiological changes associated with running, and 
establish guidelines for better performance, recovery, and general health. But above 
all, to determine long-term negative effects on acute metabolism changes that occur 
in each race. 
From the SUMMIT project (Health in the UltraMarathons and their limits) started in 
2012, the objective was to group the knowledge of different institutions, from 
Universities and Hospitals, and together deepen a broad knowledge of the limits of a 
runner. SUMMIT with the Electronic Engineering Department of the Universitat 
Politècnica de Catalunya, the Germans Trias i Pujol Hospital and the Santa Creu i 
Sant Pau Hospital have analyzed different blood and saliva variables together with 
bioimpedance measurements and dietary intake analysis on asphalt marathoners, 
that are reflected in this doctoral thesis.  
The works that make up this doctoral thesis are the first publications in journals 
indexed in the JCR (Q1 and Q2) related to the impact of a marathon run at different 
levels. 
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Chapter 1: Introduction 
Someone who decides to run more than 1 h non-stop, must consider some previous 
tasks like appropriate training of the selected distance, good nutrition and hydration 
preparation, supplementation if needed, suitable rest, appropriate equipment and 
above all to be healthy with a good report from a medical check-up. Even if we run 
and perform correctly, we are not exempt from related dangers, although what can 
really kill us is a sedentary lifestyle. 
Despite the fact that exercise is a fundamental component of the human condition for 
evading predators and food procurement, we are the only primates capable of 
running long distances, standing out above other primates (Bramble and Lieberman, 
2004). The exercise undertaken to an individual’s maximum can be a complex 
process involving synchronized and integrated activation of multiple tissues and 
organs at a cellular and systemic level, representing a major challenge to whole-
body homeostasis. Muscle contraction, for example, increases metabolic activity and 
requires fuel and oxygen to maintain itself, activating systemic responses such as 
cardiovascular, respiratory, neuronal, and hormonal that mitigate homeostatic threats 
(Figure 1) (Hawley et al., 2014). 
The lower limit of physical exercise that brings great health benefits daily is known to 
be moderate aerobic exercise for a minimum of 30 minutes 5 days a week (Rowe et 
al., 2014; Subirats et al., 2012), but there is a great lack of knowledge about where 
the dividing line of the upper limit is, from which sport does not provide a clear 
benefit (Figure 2) (Hoffman and Krishnan, 2014; O’Keefe et al., 2014). Is an 
endurance exercise, like a marathon or an ultramarathon, an activity that goes over 
this limit? 
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Figure 1. Outline of some physiological responses to exercise. Retrieved from 
Hawley et al. (2014). 
It must be considered that each person has their own response to physical exercise, 
and for example, the effect that training can have on physiological adaptations is 
interpersonal (Noakes, 2002). For this reason, each one must be their own reference 
and act accordingly. A personalized exercise prescription may confer the health 
benefits of regular training, and we cannot emulate other runners that may have 
nothing to do with us. There is complex biology behind the diversity in the adaptive 
response to training between runners. Being able to describe this response through 
the identification of molecules, metabolic pathways, and even new treatments, the 
benefit that exercise gives to each person can be maximized (Gabriel and Zierath, 
2017). When our preparation nor nutrition is inadequate, numerous homeostatic 
processes are affected, some key biomarkers can be altered and can limit our 
health, performance, and recovery. Data from long-term biomarker analysis 
associated with nutrition, hydration, muscle status, cardiovascular endurance, injury 
risk, and inflammation can help in the preventative detection of injury or sport 
negative effects on performance (Lee at al., 2017). 
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The number of non-elite runners participating in such long races is dramatically 
increasing every day (Hoffman et al., 2010; IAU Ultra Marathon). Marathon races 
have become mass events where many runners are not sufficiently prepared for, 
because the average finishing times of nearly all the most important city marathons 
increased continuously in the last 15 years (Marathon Guide, 2014). 
Either marathon or ultramarathon viewed from the perspective of social and cultural 
anthropology is a "sacrificial" sport. It supports psychological and physical pain, its 
growth is unstoppable and goes beyond a commercial, pedagogical, or healthy 
value. According to sociologists, those who practice this type of sport do so, more as 
a social ritual that reinforces the identity of oneself and not as a mere healthy 
physical exercise (Cachan, 2014). Nowadays finishing a race or improve a personal 
best, rather than besting the opponents, serves a great majority of runners as a 
precept of sacrifice and becomes a philosophy of life in its most existential sense 
(Cachan, 2014), but at what price? 
               
Figure 2. Benefits of regular endurance exercise. Adapted from Rowe et al. (2014). 
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Much of a marathon battle is mental, and often fatigue becomes more bearable the 
nearer we get to the finish. But normally when we are running a marathon or 
ultramarathon poorly, being an elite or non-elite athlete, means that we are probably 
underperforming due to muscle damage. The reason we are running slowly is that 
our brain is trying to tell us to stop moving, the brain is responding to negative 
messages from the muscles, which are trying desperately to tell our brain that they 
are distressed and in need of rest (Noakes, 2002). Our brain is using the symptoms 
of fatigue as key to a regulator to insure that the exercise is completed before harm 
develops, but we do not always obey, we want to finish the race at any risk, and 
there can be consequences. 
The biomarkers analyzed in this thesis, both in blood and saliva, are related to 
performance, recovery, and health in general. These biomarkers evaluate muscle 
and cardiac damage, inflammation, immunity, infection, renal function, as well as 
nutritional status, and hydration. In addition, localized and global bioimpedance 
measurements, have been used as a fast and non-invasive method, to assess 
different muscle group symmetry, activation, injury, hydration and other clinical 
settings (Nescolarde et al., 2008, 2015 and 2017).  
We must consider that the reference ranges of the biomarkers analyzed are based 
on the general population and not specifically on runners. Repeated measurements 
in future studies which in this population type must be done, can help doctors, 
trainers and athletes to identify more specific changes associated with the risk of 
injury, overtraining, or diminishing performance. 
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1. Endurance exercise and electrical bioimpedance 
measurement 
1.1 Bioimpedance basics and biological variables 
Bioimpedance (BIA) is a non-invasive, fast, painless, and portable method that deals 
with a passive electrical property of the tissue: the ability to oppose electric current 
flow. BIA is an indirect assessment of human body composition, it serves as a 
support tool in the analysis of changes in hydration and nutrition with global 
bioimpedance (BIA “whole-body”) (Foster and Lukaski, 1996; Lukaski and Piccoli, 
2012); or in the detection of overactivation and muscle injury with localized 
bioimpedance (L-BIA) (Nescolarde et al., 2013). 
BIA, based on the principle that biological tissue behave as conductors to a greater 
or lesser extent of electric current and/or dielectrics (insulators) depending on their 
composition can be represented by a model shown in Figure 3. This model includes 
a resistance attributable to an extracellular path, dependent on the amount and 
composition of extracellular fluid, and a complex intracellular path, including cell 
membrane capacitance and resistance. The model indicates three critical biological 
indexes (intracellular conductor, extracellular conductor, and membrane 
capacitance) that may be approximated with bioelectrical impedance variables 
(Lukaski, 1996).  
Resistivity (inverse of conductivity) and permittivity (accumulation of charge at 
interfaces) are two intensive material properties in which frequency values 
dependency vary among tissues, being the muscle with the highest permittivity and 
the bone with the highest resistivity (Foster and Lukaski, 1996). For this reason, intra 
and extracellular electrolyte solutions of all soft tissues (in particular non-fatty 
tissues) are good conductors and optimally analyzed by BIA, whereas bone is not so 
easily crossed by the electric currents and behaves like a bad conductor (insulator). 
In adipose tissue, the current can pass through the electrolyte solutions of the 
interstitium and the adipocytes, but not by the hydrophobic lipid drops, which do not 
conduct current (Grimnes and Martinsen, 2000; Piccoli et al., 2002a). 
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Figure 3. Electric model of a cell. RE extracellular resistance, CM capacitive influence 
of cell membranes, RI intracellular resistance. Retrieved from Lukaski (1996). 
Many diverse models of cell suspension like that depicted in Figure 3, in series and 
parallel orientations, form the human body and they are characterized by mixtures of 
physiological fluids and electrolytes acting as resistors, cell membranes, and tissue 
interfaces acting as capacitors. The term used to describe the opposition to the flow 
of an alternating current by any biological conductor is the Impedance (Z) (called 
resistance, R, when direct current is applied). The alternating current flows through 
resistive and capacitive elements that can be measured with the impedance 
components: 
-The resistance component (R, Ω) or the real part of Z, is frequency independent (it 
has the same measurement value with either direct or alternating current) opposition 
to the flow of current, being the inverse of conductance. According to Ohm’s Law, R 
equals the voltage (E) divided by the current (I) transmitted by ions in aqueous 
solution (R= E/I). Resistance arises from collisions of the current-carrying charged 
particles through the intra- and extra-cellular electrolyte solutions, indicating 
extracellular fluid (ECF) and electrolyte composition.  
-The reactance (Xc) or the imaginary part of Z, is an additional frequency-dependent 
opposition to the movement, being the reciprocal of capacitance or the voltage 
stored by a condenser for a brief period of time. It is determined by the differential 
properties of the tissues and indicates cell membrane mass and function. 
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Impedance is described as a complex number (Z2 = R2 + Xc2) and characterizes the 
specific fluid and cellular components of an organism (Lukaski, 1996). Impedance is 
calculated as the vector with length and position on the bivariate RXc graph and the 
phase angle (PA) describes the position of Z, evaluating the intra- and extra-cellular 
fluid (Figure 4a). The phase angle is also the geometric representation of the phase 
change created when the administered current is delayed behind the voltage due to 
capacitance causes (Figure 4b) (Lukaski et al., 2019). 
Figure 4. (a): Geometric relationships among the resistance (R), reactance (Xc, as 
CM capacitance), impedance (Z), and phase angle with the respective formulas. (b): 
Representation of the body as a parallel resistor-capacitor (RC) equivalent circuit. 
Retrieved and adapted from Lukaski et al. (2019). 
The calculation of fluid volumes and compartments derived from conventional BIA is 
based on the proportionality between Z and the dimensions of length and area of a 
conductive cylinder. The extremities and trunk of the human body can be considered 
as conductors of irregular cylindrical shape, with a length L (m) easily determinable 
using the hand-foot distance of the person (in the standard BIA height is used as a 
surrogate for the length of the body), and an area in its cross-section A (m2) more 
difficult to determine. By Ohm’s law, the impedance Z in a cylindrical conductor is 
proportional to the length multiplied by a complex resistivity (ρ) that varies among 
tissues, and inversely proportional to the cross-section, Z = ρ L / A. This formula, in 
general, has prediction errors like the electric-volume model based on the tissues 
anisotropy (current conduction is not constant in different directions), human body 
geometry different than a cylinder or the biological variability among subjects with 


        

(a)
Z = R2 + Xc2 Φ = arctan Xc
R


(b)
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different body composition and body geometry (Kushner, 1992; Lukaski, 1996; 
Piccoli et al., 2005). 
When a current under 10 GHz is used to go through soft tissues, there are three 
different frequency intervals due to dispersion phenomena and dielectric relaxation 
(Schwan, 1957). Each of these frequency zones has a concrete name: alfa (related 
with low frequencies, Hz) beta (related with middle frequencies, kHz) and gamma 
(related with high frequencies, GHz) (Figure 5). At high frequencies the current 
penetrates cells, whereas at low ones the current moves around cells. Multi-
frequency measurements can provide a precise index of extracellular water (ECW), 
total body water (TBW) and free fat mass (FFM), but is very complex, has high 
instability, low repeatability (there are a lot of inter-individual differences in the 
distribution of fluids) and is still under investigation. On the other hand, mono-
frequency with 50 kHz measurement that has a maximum Xc and Pa value among 
the 1 kHz-1 MHz range, it is validated by bioimpedance spectroscopy (BIS) following 
the Cole’s model approach (Figure 6) and predominantly intervene polarization and 
relaxation phenomena in the interfaces, especially in the cell membrane. For this 
reason, in body tissues with a clinical objective, 50 kHz is the optimum frequency to 
use in the alfa frequency zone far below the thresholds of human body perception 
(Piccoli et al., 2005). Also at 50 kHz the measurement error (as coefficient of 
variation) of the standard mono frequency technique is small, around 2% (Piccoli et 
al., 2002b). 
                    
Figure 5. Dispersion regions for biologic tissue proposed by Schwan (Schwan, 
1957). 
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Figure 6.  (a) In body composition analysis, the semi-circle of Cole’s model for cell 
suspension is utilized. (b) The curve formed by Z vectors on the R-Xc plane 
(impedance locus) is a semicircle with a depressed center; smaller versus larger 
circles correspond to a more versus less hydrated status as progressive tissue 
dehydration increases tissue impedance. (R: resistance; R0: resistance at 0 
frequency; R∞: at infinity; Xc: reactance). Retrieved from Piccoli et al. (2005). 
1.2 Bioimpedance measurements 
BIA measurements, depending on the position of the electrodes, can be useful to 
analyze the body composition of the whole-body or of some body regions. 
Measurements are made at 50 kHz, with the phase-sensitive analyzer BIA-101 
Anniversary Sport Edition (AKERN-Srl, Florence, Italy) injecting a sinusoidal 
alternating current at 245 µARMS to measure R and Xc, with an error of system 
measurement, determined with a precision resistor and a capacitor (<1 Ω for R and 
<2% for Xc). The contact electrodes used (two for injecting of current I and two for 
detecting voltage V) are single-use pre-gelled Ag/AgCl Covidien Ref. 31050522 
(Covidien llc, Mansfield, IL, USA) because they present very low intrinsic impedance 
(Nescolarde et al., 2016).  
1.2.1 Whole-body bioimpedance 
Four electrodes are placed (tetra-polar measurement) with the individual in supine 
position: two electrodes (an injector I, and a detector V) are placed in the dorsal face 
of 3rd right metacarpal’s head and in the dorsal face of the right carpometacarpal 
joint, respectively; two more electrodes, an injector and a detector, are placed in the 
dorsal face of 3rd right metatarsal’s head and in the dorsal face of the right 
tarsometatarsal joint, respectively (Figure 7). 
(a)


(b)
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With the configuration shown in Figure 7, under uniform hydration conditions (Foster 
and Lukaski, 1996; Houtkooper et al., 1996; Lukaski, 1996; Ellis, 2000; Grimnes and 
Martinsen, 2000), the total bioimpedance is composed of: 
- 50% of total bioimpedance is determined by lower limbs. 
- 40% of total bioimpedance is determined by upper limbs. 
- 10% of total bioimpedance is determined by the rest of the body.  
           
Figure 7. Electrode configuration, injectors and detectors (I,V), for standard 
measurement or whole-body.  
Whole-body bioimpedance has the main objective to analyze hydration and nutrition 
changes in a non-invasive, fast, and repetitive method. For this reason there are 
many medical applications derived in different areas (Lukaski and Piccoli, 2012; 
Lukaski, 2013) like nephrology (Maioli et al., 2018; Nescolarde et al., 2004; Piccoli et 
al., 1994, 1995 and 1998; Tabinor et al., 2018), cardiology (Gastelurrutia et al., 2010; 
Massari et al., 2019; Nuñez et al., 2016; Santarelli et al., 2017), children and 
newborns (De Palo et al., 2000; Piccoli et al., 2002c), obese adults (Piccoli et al., 
1998), patients undergoing peritoneal dialysis and hemodialysis (Nescolarde et al., 
2008; Piccoli, 2004; Piccoli et al., 2005) among others. Also, in an elite sport where 
the nutritional condition and hydration is very important, whole-body BIA has been 
assessed. One example is in professional soccer players, showing how an increment 
in the resistance (R) is translated into dehydration and a decrease from the 
reference value is translated into a hydration status (Bonuccelli et al., 2011; Gatterer 
et al., 2011).  
V    I
V         I
Chapter 1 11
1.2.2 Localized bioimpedance 
Another way to measure bioimpedance is by means of a localized four-electrodes 
measurement, known as L-BIA, where the two injector electrodes (I) and the two 
detectors (V) are placed on the area to be analyzed (Figure 8). This non-invasive 
method in the muscle assessment is supported by magnetic resonance imaging 
(MRI) and ultrasound (US) (Nescolarde et al., 2013, 2015 and 2017). 
The L-BIA is useful because it measures the electrical variables of the changes that 
are produced by reactance (Xc), which identifies tissue destruction, and resistance 
(R), which identifies liquid content reorganization (Lukaski and Piccoli, 2012). For 
this reason it has been used as a non-invasive evaluation of muscle structure in 
patients with muscle atrophy (Rutkove, 2009), to identify regional alterations in fluid 
balance and soft tissue injuries associated with wounds in the lower part of the leg 
(Lukaski and Moore, 2012), and on the four main groups of the lower extremities to 
establish a pattern of muscle injury. In professional football players, L-BIA is used to 
assess muscle injury (Nescolarde et al., 2013 and 2015), and a follow-up until the 
return to play according to muscle gap (Nescolarde et al., 2017) finding a pattern of 
reduction in R and Xc directly related to the severity of the muscle injury according to 
cell disruption, being more pronounced this decrease (-12 to -56%) in the reactance 
(Xc). These findings highlight the sensitivity of L-BIA to identify fluid accumulation 
and muscle cell disruption. 
Figure 8. Location of the L-BIA electrodes in (a) twin muscle in Menorca Ultra Trail 
and (b) hamstring muscle in the Barcelona Marathon. 
(a) (b)
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1.3 Bioimpedance measurement interpretation 
Regarding body composition analysis based on impedance, two main interpretations 
can be found. Whole-body or right-side bioimpedance is the standard assessment, 
performed in the right side of the body, considering it as a cylinder with a given 
height and constant section area (Kushner, 1992; Lukaski et al., 1986). The 
conventional whole-body BIA equations are only accurate in healthy people, 
equations that are useful to estimate the body compartments like FFM, TBW, FM, 
ECW, ICW, among others (Nescolarde et al., 2008). Also, Bioelectrical Impedance 
Vector Analysis BIVA used in the classification and ranking of hydration status in 
conditions with perturbations in fluid balance is very expanded (Lukaski and Piccoli, 
2012). One of the BIVA main advantages is its independence from the use of body 
weight and from any assumption about constant soft tissue hydration and chemical 
composition of the fat-free body mass. BIVA only depends on its reproducibility and 
accuracy measurements and the body composition intraindividual variability 
(Nescolarde et al., 2016). 
1.3.1 Conventional bioelectrical impedance methods 
The standard Bioelectrical Impedance Analysis (BIA) is measured between the right 
arm and the right leg as shown in Figure 7. Based on this measurement, body 
compartments (FFM, FM, ECW, ICW, etc) are estimated using multiple regression 
equations that include one of several terms related to the measured impedance and 
additional anthropometric terms like stature, weight, age, and gender.  
There are equations to estimate volumes (intracellular, extracellular), mass (fat, fat-
free, cellular), basal metabolism, and other variables (cellular Na/K, body density, 
etc). For example, total body water (TBW) is estimated using the impedance 
component R, the FFM is estimated assuming constant soft tissue hydration or the 
fat mass is calculated as the difference between the FFM and the body weight. In 
most of the regression equations, the Xc component is ignored (Ellis, 2000; 
Houtkooper et al., 1996; Piccoli et al., 2002b; Sun et al., 2003). 
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1.3.2 Bioelectrical Impedance Vector Analysis (BIVA) 
The BIVA method (Piccoli et al., 1994) uses the measurement of the standard tetra-
polar whole-body configuration as shown in Figure 7 (Lukaski et al., 1986). In 
contrast to other bioimpedance methods, BIVA does not yield any absolute estimate 
of ECW, ICW or TBW, makes no assumptions about body tissue isotropy or body 
models, hydration state, or the electrical model of cell membranes and it is 
unaffected by regression adjustments.  
The impedance vector, the resistance R and the reactance Xc, are normalized by the 
height of the individual (R/H and Xc/H) and represented in the RXc graph (abscise R/
H, ordinate Xc/H) (Figure 9). This technique allows the variations to be identified 
graphically with respect to the hydration of an individual or the amount of soft tissue, 
comparing the impedance vector with the distribution of the vectors of the reference 
population. The individual’s vector is compared against the normal interval of the 
reference population, expressed in percentiles of 50%, 75% and 95% of the normal 
distribution (Gaussian) bivariate, probabilistic graph (Piccoli et al., 1994 and 1995). 
The correlation between R and Xc determines the ellipsoidal form of bivariate 
probability distributions (Lukaski and Piccoli, 2012).  
If it is considered that the R is inversely proportional to the water content and the Xc 
directly proportional to the content of body cell mass contained in the soft tissues, 
the clinical interpretation of Figure 9 is as follows: variations in hydration, without an 
alteration of tissue mass-structure, are associated with a shortening (hyper-hydrated) 
or an enlargement (dehydrated) of the vector in the greater axis direction of the 
tolerance ellipses. On the other hand, variations in the structure of soft tissue are 
associated with a migration of the vector in the smaller axis direction of the ellipses, 
with either an increase in the phase angle (obese, athletic) or a decrease in it (lean, 
cachectic). Combined variations of hydration and nutrition are associated with the 
migration of the vector in the direction of the union of the two principal directions 
(Piccoli et al., 2002a).  
The RXc graph method allows different evaluations of an individual vector:  
- The parallel displacements to the major axis of tolerance ellipses indicate 
progressive changes in tissue hydration whereas displacements parallel to the 
minor axis are associated with changes in cell mass, contained in soft tissues. 
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Different trajectories indicate combined changes in both hydration and tissue 
mass. 
- Evaluation of bioimpedance follow-up through the trajectory of the successive 
measurements of the impedance vector. 
- Evaluation of groups of subjects using the bivariate 95% confidence ellipses of the 
mean vectors. 
The applications of BIA measurements phase-sensitive at 50 kHz in the BIVA model 
are increasing, since apart from being used in the evaluation of global hydration, 
progress is being made in a variety of clinical conditions and in the evaluation of 
malnutrition, especially in diseases with muscle loss when hydration is altered. The 
position of the BIVA vector is easily interpreted as a normal or abnormal hydration 
based on the distance of the mean vector, but also its shortening or lengthening 
serves to interpret the response to the progression of a physiological process, a 
pathology or an intervention because it is reflected as a change in hydration (gain or 
loss of fluids) (Lukaski et al., 2019). 
 
Figure 9. BIVA pattern (RXc graph). The three tolerance ellipses represent the 50th, 
75th and 95th percentiles of the impedance vector bivariate normal distribution of a 
reference population of healthy caucasian males. Retrieved from Piccoli et al. (1994, 
2002c). 
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2. Endurance exercise and skeletal muscle  
2.1 Muscle tissue 
Muscle is one of the four primary tissue types in the body and is responsible for most 
types of body movement, maintain postures, stabilize joints, and generates heat 
(Table 1). 
Table 1. Main characteristics of Skeletal and Cardiac muscle (smooth muscle not 
shown). Adapted from Marieb, Human Anatomy and Physiology (2004). 
Skeletal muscle is the largest tissue in the body and is composed of a number of 
elongated cells known as fibers. The muscle fiber or myocyte grouped into fascicles 
is composed of parallel myofibrils (Figure 10), a sarcomere as the functional or 
contractile unit, a cell membrane called the sarcolemma, mitochondria arranged 
under this membrane and between myofibrils. The muscle cytoplasm is called 
sarcoplasm. In addition, the muscle fiber has multiple nuclei permitting the 
production of large amounts of proteins and enzymes needed for muscle contraction, 
and has a specialized smooth endoplasmic reticulum called sarcoplasmic reticulum 
that stores, releases, and retrieves calcium ions (Ca+2) (Marieb, 2004). There are 
two main components of skeletal muscle that make the contractile function possible 
and efficient: myofibers and connective tissue. Each myofiber is attached at both 
ends to the connective tissue of a tendon or tendon-like fascia. The connective 
tissue provides the framework that binds the individual muscle cells during muscle 
contraction and embraces the capillaries and nerves within the muscular structure 
(Jarvinen, 2005).  
Skeletal muscle Cardiac muscle
Description Long, cylindrical, striated with multinucleate cells.
Branching, striated with generally 
uninucleate cells.
Function
Voluntary movement; locomotion; 
manipulation of the environment; 
facial expression; voluntary control
As it contracts, it propels blood into 
the circulation; involuntary control
Location In skeletal muscles attached to bones or occasionally to skin
The walls of the heart
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The skeletal muscle is heterogeneous in nature and the selective recruitment of 
motor units enables a muscle to respond in the best manner to the functional 
demands. This heterogeneity is the base of the flexibility which allows the same 
muscle to be used for different tasks, for example, continuous low-intensity activity 
(posture), repeated sub-maximal contractions (locomotion), or fast and strong 
maximal contractions (jumping, kicking). In addition, due to the structural and 
functional properties of the fibers, the muscle has plasticity or malleability and can 
change in response to hormonal and neural influences, nerve-activity being a major 
determinant of the fiber type profile (see 2.1.1) (Schiaffino and Reggiani, 2011). 
Figure 10. Muscle fiber organization. Retrieved from Hedegard and OpenStax, 
Anatomy and Physiology: Support and Movement (2014).
The striated muscles (skeletal and cardiac) begin the contracting process 
(shortening) when the actin protein (thin filament) is pulled by the protein myosin 
(thick filament) by cross-bridges between them. The contraction occurs after specific 
binding sites on the actin have been exposed in response to the interaction between 
calcium ions (released from the sarcoplasmic reticulum) and proteins (troponin and 
tropomyosin) (Figure 11). 
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Figure 11. (a) Sarcomere structure with actin and myosin units as main proteins (b) 
Contraction sequence. Retrieved from Hedegard and OpenStax, Anatomy and 
Physiology: Support and Movement (2014). 
The contraction cannot take place if ATP is not supplied as an energy currency. 
Thanks to ATP energy, the active-transport Ca+2 pumps in the sarcoplasmic 
reticulum can work. But the amount of ATP stored in muscle is very low (only 
sufficient to power a few seconds worth of contractions), and when it’s used, it must 
be quickly regenerated and replaced to maintain a sustained contraction. Then there 
are three ways to regenerate ATP: creatine phosphate metabolism, anaerobic 
glycolysis, and aerobic respiration (Figure 12). 
Thanks to the energy contained in phosphate bonds that the creatine phosphate 
molecule has, more ATP can be made for about 15 seconds. Creatine kinase (CK) is 
the enzyme responsible to catalyze the reaction that creatine phosphate transfers its 
phosphate back to ADP to form ATP and creatine (Figure 12a). But after this short 
period of time the muscle needs more ATP to maintain the contraction and then 
switch to glycolysis, an anaerobic (non-oxygen-dependent) process that breaks 
down glycogen to produce ATP (but not as fast as creatine phosphate does). The 
glucose used in this mechanism mainly come from glycogen stored in the muscle. 


(a)


(b)
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The two pyruvic acid molecules obtained with two ATP, can be used in the aerobic 
process converted to lactic acid (which quickly dissociates to lactate and hydrogen 
ion) (Figure 12b). Depending on the process then, glycogen from muscle reserves 
can go anaerobically to lactate or aerobically to pyruvic acid. 
Aerobic respiration takes place in mitochondria with oxygen and is the breakdown of 
glucose and fatty acids to produce carbon dioxide, water, and ATP. This mechanism 
provides most of the energy needed for resting or moderately active muscles (Figure 
12c). Another source of energy in long distance running are amino acids, which can 
be metabolized to produce glucose (Alberts et al., 2002). 
 
Figure 12. Three mechanisms by which ATP can be regenerated: (a) creatine 
phosphate metabolism, (b) anaerobic glycolysis and (c) aerobic respiration. 
Retrieved from Hedegard and OpenStax, Anatomy and Physiology: Support and 
Movement (2014). 
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2.1.1 Muscle training 
There are large inter-individual responses to exercise training and huge differences 
in performance between individuals along with the role of genetic and epigenetic 
factors that affect them (Bouchard et al., 2011). During muscle contraction, there are 
tones of conversions of molecular events to chemical, electrical, and mechanical 
signals that promote physiological responses. These responses produce adaptations 
that can go from the activation and/or repression of specific signaling pathways 
regulating exercise-induced gene expression and protein synthesis and/or 
degradation (Hawley et al., 2014), to changes in contractile function, mitochondrial 
function, or metabolic regulation (Egan and Zierath, 2013). When someone is 
trained, moderate aerobic exercise produces only minimal increases in oxidative 
stress and inflammation, as opposed to the effects produced due to intensive training 
or excess exercise when one is poorly trained. This is partly because the training 
increases the activity of antioxidant enzymes and exerts a protective effect on 
cytoskeletal proteins (Brancaccio et al., 2010).  
There are two basic types of training on which its effect is studied: endurance versus 
resistance exercise training. Endurance training is what we refer to as aerobic 
exercise (run, bike, walk, swim,...). In contrast, resistance training involves "pumping 
iron" and improving muscle strength and endurance. Resistance and endurance 
exercises induce different protein synthesis and depend on the training level. 
Resistance exercise training results in increased strength and muscle fiber cross-
sectional area. Endurance exercise training is characterized by fatigue resistance 
due to increased oxidative capacity and mitochondrial density (Wilkinson et al., 
2008). 
In addition, it has been studied that the skeletal muscle has certain plasticity and 
adapts its response to a given exercise by converting one fiber into another. Different 
fiber types have been identified due to their contractile characteristics (they contain 
different myosin isoforms): type I (‘‘slow-twitch fibers’’ with high oxidative potential), 
type IIa (‘fast-twitch’ myofibers with high oxidative potential but a rapid fatigue profile) 
and type IId/x (primarily glycolytic) (Figure 13). Endurance training can change the 
myofibrillar content in muscle fibers by expanding mitochondrial and vascular 
networks (Rowe et al., 2014) or by enhancing the oxidative potential of type IId/x 
fibers (and thus significantly surpassing the aerobic capacity of type I fibers of 
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untrained persons) (Hawley et al., 2014). The pathways affected in fast or slow 
muscle fibers differ, specifically the metabolic fuel of glucose, lactate, and fatty acids 
(Figure 14). The variety of responses to exercise is a fact, each person has to act in 
consequence and program the right training for the objective to achieve, taking into 
consideration which fiber will be needed most. 
                       
Figure 13. Outline of the muscle fiber types ranging from fast and glycolytic fibers to 
slow and mostly oxidative fibers. Retrieved from Rowe et al. (2014). 
In addition to muscle typology there are other factors that determine the aerobic 
performance (Borresen and Lambert, 2009; Coyle, 1995): 
• The economy of movement: defined as the oxygen cost to exercise at a given 
exercise intensity (velocity or %VO2max).  
• The lactate threshold: defined as the exercise intensity (velocity or %VO2max) at 
which blood lactate increases significantly above the baseline level. Lactate 
threshold has been proposed as a measure of endurance fitness and also as a 
means to standardize training intensity, but it has limitations because its 
concentration depends on many variables. Lactate concentration can be influenced 
by exercise duration, intensity, rate of change, prior exercise, diet, muscle glycogen 
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content as well as exercising with damaged muscles, training status, and 
overtraining. In any case, the intensity of exercise required to induce optimal 
physiological adaptations for resistance events has been suggested as that which 
causes a lactate concentration of approximately 4 mmol/L. World-class athletes, for 
example, have a lactate threshold of 70-90% compared to 50-60% in untrained 
individuals (Finsterer, 2012). 
• The individual perception of the effort conditions, the intensity and duration of the 
exercise, and is inherent to the physiological stress experienced during the 
exercise. It has been demonstrated how the Borg scale (RPE, rating of perceived 
exertion) is a valid measure of this perception (Foster et al., 2001). 
A runner's performance is limited when they reach their maximum oxygen 
consumption (VO2max), from which they can no longer burn more fuel for energy. 
VO2max is defined as the maximum amount of oxygen that an athlete can absorb, 
transport and use to produce the energy needed to allow maximum intensity effort. 
For a healthy adult human at rest, whole-body oxygen consumption (VO2) averages 
about 3.5 mL/kg/min which corresponds to one MET (metabolic equivalent of a task 
or to perform the activity). The 20%–25% of this consumption is used by resting the 
skeletal muscle, and for example a 70 kg person, whose resting O2 consumption is 
250 mL/min, the skeletal muscle will use 50 mL/min. In healthy untrained adults, 
VO2max is typically 10–15 times resting values (35-53 mL/Kg/min), while in elite 
endurance-trained athletes, VO2max values can exceed 85 mL/kg/min (Hawley et al., 
2014). Some examples of incredible VO2max in elite athletes can be the runner Kilian 
Jornet with 92 mL/kg/min, the cyclist Miguel Indurain with 88 mL/kg/min or the cross-
country skier Bjørn Erlend Dæhlie with 96 mL/kg/min (TopendSports, 2019). 
A runner with a VO2max of 53 mL/kg/min, a maximal intensity in MET’s can be 
calculated using the equation: 
Maximal Intensity = [53 mL/kg/min] / [3.5 mL/kg/min] = 53 / 3.5 = 15.14 METs 
A MET is equivalent to 0.0175 Kcal/kg/min and thus it is possible to convert the 
METs to Kcal/min with the formula: Kcal/min = MET x 0.0175 x weight (kg). 
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Figure 14. Pathways related to glucose, lactate, and fatty acid metabolism in fast 
(red arrows) or slow (green arrows) muscle fibers. DHAP, dihydroxyacetone 
phosphate; GLUT4, glucose transporter 4; F-6-P, fructose-6-phosphate; FAT/CD36, 
fatty acid translocase; FFA, free fatty acids; F-1,6-P, fructose-1,6-bisphosphate; 
F-2,6-P, fructose-2,6-bisphosphate; G-3-P, glyceraldehyde-3-phosphate; G-6-P, 
glucose-6-phosphate; GPD1, glycerol-phosphate dehydrogenase 1 (cytoplasmic); 
GPD2, glycerolphosphate dehydrogenase 2 (mitochondrial); HK, hexokinase; LDH, 
lactate dehydrogenase; MCT1, monocarboxylic acid transporter 1; MCT4, 
monocarboxylic acid transporter 4; PDH, pyruvate dehydrogenase; PFK, 
phosphofructokinase; PFKFB3, phosphofructokinase-fructose bisphosphatase 3; TG, 
triglycerides. Retrieved from Schiaffino and Reggiani (2011). 
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Each physical activity and depending on the intensity has assigned specific METs 
(Table 2), for example 1 MET is the rate of energy expenditure while at rest and 4 
MET activity expends 4 times the energy used by the body at rest. MET values of 
activities range from 0.9 (sleeping) to 23 (running at 22.5 km/h or a 4:17 mile pace) 
(Ainsworth et al., 1993 and 2000). 
Table 2. MET metabolic equivalent task of some main activities and its equivalent in 
Kcal/min for a person with 70 kg weight. mph, miles per hour. Adapted from 
Ainsworth et al. (1993, 2000). 
Type of activity Activity characteristics MET Kcal/min  (person of 70 kg)
Inactivity
sleeping 0,9 1,10
lying quietly 1 1,23
Home activities cleaning house or cabin 3 3,68
Walking
backpacking 7 8,58
downstairs 3 3,68
hiking, cross country 6 7,35
3 mph, moderate pace, firm surface 3,3 4,04
Bicycling
<10mph, general,leisure 4 4,90
14-15,9 mph, racing or leisure, fast, vigorous effort 8 9,80
>20 mph, racing, not drafting 16 19,60
Running
jogging 7 8,58
6 mph 10 12,25
10 mph 16 19,60
cross-country 9 11,03
stairs, up 15 18,38
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2.1.2 Muscle fatigue 
Physical fatigue is the transient inability of a muscle to maintain optimal physical 
performance. During physical exercise, fatigue is a multifactorial symptom that may 
be related to both central and peripheral factors, all of which can be influenced by 
the intensity and duration of the exercise, the nutritional intake, and the training 
status of the individual (Blomstrand, 2006).  
Peripheral fatigue can be due to depletion of muscle glycogen (chronic fatigue) or 
phosphocreatine, accumulation of protons from acid lactic (acute fatigue), and failure 
of neuromuscular transmission. Muscle function is reduced when ATP reserves 
(needed for normal muscle contraction) decline. The induced acidosis of lactic acid 
can accelerate fatigue during high-intensity exercise in events that last from 1 to 10 
minutes, but in marathons and ultramarathons lactic acid provides benefits. This 
lactic acid or lactate/H+ can be converted back into pyruvic acid to be metabolized 
with oxygen, or it can be reconverted into glucose mainly at the renal and hepatic 
level, and also this glucose can replenish glycogen stores in the muscles (Cairns, 
2006).  
Central fatigue due to neurobiological factors is less well known. During the 
prolonged exercise of moderate intensity, fatigue comes when blood glucose levels 
decrease. This decrease is due to a depletion of the liver glycogen stores or an 
increase in neurotransmitter release like 5-hydroxy-tryptamine (5-HT). It has been 
studied how a BCAA ingestion can delay fatigue due to a tryptophan decreased 
transport into the brain with a decrease in 5-HT synthesis (Blomstrand, 2006). Also, 
there is a ‘‘central governor model’’ (CGM) that can explain fatigue under all of the 
exercise conditions that have previously been attributed to task dependency as a 
general model of fatigue. This CGM explains how the subconscious brain determines 
the number of motor units that are activated and thus determines the intensity of the 
exercise. When there is a difficulty in maintaining homeostasis at a given intensity of 
exercise, the subconscious brain informs the conscious brain that it interprets it as 
an increase in the sensation of fatigue (Weir et al., 2006). When a runner’s 
oxygenation reaches the limits of what is safe, the brain’s motor cortex (which 
recruits the exercising muscles) stops recruiting additional muscle and the body 
experiences fatigue. The work output stopped by muscle and heart, reduces the 
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heart oxygen demand and protects the body from damage caused by oxygen 
starvation (Noakes, 2002). 
2.1.3 Muscle damage and injury 
If we analyze only the adverse effects when we practice moderate aerobic exercise, 
there are two main types of risk: the risk of injuries in the locomotor system (0.19 to 
1.3 injuries per 1000 hours of physical exercise is observed, which is equivalent to 
one injury per person every 4 years) and the cardiovascular risk (sudden death and 
acute myocardial infarction, generally in people with underlying structural heart 
disease) (Subirats et al., 2012). But marathon and ultramarathon events are not 
moderate aerobic exercises, they are severe bouts of running exercise that 
comprises a distance of 42.195 km or more. Unlike marathons, ultramarathons occur 
in more extreme environments with variations in terrain, temperature and humidity, 
particular factors that may contribute to injury and illness (Krabak et al., 2013). More 
than 25% of the new runners face an ultramarathon in a period less than three years 
after starting, which leads to possible health problems that can become serious. For 
example, there are more stress fractures involving the foot especially in less 
experienced runners (Hoffman and Krishnan, 2014) and there are lower extremity 
running injuries predominantly in the knee that can be reduced by an increase in 
training distance per week (Gent et al., 2007). Regarding an asphalt marathon, there 
is eccentric hamstring fatigue that may be a potential risk factor for knee and soft 
tissue injuries during the run (Koller et al., 2006), these injuries are very common 
among recreational male marathoners (Middelkoop et al., 2008). It has been seen 
that training diminishes the muscle fiber injury adding sarcomeres to regenerate 
fibers (Proske and Morgan, 2001) or protecting the mitochondria integrity (Carmona 
et al., 2018). For this reason, training is a powerful tool to protect us. 
According to Guerrero et al. (2008), our muscles are made up of a mixture of slow 
and fast-twitch fibers with approximately 50% of each, very different compared to 
animals, which have only one fiber predominantly, and fast fibers are more easily 
fatigued and more sensitive to injury. Even though the skeletal muscle has certain 
plasticity and adaptability, numerous issues relating to the speed, force, duration, 
and intensity of muscle contractions, along with the total muscle mass engaged in 
the activity, are important for a complete understanding of the physiological 
responses to exercise. A sarcomere disruption, a loss of sarcolemma integrity, a loss 
26 2. Endurance exercise and skeletal muscle 
of mitochondrial integrity, an increase of membrane permeability, a disintegration of 
the Z-discs, contracture knots, and/or accumulations of erythrocytes and phagocytes 
within the muscle fibers lead to the presence of enzymes in the blood that are 
normally located in muscle fibers.  
The muscle damage that the runners can suffer, increase both with intensity and 
duration of the exercise, with intensity the greater influence (Armstrong, 1986). The 
symptoms of muscle pain (from 1 to 7 days following the race), spasms or some 
swelling, may occur as a result of injury or when the muscle produces more physical 
work than it is used to produce (Brancaccio et al., 2010). But before a muscle is 
injured, there are three main phases of muscle damage that can occur with exercise 
(Noakes, 2002): 
1st: After hours of unaccustomed exercise in trained athletes there’s a leakage of 
moderate amounts of muscle enzymes into the bloodstream, peaking at 24-48 h 
after exercise. 
2nd: After 4 to 6 days of unaccustomed eccentric exercise in untrained athletes 
there are much higher rates of enzyme leakage into the blood, infiltration of muscle 
by inflammatory cells, and degeneration of muscle cells, with the latter peaking 
10-12 days after exercise. Initiation of an inflammatory response 24-48 h after 
exercise, stimulates nerve endings in the damaged tissue, causing the typical pain of 
delayed soreness. The Z-band of the sarcomere is the most affected and its 
disruption provokes a release of protein breakdown products that lead to fluid 
accumulation and swelling of the muscles, then the intramuscular pressure elevates 
and increases the muscle soreness. 
3rd: Tissues can be damaged by the free radicals released when the oxygen is used 
actively. These radicals attack cell membrane lipids and damage them in a 
peroxidation reaction. 
The most common muscle injury to marathoners are (Noakes, 2002):  
- Delayed onset muscle soreness (DOMS): muscle discomfort 24 to 48 h after 
unaccustomed or particularly severe exercise, especially if it involves eccentric 
muscle contractions, due to muscle damage, in particular, the connective tissue 
and the contractile proteins. 
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- Exertional muscle cramps tend to appear in people who run farther or faster than 
the distance or speed to which they are accustomed to. Only muscles that 
undergo lengthening frequently during prolonged exercise may be prevented from 
cramping. Runners with cramps don’t have gross disturbance in blood electrolyte 
levels, and they are not more dehydrated than the runners without cramps. 
As Armstrong (1986) and Noakes (2002) described, 3 proposed mechanisms work in 
concert to produce DOMS following eccentric exercise: structural damage to muscle, 
disruptions in calcium homeostasis, and/or sensitization of type IV nerve endings by 
means of the products of invading inflammatory cells. But recent reviews of muscle 
inflammation post-injury provide more comprehensive details of this complex and 
highly coordinated response (Figure 15) (Hyldahl and Hubal, 2014). 
 
Figure 15. Theoretical framework summarizing possible mechanisms for delayed 
muscle soreness following eccentric exercise. In response to strain (1) from 
eccentric actions, cc-chemokines and other signaling proteins are produced and 
released (2) from damaged or stimulated myofibers. Also chemokine release may be 
from interstitial cells residing in the extracellular matrix (dotted line). Chemokines 
enter the circulation (3), and recruit inflammatory cells (4). Inflammatory cells 
infiltrate the skeletal muscle (5) and release chemical mediators such as bradykinins 
(BDK), and prostaglandins (PTG E2) (6), which may act directly on muscle 
nociceptors to produce muscle soreness, or bind to extracellular receptors (7) and 
up regulate the expression of proteins (i.e., nerve growth factor) (8) that are excreted 
from the muscle fiber and act on muscle nociceptors to produce soreness (9). 
Retrieved from Hyldahl and Hubal (2014). 
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2.2 Muscle blood biomarkers  
One of the ways to objectively measure physiological or pathogenic processes in the 
body that occur during a marathon is through biomarkers (biological markers). These 
are measurable products or substances of an organism that are used as indicators 
of a biological state. Specifically in this chapter, the biomarkers assessed are from 
the cytosol (not from the cell structure) and indicate a change in the expression or 
state of a protein that correlates with muscle damage and inflammation. 
2.2.1 Muscle damage biomarkers 
When exercise intensity exceeds the aerobic range, membrane permeability 
changes and enzymes are released. When a load of muscle tissue exceeds a 
certain limit, creatine kinase (CK) and other intracellular proteins are filtered in the 
interstitial fluid, absorbed by the lymphatic system and returned to the circulation 
(Brancaccio et al., 2010). 
Creatine kinase 
Creatine kinase (CK) is a dimeric globular protein with a molecular mass of 43 kDa 
for each subunit. As seen in Figure 12a, it catalyzes the reversible exchange of high-
energy phosphate bonds between phosphocreatine and ADP produced during 
contraction.  
At least five isoforms of CK exist and are tissue-specific: three isoenzymes in the 
cytoplasm (CK-MM, CK-MB and CK-BB) and two isoenzymes (non-sarcomeric and 
sarcomeric) in mitochondria. On injured tissues, CK isoenzymes can give specific 
information because of their localization. In fact, CK-MM is found in several domains 
of the myofiber where ATP consumption is high and is a marker of muscle disease, 
CK-MB increases in acute myocardial infarction, CK-BB increases in brain damage 
and mitochondrial CK is raised in mitochondrial myopathies (Brancaccio et al., 
2007). 
Since the beginning, creatine kinase found almost exclusively in muscle tissue 
(skeletal and cardiac), has been considered the best indicator of muscle damage 
after an exercise such as a marathon (Apple et al., 1985). The reason is mainly 
mechanical because it starts with the damage of the structure of the skeletal muscle 
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cells at the level of sarcolemma and Z disks as already mentioned in section 2.1.3. 
Normally, only CK-MM is present in the serum, but prolonged and strenuous 
exercise increases the serum activity of all three CK-isoenzymes in the absence of 
myocardial damage. As total CK is not fiber-type-specific, other biomarkers have 
been used in order to characterize the exercise impact on muscle fibers, like slow 
and fast myosin as indirect biomarkers of fiber-specific sarcomere damage 
(Carmona et al., 2018). 
CK activity is markedly elevated for 24 h after exercise, remains elevated for 48 h 
and can be pronounced between 2-7 days when there is muscular damage due to 
an eccentric exercise. This elevation after exercise is usually lower in trained 
individuals when compared with untrained ones, but also depends on age, gender, 
race, muscle mass, physical activity, and climatic condition. In addition, a large 
increase in serum CK levels combined with reduced exercise tolerance could be an 
overtraining marker (Brancaccio et al., 2007). 
In the context of marathons and ultramarathons, some studies have reported that 
over half of marathon participants have elevated unspecific creatine kinase 24 h 
after, which can exceed 2400 IU/L (remaining 15-fold above baseline for over a 
week) and in ultramarathon distances, nearly 6-10% of the runners recorded values 
>100,000 IU/L (Bird et al., 2014) and without apparent health consequences 
(Hoffman et al., 2012). 
With all the aforementioned, a certain degree of skeletal muscle breakdown is 
expected from endurance exercise, especially if this exercise is longer or more 
intense than a runner is accustomed to. But when many skeletal muscle cells break 
apart, they release CK along with electrolytes like potassium and calcium, and 
myoglobin, the protein from the muscle tissue. The precipitation of this protein in 
blood can damage the kidney blocking the tube-like filters and then electrolytes can 
build up in the blood causing cardiac arrhythmias. This “striated muscle breakdown” 
due to exercise is called exertional “rhabdomyolysis”, and even though it appears in 
marathon and ultramarathon runners, only a few cases are clinically significant (even 
with CK levels greater than 100,000 IU/L). Signs of clinically significant 
rhabdomyolysis are: generalized muscle pain or weakness out of proportion to the 
effort, dark-colored urine or the inability to urinate 12-24 h post-race. Risk factors for 
exertional rhabdomyolysis are: unaccustomed and/or eccentric exercise, heat/cold, 
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dehydration/over hydration, nonsteroidal anti-inflammatory drugs (NSAID) and other 
medication use, current infection, male sex and genetic predisposition (Scalco et al., 
2016). Some ways to avoid rhabdomyolysis are specific training and proper 
hydration. 
Lactate dehydrogenase 
Lactate dehydrogenase (LDH) is a tetramer with a molecular mass of 144 kDa. It is a 
hydrogen transfer enzyme that is found in the cytoplasm of most body cells and its 
isoenzymes are tetramers of either heart (H) or muscle subunits (M). All tissues 
contain various amounts of the 5 LDH isoenzymes; however, muscle, liver, and red 
blood cells are the major sources of serum LDH activity (Markert, 1984). 
LDH is a glycolytic enzyme that catalyzes the conversion of lactate to pyruvate, 
whereas NAD+ is reduced to NADH or vice versa, during glycolysis in conditions of 
hypoxia. It is found in almost every tissue, especially in skeletal muscle, heart, liver, 
kidneys, brain, lungs, and red blood cells.  
Serum LDH activity is a marker of cell/tissue damage, and the specific increase in 
isoenzymes may be helpful for the diagnosis in non-traumatic acute rhabdomyolysis. 
Its elevation in serum can contribute to muscle and liver damage, common injuries 
and disease such as heart failure and cardiac stress (Lippi et al., 2011). Also, 
exercise induces a significant increase in LDH and the degree of this increase 
depends on the intensity and duration of the effort and its peak can be observed 
within 48 to 72 h after the effort. After prolonged endurance exercise like a marathon, 
the LDH activity can be doubled and remain increased for 2 weeks (Brancaccio et 
al., 2010). 
The normal range of serum LDH in a healthy adult is 50-150 U/L, and after a 
marathon especially when the pace is reduced due to muscle damage, LDH values 
can increase nearly to 700 U/L (Del Coso et al., 2013) or 1000 U/L after an 
ultramarathon (Shin et al., 2016). 
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2.2.2 Inflammation biomarkers 
C-reactive protein 
C-reactive protein (CRP) is a member of the pentraxin proteins with a molecular 
mass of 118 kDa. It has five non-covalently bonded and non-glycosylated identical 
subunits of 206 amino acids each that form a disk-shaped pentagon. 
CRP is a pattern recognition protein found in blood plasma and it is an integral part 
of the innate immune system. It was discovered by Tillet and Francis in 1930 in 
patients with acute pneumococcal pneumonia, where CRP interacted with the C-
polysaccharide of streptococcus pneumoniae cell wall (hence the term C-reactive 
protein) (Bray et al., 2016).  
CRP is produced and synthesized in the liver in response to inflammatory cytokines 
and assists in complement binding and phagocytosis by macrophages. Its 
physiological role in innate immunity as an early defense system against infections is 
to bind to lysophosphatidylcholine expressed on the surface of dead or dying cells 
(and some types of bacteria) in order to activate the complement system (Thompson 
et al., 1999; Bray et al., 2016). CRP coordinates the host's immune response against 
pathogens and damaged tissues as a class of acute-phase reactant and the first 
pattern recognition receptor (Figure 16). Pathogen-associated molecular patterns 
(PAMPs) drive nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) 
activation and other inflammatory pathways by surface-expressed toll-like receptors 
(TLR) and induce the release of inflammatory cytokines from macrophages (Figure 
16 left). In a parallel activation pathway, major tissue injury activates the “sterile 
inflammation pathway” by the release of damage-associated molecular patterns 
(DAMPs) to activate the inflammasome-mediated processing of IL-1β and IL-18 after 
binding to endosomal receptors (Figure 16 right). Finally, CRP binds to target tissues 
via Fc receptors or other binding molecules such as M-ficolin (Vashist et al., 2016). 
The normal concentrations of CRP in a healthy adult varies between 0.8 mg/L to 
3.0 mg/L, but they can rise 10,000-fold after a stimulus with peaks at 48 h. The only 
factor that affects the level of serum CRP is its rate of production because the 
plasma half-life is 19 h. This rate of production increases with inflammation, infection, 
trauma, tissue injury, necrosis, malignancy, and allergic reaction (Pepys and 
Hirschfield, 2003). 
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CRP is one of the proteins involved in physical stress reactions, implicated in the 
cardiovascular system and renal function. Elevated levels of CRP are directly 
associated with cardiovascular risk, atherothrombotic disease, acute myocardial 
infarction, and acute coronary syndrome. Associations of CRP with cardiovascular 
disease, for example, are due to the selective binding of CRP with LDL, depositing in 
most atherosclerotic plaques with the activated complement (Pepys and Hirschfield, 
2003). The muscle cell damage after a marathon results in the transient rise of 
serum creatinine that meets the clinical criteria of acute kidney injury (AKI) (Bekos et 
al., 2016). CRP is considered a biomarker of inflammation in AKI, impairing tubular 
regeneration and promoting fibrosis of injured renal tissue (Tang et al., 2014 and 
2018). It remains unknown the impact of repetitive episodes of AKI on long-term 
kidney function. 
After prolonged exercise, CRP serum concentrations start to rise within 8 h after 
exercise and peak 24 h after. This rise depends on the exercise duration; running 
events of up to 21 km cause only a marginal elevation in serum concentrations while 
a marathon or ultramarathon result in much higher levels. The CRP levels found after 
a 90 km ultramarathon are similar to those measured in persons with mild heart 
attacks (Noakes, 1987). Some studies showed how CRP plasma levels increased 
3.4-fold, one day after a marathon and returning to the pre-race level on day 4, 20-
fold after a 168 km ultramarathon (Waskiewicz et al., 2012), or 40-fold after a 200-km 
race and was still significantly higher even after day 6 of recovery (Kim et al., 2009).  
Running a marathon or an ultramarathon leads to a substantial amount of skeletal 
muscle damage and an acute inflammatory response evidenced by a wide range of 
changes in muscle damage-related biomarkers and increased CRP levels as seen in 
this thesis. 
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Figure 16. The major pathways related to the CRP production. Retrieved from 
Vashist et al. (2016). 
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2.3 L-BIA measurements 
In general, the most common mechanism of injury of muscles in the lower limbs 
(Gent et al., 2007) is related to muscle strain with muscles being at risk of disruption 
during eccentric contraction. Eccentric exercise performed when a runner is 
dehydrated, for example, may exacerbate the skeletal muscle damage as a result of 
reduced intracellular water (Cleary et al., 2006). Different studies have found that 
repeated eccentric muscle contractions produce progressive muscle damage 
reducing its power output (Hyldahl and Hubal, 2014), and this form of fatigue is 
showed when runners hit the wall in marathon and ultramarathon races (Noakes, 
2002). Usually, a marathon run is associated with eccentric hamstring fatigue (Koller 
et al., 2006), being the hamstring strains one of the most frequently occurring injuries 
in mid- and long-distance runners, affecting 12–16% of all injuries in athletes (Chu 
and Rho, 2016) (Figure 17). Acute hamstring strains can occur with high-speed 
running or with excessive lengthening of the hamstrings, especially in runners 
without enough flexibility, strength and core stability, or due to a muscle fatigue (Chu 
and Rho, 2016). The L-BIA measurements are a non-invasive alternative to evaluate 
runners with high and continuous muscle stress and prevent running muscle injuries 
like the hamstring ones. 
                                        
Figure 17. Drawing of muscle damage due to hamstring strain. Image retrieved from 
http://www.aidyourhamstring.com/hamstring-pain/hamstring-strain.php . 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3. Endurance exercise and cardiovascular health 
The heart is a muscle of only 250 grams that works tirelessly day and night, beating 
100,000 times and driving 8,000 liters of blood through more than 160,000 km of 
blood vessels in our body every day. The heart has two very effective activities, one 
electrical with stimulation, and the other one with contraction, and its coordination 
must be perfect. The electrical activity, both of the atria and the ventricles, can be 
measured with the electrocardiogram, and mechanics with imaging techniques, such 
as echocardiography. 
The heart of the athlete presents adaptive changes, when it contracts it expels more 
blood in each beat and has a lower heart rate, thus having a longer ventricular filling 
time. Cardiac output at rest is approximately 5 L/min but increases 5-fold to about 25 
L/min during vigorous exercise. In response to chronic physical exercise, the heart 
experiences structural and functional changes that are especially related to the 
intensity and duration of this exercise and therefore a medical evaluation is essential 
to ensure that the heart can withstand it.  
Numerous epidemiological studies suggest that regular physical activity (or moderate 
to high levels of cardio-respiratory fitness) protects against cardiovascular diseases 
(CVD), but the intensity of this exercise can trigger the risk, especially in those 
individuals with known or occult CVD (Franklin, 2014). Frequent high-intensity 
exercise could be associated with negative health impact and results from sub-
analysis of the Copenhagen City Heart Study suggested that jogging at a slow to 
moderate pace not more frequent than three times a week was associated with the 
lowest mortality, while no survival benefit was seen when jogging at a fast pace, or 
more than three times a week (Schnohr et al., 2013). 
At the end, it is a question of progression during the physical activity and common 
sense, and for sure a medical evaluation is urgent for those who plan to remain 
inactive, but also for those more than 35 years old, who want to be in shape (Figure 
18).  
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Sudden cardiac death in apparently fit athletes mostly occurs in the absence of any 
warning symptoms or a history of heart disease (Finocchiaro et al., 2016). The 
current 
American Heart Association (AHA) recommendations related to a pre-participation 
screening to identify the presence of silent heart diseases can reduce the risk of 
sports-related sudden death, like personal history, physical examination, and 
electrocardiogram (ECG) test (Maron et al., 2007). The addition of 12-lead ECG in 
the screening can increase the sensitivity in detecting significant silent cardiac 
abnormalities, but there is a divide in North America versus Europe guidelines 
regarding incorporating ECG as a mandatory test for pre-participation screening 
(Vora et al., 2018). According to Corrado et al. (2006 and 2011) ECG in pre-
participation screening in young athletes reduced 90% of the sports-related mortality, 
however, in a study of Steinvil et al. (2011), ECG was not associated with a reduction 
in adverse cardiac events. In the SUMMIT project, for example, an ECG before an 
ultramarathon saved one runner’s life, finding severe atrial fibrillation. 
 
Figure 18. The evolutionary cardiovascular disease pyramid. The way to prevent 
initial or recurrent cardiac events is to modify unhealthy lifestyle habits that are the 
base of the pyramid (CHF: congestive heart failure; MI: myocardial infarction; PAD: 
peripheral arterial disease). Retrieved from Franklin (2014). 
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3.1 Cardiac muscle 
Cardiac muscle tissue is only found in the heart and even though it is similar to 
skeletal muscle (striated and organized into sarcomeres), the cardiac tissue fibers 
are shorter, contain a nucleus and have active mitochondria and myoglobin because 
ATP is produced primarily through aerobic metabolism (Figure 12c). Cardiac muscle 
fiber cells are extensively branched and connected by intercalated discs, which are 
part of the sarcolemma and contain two structures important in cardiac muscle 
contraction: gap junctions and desmosomes. The heart can work as a pump 
because these discs allow the cardiac muscle cells to contract in a wave-like pattern 
(Figure 19). Heartbeats are controlled by specialized cardiac muscle cells called 
pacemaker cells that directly control heart rate. These cells cannot be consciously 
controlled, they respond to signals from the autonomic nervous system (ANS) to 
speed up or slow down the heart rate and can also respond to various hormones that 
modulate heart rate to control blood pressure. 
 
Figure 19. Cardiac muscle and its intercalated discs with gap junctions and 
desmosomes. Retrieved from Betts et al. and OpenStax, Anatomy and Physiology: 
Cardiac Muscle Tissue (2017). 
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3.2 Athlete’s heart 
The effects of training are difficult to define clearly, but in general, it is accepted that 
bradycardia is at rest, lower systolic and diastolic blood pressure and the increase in 
the size of the cardiac cavities (Mitchell and Raven, 1994). The heart is probably the 
organ that supports greater overload during the practice of physical exercise, 
undergoing notable changes both morphological and functional, which is classically 
referred to as the athlete's heart. This cardiac remodeling is the process resulting 
from changes in the geometry and structure of the myocardium, and, in some cases, 
the appearance of fibrotic tissue accompanied by alterations in myocardial 
contractility. 
There are 2 types of enlarged hearts. The first type, athlete’s heart, is caused by 
normal muscle growth in the heart due to the practice of vigorous sports and does 
not put the athlete at risk. However, the second type, hypertrophic cardiomyopathy, 
is a very risky disease and can cause malignant heart arrhythmias that can lead to 
sudden death (Figure 20). 
Athlete’s heart with a normal cardiac function is the result of reversible physiological 
remodeling resulting in increased cardiac mass (Weeks and McMullen, 2011). There 
are slight differences in the extent of remodeling based on the type of exercise. In 
endurance runners, for example, there is eccentric myocardial hypertrophy due to 
volume overload, the left ventricle’s walls thicken and left ventricle dialates (Galanti 
et al., 2016; Weeks and McMullen, 2011). 
Athlete’s heart is considered reversible, but studies of retired athletes show that even 
years into retirement, the heart does not completely regress to normal physiology 
(O’Keefe et al., 2012). Also, new studies are beginning to show that athletes who 
undergo chronic high-intensity and high endurance exercise training may exhibit 
cardiac remodeling (that is not completely benign), increased vagal and sympathetic 
tones, bradycardia, inflammatory changes, myocardial fibrosis and atrial dialation 
(O’Keefe et al., 2012). 
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Figure 20. Normal heart vs athlete's heart vs pathological heart. Retrieved from 
Medical doctor (https://www.picluck.net/media/947934150023816202_1591812152). 
The most evident changes found during exercise are: 
• Acute dilation of the right atrium 
• Acute dilation of the right ventricle 
• Sudden decrease in right ventricular ejection fraction (EF) 
• Elevated troponin and B-type natriuretic peptides 
• Myocardial fibrosis 
• Aortic valve stiffness 
• Higher than expected levels of coronary artery calcium and calcified coronary 
plaque volume. 
Another consequence of the endurance training is the considerable remodeling of 
the vascular system, especially in the skeletal muscles subjected to the exercise, 
including an increase in the diameter of large conducting vessels like the femoral 
artery, in the number of arterioles and in the capillary density. This type of training 
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promotes volume hypertrophy that also involves de novo cardiomyocyte formation 
(Hawley et al., 2014). More research in recreational athletes finishing a marathon 
has found changes in cardiac dysfunction and injury, strongly influenced by the level 
of preparation undertaken. The majority of the most marked abnormalities in cardiac 
structure or function, as well as cardiac biomarker changes, were seen in those 
athletes training less than 35 miles/week before the marathon (Neilan et al., 2006).  
On the other hand, it has been shown that intense races such as marathons and 
ultramarathons in most of the runners, reduce cardiac function temporarily once the 
race has ended. But this reduction does not imply permanent damage to the heart 
and returns to the baseline within a week. Anyway, physicians are worried about the 
immediate post-marathon elevation of enzymes such as cardiac troponin that are 
normally released during a heart attack. However, these biomarkers quickly return to 
their normal reference level during 24 h after a marathon, while in a myocardial 
infarction they remain elevated for a week. These biomarkers elevations are 
considered inherent and expected with exercise as a sign of cardiac stress or simply 
due to the increase in acidity or temperature of the blood, and in any case, it has 
been considered to be a sign of permanent cardiac damage or negative health 
(George et al., 2012). In Chapter 2 a noticeable increase of 3 cardiac biomarkers 
after a marathon is assessed and how it affects the preparation and participation to 
the race. 
3.3 Sudden cardiac death in athletes 
Physical inactivity increases the risk of developing a variety of diseases, including 
obesity, diabetes, hypertension, osteoporosis, or depression. Most of the benefits 
that regular exercise contributes are shown in Figure 2. In addition, studies based on 
nearly 900,000 participants, demonstrated that physical activity is associated with a 
marked decrease in cardiovascular and all-cause mortality, with risk reductions of 
30–50% for cardiovascular mortality and 20–50% for all-cause mortality (Nocon et 
al., 2008). Episodes of vigorous exercise (as explained in 2.), such as marathon 
running may precipitate acute coronary syndrome (ACS) and sudden death in 1 per 
50,000 marathon participants (Siegel et al., 2008). Without an underlying heart 
condition or disease, the risk of sudden cardiac death during a race is extremely low. 
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There is only a slightly increased risk of a cardiac arrest during strenuous exercise if 
the runner is predisposed. While most deaths may be attributed to inherited 
cardiomyopathies and channelopathies in those younger than 35 years old, there is 
no absolute cutoff. Thus, athletes in their thirties and forties (the median age in many 
competitive sports) are at greatest risk of sudden cardiac death caused by inherited 
and acquired causes (Figure 21), as is the coronary atherosclerotic disease that 
begins to express itself at this age (La Gerche et al., 2013). Cardiac arrest can be 
caused by a lack of blood flow to the heart due to coronary-artery disease, or by a 
structural abnormality of the heart that causes it to suddenly start beating irregularly 
(an arrhythmia) and ineffectively (Kim et al., 2012). These situations are more likely 
to occur when the heart pumps 5 times more blood during exercise. Sudden cardiac 
death caused by either a “heart attack” or an arrhythmia can sometimes be reversed 
with cardiopulmonary resuscitation (CPR), especially if it started quickly after the 
collapse and a defibrillator is present. Some cases in races I have done were in 
Comrades Marathon in 2007 with 2 men over 25,000 runners, in Marathon des 
Sables in different years with 4 men over 20,000 participants, and less prevalent 
cases in Cursa dels Bombers, Mitja marató de Gavà, Behobia Sant Sebastian, 
Triatló Berga, Garmin Barcelona Triatló among others. 
Intense physical exercise, in people with structural heart disease, increases 
cardiovascular risk during or in the hour after exercise and the most relevant 
complications are sudden death and acute myocardial infarction (AMI) (Mons et al., 
2014). On the other hand, athletes most prone to atrial fibrillation (AF) are those 
males, in their 4th-5th decade of life, who have exercised resistance at high-intensity 
for more than 10 years (Drca et al., 2014). Another study with older men and women 
(mean age 73 years) reported that exercise intensity showed the familiar reverse J-
shaped relationship with the risk of atrial fibrillation (AF) (Figure 22) (Mozaffarian et 
al., 2008), and veteran male endurance runners (who had run at least 1 marathon 
each year for 25 consecutive years) had significantly increased amounts of coronary 
plaque, both hard and soft (Figure 23) (O’Keefe et al., 2014; Schwartz et al., 2014).  
42 3. Endurance exercise and cardiov health 
 
Figure 21. Age-dependent changes in incidence and etiology of sudden cardiac 
death. RV, right ventricular; VT, ventricular tachycardia. Retrieved from La Gerche et 
al. (2013). 
Male marathon participants are associated with a low overall risk of cardiac arrest 
and sudden death, but the incidence rate has increased during the past decade. In 
Figure 24 the cardiac arrest causes from 59 runners where 71% died are illustrated. 
The incidence rates of cardiac arrest and sudden death during long-distance running 
races from 2000 to 2010, were 0.54 per 100,000 (Kim et al., 2012), better rates than 
the ones from Siegel et al. (2008) or from the systematic review done by Waite et al. 
(2016), where the incidence of sudden cardiac death rate in marathoners was 
0.6-1.9 per 100.000 runners (34-year period involving nearly 4 million runners). 
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Figure 22. Risk of new-onset atrial fibrillation (AF) in older adults depending on 
exercise intensity. Retrieved from O’Keefe et al. (2014) and adapted from 
Mozzafarian et al. (2008). 
 
Figure 23. Total coronary plaque volume (noncalcified plaque volume and calcified 
plaque volume) in male marathoners compared to sedentary controls. Retrieved 
from O’Keefe et al. (2014) and adapted from Schwartz et al. (2014). 
Another study done in rats (with heart rates of 500 beats/min vs 60 beats/min in 
humans) (Benito et al., 2011), which ran at high-intensity during different periods of 
4, 8 and 16 weeks, the rats that performed more exercise compared to sedentary 
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ones, developed eccentric hypertrophy and diastolic dysfunction, atrial dilation, and 
collagen deposition in the right ventricle. In 42% of the marathon rats, a ventricular 
tachycardia could be induced. The damage observed in the myocyte may be 
associated with inflammation and subsequent myocardial fibrosis, resulting in a 
substrate for the future appearance of arrhythmias or cardiac dysfunction. But all the 
fibrotic changes caused by the 16 weeks of intensive exercise reversed after 8 
weeks of rest. Although it would be desirable to replicate this research in humans (if 
it can be done ethically), this study supports the hypothesis that running repeatedly 
at high-intensity causes an unfavorable cardiac remodeling that can induce 
arrhythmias.  
                          
Figure 24. Causes of cardiac arrest in 59 runners (42±13 years) over 10.9 million 
analyzed (HCM: hypertrophic cardiomyopathy, PHCM: possible hypertrophic 
cardiomyopathy). Retrieved from Kim et al. (2012). 
Another consequence during physical exercise at moderate to high-intensity can be 
ischemia. Perhaps it is not prolonged enough to produce irreversible myocardial 
injury but might be sufficient for shedding on the surface of the plasma membrane 
cardiac myocytes blebs (like ‘’bubbles’’). These bubbles would then be released into 
the circulation along with their cytoplasmic content. But when ischemia is prolonged, 
the blebs grow, collapse, and produce cell necrosis (Brancaccio et al., 2010). 
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On the other hand, before studying the Barcelona marathon, it was assessed in ultra 
marathoners if the endurance training was associated with marked increases in 
cardiac output requirements. We wanted to know if this workload imposed a high 
degree of stress on all myocardial structures, especially in the right ventricle which 
typically works at low pressures under physiological conditions. An acute right 
ventricle impairment was found, dilatation and decreased deformation, although a 
high individual variability was present. Also, different patterns of right ventricle 
adaptation were identified, independent of dehydration or previous training. And 
finally, it was concluded that a dynamic evaluation of the right ventricle response 
(echocardiographic analysis) could help to identify which runners have a better or 
worse right ventricle adaptation to exercise and avoid long-term consequences 
(Sanz et al., 2015 and 2016). 
Thereby, how can heart health be controlled biochemically after intense and long 
exercise like a marathon? Will the increase in circulating concentrations of cardiac 
biomarkers be sufficient? It can be, but never a single biomarker will be enough to 
evaluate how a marathon can be dangerous to our heart. That is why, in this thesis, 
several cardiac biomarkers are analyzed to evaluate which is the impact of a 
marathon on the cardiovascular system. 
3.4 Cardiac blood biomarkers 
Heart failure is a major and growing public health problem and begins with 
myocardial injury, usually secondary to myocardial infarction, ischemia, 
hypertension, or other etiologies like genetic, neurohormonal, inflammatory, and 
biochemical changes (Braunwald, 2008). Seven classes of biomarkers have been 
described as a multi-marker strategy to define risk stratification for heart failure 
(Figure 25). It has been demonstrated that using troponin together with brain-
natriuretic peptide (BNP) can achieve a more accurate stratification of risk than can 
be obtained with either biomarker alone. The accuracy of risk prediction has also 
been enhanced when a natriuretic peptide has been coupled with other biomarkers 
of myocardial stress like ST2, as well as with inflammatory biomarkers like C-
reactive protein (CRP) (Braunwald, 2008). 
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Figure 25. Seven axes profile representing biomarkers of each class. A resultant 
biomarker profile should enhance prevention, treatment and prognostication. 
Retrieved from Braunwald (2009). 
Biomarkers in heart failure can be classified into 7 main groups: inflammation, 
oxidative stress, extracellular-matrix remodeling, neurohormones, myocyte injury, 
myocyte stress and new biomarkers. In the Barcelona marathon participants, 
inflammation (C-reactive protein), myocyte injury (Hs-TnT), and stress (NT-proBNP 
and ST2) biomarkers were assessed. 
One of the things that protects against cardiac biomarkers elevations (with 
echocardiographic evidence of cardiac dysfunction) while doing endurance exercise, 
it is an appropriate individualized preparation/training (Neilan et al., 2006). And 
precisely how affects the preparation prior to the marathon and the race itself on 
cardiovascular health is what is evaluated in this thesis.  
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3.4.1 High-sensitivity troponin T (Hs-cTnT) 
Troponins are proteins that work to regulate muscle contraction, making actin-myosin 
interactions sensitive to cytosolic calcium levels. The troponin complex with the 
tropomyosin and 7 actin monomers, constitute the myocardial sarcomeric unit (see 
Figure 11). The troponin complex is composed of 3 subunits: troponin T (TnT) (37 
kDa), which anchors the complex to the tropomyosin strand of the thin filament; 
troponin C (TnC) (18 kDa), which binds calcium ions released from the sarcoplasmic 
reticulum; and troponin I (TnI) (22.5 kDa), which inhibits the enzymatic hydrolysis of 
adenosine triphosphate that powers muscle contraction (Shave et al., 2010) (Figure 
26). Different forms of TnT and TnI are found in cardiac and skeletal muscle with 
cardiac (c) and skeletal (s) isoforms of TnT (cTnT, sTnT) and TnI (cTnI, sTnI) each 
encoded by separate genes. The sensitivity and specificity of cTnT and cTnI for the 
detection of myocardial injury are superior to older biomarkers, including LDH, CK, 
CK-MB, and myoglobin. Troponin tests have improved over the past 10 years, since 
2012 cTn high-sensitivity (hs) assays, which have the ability to reliably detect very 
low troponin levels in plasma (enabling the early detection of troponin release and 
allowing an earlier diagnosis), and have a much lower absolute coefficient of 
variation (enabling the reliable detection of small variations over the time and 
differentiates chronic elevations from those acute) (Costabel et al., 2017). In this 
thesis, we have used Hs-cTnT because of its sensitivity and because it is the 
preferred biomarker in the diagnostic of myocardial infarctions. 
                                        
Figure 26. Scheme of the cardiac muscle where the 3 troponin isoforms can be 
located in relation to actin and tropomyosin. Retrieved from Shave et al. (2010). 
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High-sensitivity troponin T is the myocyte stress/injury biomarker. Its elevation is 
associated with an incomplete myocardial adaptation to exercise (Gresslien and 
Agewall, 2016). The post-exercise cardiac troponin increase is related to the training 
status and it is greater in the less trained marathoners (Mehta et al., 2012). Also, this 
increase is directly related to the intensity (Brancaccio et al., 2010; Richardson et al., 
2018) and the duration of time spent participating in a marathon (Schmied, 2014). 
The release of hs-cTnT is likely multifactorial and it can also depend on 
subendocardial ischemia due to wall stress, myocardial apoptosis, or oxidative injury. 
When a correlation between echocardiograms and blood biomarkers has been done 
in recreational athletes completing a marathon, there is evidence of cardiac 
dysfunction and injury. With prolonged exercise, there is an increased pulmonary 
artery pressure, increased right ventricle dimensions, and decreased right ventricle 
function, all of which correlate with the release of cTnT. This exertion also provokes 
alterations in left ventricle diastolic function, which correlates with an increase in 
another biomarker called NT-proBNP (see 3.4.2). All these changes are strongly 
influenced by the level of training undertaken by these amateur athletes, such that 
the majority of the most marked abnormalities in cardiac structure or function, as well 
as cardiac biomarker changes, are seen in those athletes training less than 35 miles/
wk before the marathon (Neilan et al., 2006). 
Normal values of hs-cTnT are under 14 ng/L. A meta-analysis made with 16 studies 
of 939 marathon runners showed high levels of troponin T after the race (Regwan et 
al., 2010). The majority of the studies of troponin and marathon running have 
revealed increased levels in between 0 and 100% of subjects, but multiple factors 
can influence the post-exercise levels of troponin (especially intensity, age, training 
experience, time of sampling and type of essay) (Gresslien and Agewall, 2016). 
Even now, the cardiac troponin level increase in marathoners is not understood, and 
it will be necessary to cross these values with other biomarkers, not only cardiac, to 
draw conclusions. 
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3.4.2 Amino-terminal pro-B type natriuretic peptide (NT-proBNP) 
During an episode of hemodynamic stress, when the ventricles are dilated, 
hypertrophic, or subject to increased wall tension, a pro hormone BNP is cleaved by 
a circulating endoprotease into two polypeptides; the inactive NT-pro-BNP of 76 
amino acids (with a longer half-life), and the bioactive peptide BNP of 32 amino 
acids. BNP causes actions that oppose the physiological abnormalities in heart 
failure, like arterial vasodilation, diuresis, and natriuresis, and reduces the activities 
of the renin–angiotensin–aldosterone system and the sympathetic nervous system 
(Braunwald, 2008) (Figure 27). The natriuretic peptides are cleared by the kidneys, 
and the hypervolemia and hypertension characteristic of renal failure enhance the 
secretion and elevate the levels of BNP, especially the NT-pro-BNP (Daniels and 
Maisel, 2007). There are three major natriuretic peptides that share a common 17-
amino-acid ring structure; atrial (A-type) natriuretic peptide (ANP) and B-type 
natriuretic peptide (BNP) are of myocardial cell origin, and C-type natriuretic peptide 
(CNP) is of endothelial origin. All three peptides are secreted in an attempt to correct 
the vasoconstrictive, retain sodium, antidiuretic, and antifibrotic effects caused by the 
neurohormonal imbalance in heart failure (Bhalla et al., 2004).  
Both BNP and NT-proBNP levels in the blood are used for screening and diagnosing 
acute congestive heart failure and may be useful to establish prognosis in heart 
failure, as both markers are typically higher in patients with worse outcomes. Both 
are myocyte stress biomarkers. 
                                
Figure 27. The structure of proBNP, BNP, and N-terminal proBNP (BNP=B-type 
natriuretic peptide; RAAS=renin-angiotensin-aldosterone system). Retrieved from 
Bhalla et al. (2004). 
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The cutoff value for NT-proBNP is 94 ng/L and a value higher than 125 ng/L is 
considered clinically relevant and an indicator of cardiac damage risk (Koç et al., 
2009). In the context of marathon running studies, NT-proBNP is reported to be 
elevated after the race with concentrations of 183 and 137 ng/L. Other authors also 
reported that 38 of their 46 subjects recorded concentrations that were comparable 
with those indicating cardiac events and disease. Similarly, another study that 
measured proBNP following repeated bouts of severe prolonged running, reported 
that while some runners displayed elevated concentrations of pro-BNP >100 ng/L 
above pre-exercise concentrations (>200% increase), these did not exceed the 
clinical cut off (>125 ng/L) for congestive heart failure patients, and had returned to 
pre-exercise concentrations within 24 h of the last exercise. So, despite the 
temporary elevations in these biomarkers, it has been shown how severe prolonged 
running has a minimal clinical impact (Bird et al., 2014). 
Other studies of changes in cardiac troponin T and I and B-type natriuretic peptide 
(BNP and NT-proBNP) levels in asymptomatic runners who completed a marathon 
have demonstrated that mild to moderate elevations are common without apparent 
acute coronary syndrome or heart failure. However, even though the mechanism of 
cardiac injury and myocyte stress (reflected by elevation of troponin and B-type 
natriuretic peptide concentrations respectively) remains under debate, presumably 
these elevations result from an incomplete myocardial adaptation to training in which 
vulnerable myocytes are selectively eliminated, particularly in athletes with lesser 
training (Siegel et al., 2008). 
3.4.3 Suppression of tumorigenicity 2 (ST2) 
Beyond the natriuretic peptides, there is increasing interest in a class of markers that 
predict deleterious processes subsequent to ventricular remodeling (wall stretch) like 
ST2. When cultured monocytes are subjected to mechanical strain, the protein ST2 
is secreted. It is a member of the interleukin-1 receptor family. Infusion of soluble 
ST2 appears to dampen inflammatory responses by suppressing the production of 
the inflammatory cytokines interleukin-6 and interleukin-12. 
ST2 is an extracellular matrix remodeling and fibrosis, inflammation and 
myocardial strain biomarker. 
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Despite the well-documented successes and strengths of natriuretic peptides, there 
is room for improvement in the evaluation and risk stratification of patients with HF or 
at risk for HF. One of the biomarkers to fill this gap is ST2. As ST2 reflects 
inflammation, fibrosis, and cardiac strain, it can be an independent predictor in an 
inflammatory status as secondary to HF and renal dysfunction. Also, ST2 is valuable 
for predicting sudden cardiac death in ambulatory patients with mild to moderate 
chronic HF and left ventricular systolic dysfunction, and is a strong prognostic 
marker for short-term mortality risk (Bayés-Genis et al., 2015). In patients with acute 
myocardial infarction, elevated soluble ST2 (sST2) levels are associated with an 
increased risk of mortality or HF, independent of natriuretic peptides (Shah and 
Januzzi, 2010). And this elevated level of ST2 in patients with severe HF are the 
result of cellular death, tissue fibrosis, reduced cardiac function, and an increase in 
the rate of disease progression (Braunwald, 2008). 
Individuals are at a higher risk of adverse outcomes when ST2 levels are above a 
cut-off value of 35 ng/mL (Weinberg et al., 2003). No studies have been done with 
marathoners and ST2 save the one presented in this thesis, where levels of ST2 
before and 48 h post-marathon were elevated in nearly 50% of the runners, and just 
finishing the ST2 levels were over the cut-off in nearly 90% of the runners. Recently 
it has been published in another study related to marathon and ST2 and found 
increased ST2 concentrations in amateur marathoners with ST2 concentrations 
exceeding cutoff values both at baseline (48%) and finish (94%) and found higher 
ST2 concentrations in faster runners (Aengevaeren et al., 2019). 
Far from supplanting natriuretic peptides and sensitive troponin assays, novel 
markers such as ST2 will be complementary and powerful predictors of 
cardiovascular risk. There is substantial experience with measuring the natriuretic 
peptides like NT-proBNP (for which excellent assays are available) or troponins, but 
less information is available for ST2 and analytic methods for determining ST2 have 
not yet been standardized (Braunwald, 2008). That’s why analyzing ST2 in 
marathoners is pioneering and can contribute to the other biomarkers evaluated in 
order to present an excellent risk profile related to cardiovascular events in runners. 
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4. Endurance exercise and immunity 
Plenty of hostile bacteria, fungi, and viruses live around us, but we remain healthy 
most of the time thanks to the two intrinsic defense systems that act both 
independently and cooperatively to provide immunity: the innate/nonspecific system 
and the adaptative/ specific defense system (Figure 28). The first one responds 
within minutes with the “first line of defense” (external body membranes as skin and 
mucosa) and “the second line of defense” (antimicrobial proteins and phagocytes 
among others triggering inflammation). The second one attacks particular foreign 
substances and is the “third line of defense”. Our body is protected from most 
infectious microorganisms, cancer cells, and transplanted organs or grafts, thanks to 
a direct (cell attack) or indirect (releasing mobilizing chemicals and protective 
antibody molecules) actions (Marieb, 2004). 
                        
          
Figure 28. Cooperation between Innate and Adaptive Immune Responses being 
more effective. Retrieved from Betts et al. and OpenStax, Anatomy and Physiology: 
The Lymphatic and Immune System (2017). 
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Heavy exertion or exercise lowers resistance and is a predisposing factor to 
respiratory tract infections (RI). However, at the same time, regular exercise confers 
resistance against infection. The relationship between exercise and RI may be 
modeled as a “J” curve (Figure 29). This model suggests that while doing moderate 
exercise the RI risk decreases below of a sedentary individual, but doing high-
intensity exercise the RI risk is the highest. Several epidemiological reports suggest 
that athletes engaging in marathon-type events and/or very heavy training are at 
increased risk of RI (lower distances even have a slight reduction of RI incidence). 
The risk appears to be especially high during the 1- or 2-week period after the 
marathon (Nieman, 1997). But the acute decrease in immune function is transient 
and is dependent on the exercise intensity (as shown in Figure 29) and duration. 
Repeated activity with insufficient recovery, such as during heavy periods of training 
and competition, appears to exacerbate the situation leading to a chronic depression 
of several aspects of immune function (Bishop and Gleeson, 2009). 
Research in more than 2300 marathoners has shown that training more than 96 km/
week doubled their odds for sickness compared with those training less than 32 km/
week. Other studies in ultra runners have seen how the risk of infection increased 
100% to 500% and around 25% of finishers reported respiratory symptoms (Gill et 
al., 2013 and 2014).  
             
Figure 29. “J” shaped model suggesting that moderate exercise may lower risk of 
respiratory infections while very high-intensity exercise may increase the risk. 
Retrieved from Nieman (1997). 
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When an increased risk of RI appears, it means that the immune function is 
negatively affected. Many components of the immune system change after 
prolonged exercise (Nieman, 2000), some of these changes are: 
• High neutrophil and low lymphocyte blood count induced by high plasma cortisol 
(the immune system is suppressed and stressed, decreasing host protection 
against viruses and bacteria). 
• Increase in blood granulocyte and monocyte phagocytosis, but a decrease in nasal 
neutrophil phagocytosis (substances released from injured muscle cells initiate an 
inflammatory response). 
• Decrease in nasal and salivary IgA concentration (the major effector of host 
defense of the upper respiratory tract is reduced). 
• Decrease in nasal mucociliary clearance. 
• Decrease in granulocyte and macrophage oxidative burst activity (killing activity). 
• Decrease in natural killer (NK) cell cytotoxic activity (then the protection against 
viruses and bacteria is reduced). 
• Decrease in mitogen-induced lymphocyte proliferation (T-cell function is 
decreased). 
• Decrease in the delayed-type hypersensitivity skin response. 
• Increase in plasma concentrations of pro- and anti-inflammatory cytokines and 
chemokines. 
• Blunted major histocompatibility complex II expression and antigen presentation in 
macrophages. 
In response to a marathon, natural killer cells, neutrophils, and macrophages (of the 
innate immune system) exhibit the greatest changes in terms of numbers and 
function, of all immune cells. During this ‘open window’ of altered immunity (which 
may last between 3 and 72 hours), viruses and bacteria may gain a foothold, 
increasing the risk of infection (Figure 30). It is necessary to define if athletes with 
the most extreme immune suppression following heavy exertion are those that 
contract an infection during the following 1–2 weeks (Nieman, 2007). 
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Figure 30. The ‘open window’ theory. Moderate exercise causes mild immune 
changes while marathon-type exercise leads to immune dysfunction that increases 
the likelihood for opportunistic upper respiratory tract infections. Retrieved from 
Nieman (2007). 
In addition, when there is muscle tissue damage, physiological and immune 
responses are activated. Inflammation can be tracked indirectly through key 
components of the inflammation process that can enter into systemic blood 
circulation. Chronic inflammation that persists after damage indicates injury or stress 
from overtraining, infection, autoimmune disease, cardiovascular disease, or other 
major health concerns. In any case, chronic inflammation is a positive feedback 
phenomenon that can impact the athlete’s health and performance. When markers of 
muscle damage are released into circulation, immune cells migrate to the site of 
tissue injury and differentiate into mature pro-inflammatory macrophages. These 
macrophages also release a number of growth factors, cytokines, and other 
signaling molecules that promote the inflammatory process by recruiting other cells 
required for skeletal muscle regeneration. During inflammation, liver tissue may be 
stimulated to produce an acute-phase response that recruits vascular tissue 
activation, systemic immune response, and endocrine function among others (Lee et 
al., 2017). 
Interactions between muscle and inflammatory cells are important in determining the 
course of muscle injury and remodeling. Macrophages can injure muscle cells in 
vitro and in vivo and their cytolytic capacity is increased by the presence of 
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neutrophils. Cytotoxicity assays have shown that macrophages lyse target muscle 
cells by nitric oxide (NO)-dependent and superoxide-independent mechanism. 
Experimental observations support the potential interactions between neutrophils, 
macrophages, and muscle with a potential role in promoting injury or repair (Figure 
31) (Tidball, 2005). 
                   
Figure 31. Schematic of potential mediators of inflammatory cell interactions with 
injured muscle (NO: nitric oxide; µPAR: urokinase type plasminogen-activator 
receptor; µPA, urokinase; MCP-1: monocyte chemoattractant protein-1; 
FKN:fractalkine; MDC: macrophage-derived chemokine; VEGF: vascular endothelial 
growth factor; SOD: superoxide dismutase; MPO:myeloperoxidase). Retrieved from 
Tidball (2005). 
A physical demand, such as a marathon, increases the migration of white blood cells 
to the sites of muscle injury, and induces acute-phase inflammatory reactions, 
producing a large number of acute-phase proteins and cytokines related to innate 
immunity such as secretory Immunoglobulin A (sIgA) or inflammatory chemokines 
(Gleeson and Bishop, 2013; Trochimiak and Hubner-Wozniak, 2012). 
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4.1 Salivary immunity 
The Common Mucosal Immune System is a network of organized structures, such 
as the respiratory system and oral cavity with the nasal and bronchial/tracheal 
lymphoid tissue, and salivary glands (Bishop and Gleeson, 2009).  
Saliva, a mucosal secretion regulated by the autonomic nervous system that 
contains a significant amount of secretory antibodies, can be influenced by 
strenuous exercise like a marathon. Due to recent advances in the measurement of 
antimicrobial peptides and immunoglobulins in saliva, the study of mucosal 
immunity-related with exercise has increased. 
Saliva is produced by three pairs of major salivary glands—the parotid, 
submandibular, and sublingual; in addition to many smaller glands found in the 
submucosa under most soft tissue surfaces of the mouth. We produce around 1500 
mL of saliva each day. Whereas IgA is transported into saliva across salivary 
glandular epithelial cells, lactoferrin is synthesized and secreted by acinar cells in the 
secretory endpiece of salivary glands and lysozyme are the macrophages in the oral 
mucosa. Following secretion, both lysozyme and lactoferrin require pepsin digestion 
for activation into their anti-microbial form (Bishop and Gleeson, 2009). Fluid balance 
studies in athletes have observed significant reductions in salivary flow rate when 
hypohydration exists with different results in sIgA and Lysozyme secretion rates 
(Fortes et al., 2012; Gill et al., 2013). 
RI is protected by an array of salivary antimicrobial proteins (sAMPs) that act as the 
first line of defense against invading microorganisms. sAMPs range from small 
cationic peptides to larger polypeptides and proteins that are typically secreted by 
phagocytes, epithelial cells, and salivary glands. Exercise-induced changes in 
sAMPs depend on the fitness level, due to training-induced alterations in 
parasympathetic and sympathetic nervous system activation (Kunz et al., 2015). The 
most common antibody on the mucosal surface, sIgA, suffers a decrease after long 
bouts of exercise (more than 90 minutes), related with a high incidence of RI 
(Nieman et al., 2002). Other studies suggest that immune factors present in mucosal 
secretions, including AMPs and immune mediators such as chemokines, also 
change after prolonged running, like salivary lactoferrin (one of the most abundant 
AMPs) that increases after a 50 km ultramarathon (Ihalainen et al., 2016). 
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However, limited data regarding sIgA and other AMPs, chemokines, and the 
presence of lower respiratory tract infections in marathon runners exist. In this 
thesis, the impact of a marathon on salivary immunity and respiratory tract infections 
is analyzed.  
4.2 Saliva biomarkers 
4.2.1 Antimicrobial peptides: sIgA, lysozyme and lactoferrin 
Secretory immunoglobulin A (sIgA) is the primary immunoglobulin in saliva that 
functions as part of the body’s initial defense against invading microbes. This dimeric 
molecule is formed by two IgA monomers joined by the J-chain and covalently bound 
to a secretory component, which is produced in plasma cells that lie adjacent to 
salivary glands, from which it is excreted in a saliva flow rate-dependent fashion. 
Each IgA monomer comprises two heavy chains and two light chains, joined by 
disulfide bonds (Figure 32). While sIgA is the most abundant antimicrobial protein 
found in mucous secretions including saliva; additionally, α-amylase, lactoferrin and 
lysozyme provide the first line of defense against pathogens that might be present 
on mucosal surfaces (Bishop and Gleeson, 2009; Walsh et al., 2011). 
                      
Figure 32. Schematic representation of sIgA (Fab: fragment antibody binding 
portion, Fc: fragment crystallizable portion). Retrieved from Bishop and Gleeson 
(2009). 
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Marathon and endurance performance have been shown to negatively affect sIgA, 
and additionally, ultra-endurance events resulted in declines in immune defense in 
the oral cavity, pulmonary function, and salivary flow rate (Bellar et al., 2017). Only 
prolonged exercise and intensified training (but not moderate exercise) can evoke 
decreases in sIgA. Acute exercise altered mucosal immunity is related to the 
activation of the sympathetic nervous system and its associated effects on salivary 
protein exocytosis (a form of active transport and bulk transport in which a cell 
transports molecules out of it by expelling them) and sIgA transcytosis (a type of 
transcellular transport in which various macromolecules are transported across the 
interior of a cell) (Walsh et al., 2011). 
Lysozyme (Lys) and lactoferrin (Lac) are the two most abundant AMPs. Salivary Lys 
and Lac are produced by epithelial cells, salivary glands, and granules of 
neutrophils. Lys and Lac may function synergistically to augment immunity, but each 
one has a specific function; Lys enhances protection against gram-positive bacteria 
and Lac improves immunity by inhibiting iron uptake by microorganisms and thereby 
reducing bacterial growth (Gillum et al., 2013). One study assessing the effect of a 
short run (45 minutes) instead of a long one, resulted in increased Lac concentration 
which could lead to a decrease in inflammation. These results add evidence to the 
anti-inflammatory effects of moderate exercise. Conversely, a decrease seen in 
intracellular Lys content could be the cause of increased Lys in exocrine solutions 
(Gillum et al., 2017). 
A reliable marker of hypothalamic-pituitary-adrenal axis activity is the cortisol 
hormone, segregated in response to intense exercise to aid in the metabolism of fat, 
protein, and carbohydrates. It has been seen how cortisol can alter mucosal 
immunity through a reduction in sIgA and lysozyme. Also after analyzing 14 runners 
in a 50 km race, IgA was more sensitive to prolonged running than either Lys or Lac, 
of, which secretion rates were unaffected (Gillum et al., 2013).  
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4.2.2 Chemokines: Groα, Groβ, MCP-1 
Cytokines derived predominantly from mononuclear phagocytic cells are uniquely 
important in innate immunity and both initiate immune responses and generate 
symptoms associated with infections and inflammatory disorders. Cytokines are 
signaling molecules produced by cells for specific biological functions (interleukin for 
example is a type of cytokine produced by white cells). Cytokine is a general term 
used for all signaling molecules while chemokines (chemoattractant molecules) are 
specific cytokines that function by attracting cells to sites of infection/inflammation 
(Borish and Steinke, 2003). 
Chemokines have demonstrated an important role during exercise in the regulation 
of local immunity against infections by contributing to the tissue infiltration of 
leukocytes and in the attraction of neutrophils to the site of inflammation. Also, 
several inflammatory chemokines have demonstrated a potential role in the 
regulation of immune response during exercise (Terra et al., 2012).  
Some of these chemokines are: 
• Growth-Regulated Oncogene-alpha (Groα or CXCL1): neutrophil-activating protein 
and melanoma growth stimulating activity. It is found to be an inflammatory factor 
that plays a critical role in wound healing by modulating cell migration and 
angiogenesis. 
•  Growth-Regulated Oncogene-beta (Groβ or CXCL2): macrophage inflammatory 
protein, secreted by monocytes and macrophages and is chemotactic for 
polymorphonuclear leukocytes and hematopoietic stem cells. 
•  Monocyte chemoattractant protein 1 (MCP-1): recruit monocytes, memory T cells, 
and dendritic cells to sites of inflammation produced by either tissue injury or 
infection. It’s mainly produced by monocytes, macrophages, and dendritic cells, 
which may induce adhesion molecule expression, tissue factor secretion, and 
smooth muscle cell proliferation in the context of inflammation. The adipose tissue 
is an important source for the release of MCP-1. It is the only adipocytokine able to 
impair insulin signaling and glucose uptake in skeletal muscle and its decrease 
facilitates insulin action in the muscle (Accattato et al., 2017). 
Several studies have reported that physical activity can induce an acute-phase 
response characterized by an increase in multiple circulating cytokines and 
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chemokines, such as Interleukin-1 (IL-1), Interleukin-6 (IL-6), Tumor Necrosis Factor 
α (TNFα), Epidermal Growth Factor (EGF), and Monocyte Chemoattractant-1 
(MCP-1); however, other studies have shown no significant changes in cytokine 
levels after exercise, probably due to differences in the physical activity protocols 
applied (Accattato et al., 2017). Also, it has been described how moderate exercise 
suppress Gro-alfa (Aqel et al., 2017) and, in experimental models, exercise down-
regulated multiple inflammatory cytokines (Szalai et al., 2014), including Gro-alfa 
and Gro-beta, resulting in a systemic anti-inflammatory effect (Accattato et al., 2017). 
4.2.3 Anti-inflammatory proteins: Angiogenin, Acrp30, Siglec 5 
Other important immune factors present in mucosal secretions that change after 
prolonged exercise are anti-inflammatory proteins. Some of these proteins are: 
• Angiogenin (Ang): associated with altered normality through angiogenesis 
(stimulates new blood vessels) and through activating gene expression that 
suppresses apoptosis (is associated with cancer and neurological disease). It has 
been reported that Ang interacts with endothelial and smooth muscle cells and 
induces a wide range of cellular responses like cell migration, invasion, 
proliferation, and formation of tubular structures (Gao and Xu, 2008; Tello-Montoliu 
et al., 2006). 
• Adipokine (Acrp30 or adiponectin): is an adipocyte complement-related protein 
with roles in glucose and lipid homeostasis. It is a cell-signaling protein secreted by 
adipose tissue involved in regulating glucose levels as well as fatty acid 
breakdown (Berg et al., 2002). A negative correlation between obesity and 
circulating adiponectin has been well established, and adiponectin concentrations 
increase concomitantly with weight loss. Adiponectin decreases glucose 
production and lipid synthesis in the liver, promoting glucose and free fatty acid 
concentration decreases in blood. In addition, triglyceride production is decreased 
and fat oxidation and energy dissipation in the muscle are increased (Meier and 
Gressner, 2004). 
Sialic acid-binding Ig-like lectin 5 (Siglec5): belongs to a novel subset of structurally 
related Ig superfamily of proteins that mediate protein-carbohydrate interactions, 
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specifically interacting with sialic acids in glycoproteins and glycolipids (Cornish et 
al., 1998).  
4.3 Glycans 
Among the various biological functions of carbohydrates, there are important roles 
that require interactions between cells and the surrounding matrix in order to 
assemble complex multicellular organisms. All cells have a series of independent or 
covalently linked sugars (monosaccharides) or sugar chains (oligosaccharides) 
called glycans. Because many glycans are found on the outer surface of cellular 
macromolecules, they can modulate or mediate a wide variety of events such as cell-
cell, cell-matrix, and cell-molecule interactions that are critical to the development 
and function of an organism multicellular complex. They can also act as mediators in 
interactions between different organisms or linked to proteins, glycans can serve as 
regulatory switches. Glycans can, therefore, bind to diverse macromolecules forming 
glycoconjugates, such as glycoproteins and glycolipids (Figure 33) (Varki et al., 
2009).  
Figure 33. (a) Common classes of animal glycans; (b) schematic representation of a 
glycoprotein normally embedded in the membrane bilayer (Thy-1) with three N-
glycans (blue), a glycosylphosphatidylinositol (GPI-glycan, green), a lipid anchor 
(yellow), and a polypeptide (purple). Retrieved from Essentials of Glycobiology 
(chapter 1), Varki et al. (2009). 


(a)


(b)
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Glycoproteins occur in all cellular compartments. The glycosylation generally 
involves the covalent attachment of glycans to proteins through serine, threonine, or 
asparagine residues, or to lipids like ceramide (which is comprised of sphingosine, a 
hydrocarbon amino alcohol and fatty acid). Complex glycans are mainly attached to 
secreted or cell surface proteins and do not cycle on and off of the polypeptide. 
Glycans play diverse roles within biological systems, especially in regard to 
inflammation and immune system activation (Figure 34) (Hart and Copeland, 2010). 
Almost all the key molecules involved in the innate and adaptive immune response 
are glycoproteins, which become key components of the effectors of the immune 
system. Also, the diversity of protein glycosylation plays an important role in the 
biosynthesis and biological activity of the glycoproteins involved in the recognition of 
antigens. Oligosaccharides are important in the synthesis, stability, recognition and 
regulation of the proteins themselves and in many of their various interactions (Rudd 
et al., 2001). 
                   
Figure 34. Glycans and cellular biology. Complex glycans play critical roles in 
intercellular and intracellular processes, which are fundamentally important to the 
development of multicellularity. Retrieved from Hart and Copeland (2010). 
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Inadequate nutritional practices can compound the negative effects of intensive 
exercise on immune function. Recent studies have demonstrated that ensuring 
adequate carbohydrate intake during prolonged strenuous exercise can minimize the 
effects of exercise on measures of innate and cell-mediated immunity (Bishop and 
Gleeson, 2009). Other trials validated that polysaccharide intake enhanced the 
immune system biomarkers in the blood of healthy adults (Ramberg et al., 2010), 
affected the immunomodulation through the glycosylation of proteins, and regulated 
leukocyte activity (Johnson et al., 2013; Rabinovich and Croci, 2012). 
Other studies analyzing dietary plant polysaccharides and immunomodulatory 
potential, found increased macrophage cytotoxic and phagocytic activities, altered 
pro- and anti-inflammatory activities, Th1-Th2 balance, and altered expression of 
certain adhesion molecules. These polysaccharides could induce significant changes 
in the N-glycosylation status of serum glycoproteins. The increased sialylation 
observed can have a key role in the regulation of inflammatory processes (as in the 
case of IgG, where sialylation has been shown to function as a ‘switch’) (Alavi et al., 
2011). 
In this thesis, we wanted to investigate whether or not a glycan supplementation with 
a standardized dietary plant-derived polydisperse polysaccharide (Advance 
Ambrotose© complex powder, AA) resulted in a significant overall shift towards an 
increased sialylation of serum glycoproteins. AA is a saccharide supplement 
containing a standardized combination of plant polysaccharides (a source of 
mannose, galactose, fucose, xylose, glucose, n-acetyl-glucosamine, n-acetyl-
neuraminic acid, and n-acetyl-galactosamine) that could regulate immunity through 
salivary glycol-modifications of proteins. These modifications could regulate the 
synthesis and/or degradation of pro- and anti-inflammatory molecules participating in 
the immune response of marathon runners. 
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5. Endurance exercise and nutrition  
Being healthy is defined by the World Health Organization (WHO, https://
www.who.int/) as "a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity”, but lately some concepts have been 
redefined: “health is the ability to adapt and to self manage when individuals or 
communities face physical, mental, or social challenges” (Huber et al., 2011). 
Achieving and maintaining health is an ongoing process in everyone’s hands, and it 
depends on what type of food we eat, how much water we drink, if we exercise, if we 
sleep well, what kind of work we do, and how much stress we accumulate over the 
years. Better nutrition means stronger immune systems, less illness, and better 
health. In addition, related to physical activity, optimal nutrition enhances 
performance and recovery from exercise (Thomas et al., 2016).  
As it is well known, adequate energy intake is essential for the runner, especially with 
the intake of macronutrients and micronutrients, since it supports the optimal 
function of the body needed to perform. The majority of endurance practitioners are 
non-elite runners, and they generally focus on macronutrient intakes, disregarding 
the role of micronutrients that are mainly lost through sweat production. Therefore, 
an adequate diet should be designed considering several components like water 
with electrolytes, high vs low glycemic index carbohydrates, saturated vs 
unsaturated fat, animal vs plant-based protein, as well as the timing of nutrient intake 
(Lukaski, 2004). 
Optimal nutrition and hydration can partially attenuate central or peripheral fatigue, 
thermal stress, dehydration, and/or endogenous glycogen store depletion (Costa et 
al., 2018). Nutritional intake influences the adaptation of training and recovery to 
achieve a good performance at the end with a proper body composition over time. 
Some effects on training adaptation due to a proper nutrition, are a set of 
physiological processes such as the size and number of mitochondria (Egan and 
Zierath, 2013), increase of oxidative enzymes expression, decrease of triglyceride 
reserves in adipose tissue, increase of intramuscular triglyceride reserves, or the 
increase of intramuscular fatty acid oxidation (Bartlett et al., 2014; Noakes, 2002).
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With the strategic use of nutrition alone or in combination with training, adaptations 
can be achieved that improve the performance of the runner. This structured and 
planned process is called 'periodized nutrition' or nutritional training. One of the 
combined factors that determines the adaptive response to exercise training is the 
quality and quantity of nutrition in the pre- and post-exercise periods, aside from the 
duration, intensity, and the type of exercise (Jeukendrup, 2017). So, giving the 
deserved importance on what we eat as runners, both before, during and after 
physical activity, can make a substantial difference in performance and health. 
5.1 Energy needs 
As it is explained in section 2.1 (Figure 12), the energy in the body can be generated 
by three main ways: creatine phosphate metabolism, anaerobic glycolysis, and 
aerobic respiration. In the body we have different reserves from which to obtain 
energy with fat as the largest energy store in the body with around 9 kg compared to 
CHO with 600-700 g. The protein stores’ size is more regulated, and the protein-
breaking down by metabolic conversion to CHO is slow and well measured because 
these CHO are those that will feed certain organs such as kidneys, red blood cells, 
and brain. Regarding the weight of the whole-body composition, muscle is the 
largest organ contribution with 26 kg (or 37% from a 70-kg man), followed by fat 
tissue with 10.5 kg (15%), and bone with 10 kg (15%). Water represents up to 64% 
of total body weight or 83% of the weight of the body’s water, fat and carbohydrate 
stores (Figure 35).  
To analyze the energy a runner needs for each minute he runs, we need to know 
how much oxygen he needs. Knowing the oxygen consumption, it is possible to 
know how much energy can be produced (each liter of oxygen produces 20 kJ or 4.8 
Kcal). For example, the oxygen cost of an elite runner at a pace of nearly 20 km/h at 
67 mL O2 per kg per min is around 4.7 liters, then he will be burning 93.8 kJ (22.42 
Kcal) per minute. As 1 g of CHO provides 16.65 kJ (3.98 Kcal), the CHO stores can 
last 2h05min compared with the fat stores that provide 37.5 kJ (8.96 Kcal) per gram 
and then can fuel exercise for 59h01min (much more than with CHO). But the 
intensity plays an important role in the CHO or fat fuel uses. When the exercise 
intensity exceeds about 80% of VO2max, all the energy comes from CHO metabolism 
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and lasts little. Training and experience are factors that a runner has to not exceed 
from around 67% of VO2max and then use both fat and CHO for energy, being more 
successful performance when one is capable to extract most of the energy from fat 
(Noakes, 2002).  
Figure 35. Percentage by weight of the different organs of the body (a) and of the 
body water, fat and CHO stores (b). Adapted from Noakes (2002). 
The level of training and the diet (including fasting), affect the amount of CHO that 
can be stored (the muscle and liver have the capacity to store glycogen). Also, 
trained runners have about 10% less body weight as fat and have an improved 
utilization and availability of nutrients (Noakes, 2002). In addition, a good diet can 
accelerate recovery, because a rapid restoration of body glycogen reserves 
accelerates the repair of muscle damage and the recovery of immune function 
(Thomas et al., 2016).
5.2 Macronutrients 
Macronutrients are a class of chemical compounds which humans consume in the 
largest quantities. The main primary macronutrients are carbohydrate, protein, lipids, 
water, and fiber (Table 3). Most of them provide the bulk of energy necessary, while 
others such as fiber and water do not provide energy (Prentice, 2005). Several 
sports medicine and nutrition-related organizations recommend specific amounts of 
energy, macronutrients, and micronutrients for sustained physical activity events in 


(a)


(b)
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order to maintain body weight, replenish glycogen stores, and provide sufficient 
proteins to build and repair working tissues (Thomas et al., 2016). Macronutrient 
intake by itself doesn’t predict an ultra-endurance performance (predicting finishing 
times), but habitual dietary fat for example does (Mahoney et al., 2016). What we eat 
influences our body´s capabilities to adapt to the training, performance and to post-
exercise recovery (Williamson, 2016). 
Intensity, duration, and food intake will largely determine how much fuel is being 
sourced from carbohydrates (CHO), protein, and fat (as explained in 5.1). Although 
all three are being used as sources of energy at any given time, the intensity and 
duration of exercise are primary factors that determine the extent to which one is 
used over another.  
Table 3. List of the main macronutrients. 
Carbohydrates Protein Fats Water Fiber
Standard amino acids: Saturated fats Monounsaturated fats Polyunsaturated fats
Essential fatty acids 
(EFA)
    Glucose     Alanine     Butyric acid (C4)     Myristol     Linoleic acid (LA) -EFA  Omega-3 fatty acid
    Sucrose     Arginine     Caproic acid (C6)     Pentadecenoic     α-Linolenic acid (ALA) - EFA Omega-6 fatty acid
    Ribose     Aspartic acid (aspartate)     Caprylic acid (C8)     Palmitoyl
    Stearidonic acid 
(SDA)
    Amylose     Asparagine     Capric acid (C10)     Heptadecenoic     Arachidonic acid (ETA)
    
Amylopectin     Cysteine     Lauric acid (C12)     Oleic acid
    Timnodonic acid 
(EPA)
    Maltose     Glutamic acid (glutamate)     Myristic acid (C14)     Eicosen
    Clupanodonic acid 
(DPA)
    Galactose     Glutamine     Pentadecanoic acid (C15)     Erucic acid     Cervonic acid (DHA)
    Fructose     Glycine     Palmitic acid (C16)     Nervonic acid
    Lactose     Histidine     Margaric acid (C17)
    Isoleucine (BCAA)     Stearic acid (C18)
    Leucine (BCAA)     Arachidic acid (C20)
    Lysine     Behenic acid (C22)
    Methionine     Lignoceric acid (C24)
    Phenylalanine     Cerotic acid (C26)
    Proline
    Serine
    Threonine
    Tryptophan
    Tyrosine
    Valine (BCAA)
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5.2.1 Carbohydrates 
Glucose is the primary energy source, the only energy substrate in the body that 
works exclusively to provide energy to cells. During exercise, glucose levels in blood 
depend on exercise intensity, energy status, food intake, and glycogen storage levels 
(when there is reduced availability there is fatigue) (Lee et al., 2017). One way to 
replenish glycogen, maintain blood glucose levels, and enhance performance 
(especially for high-intensity activity) is the carbohydrate consumption before or 
during prolonged exercise (Vandenbogaerde and Hopkins, 2011). For some time 
now, it has been demonstrated that daily dietary CHO (3-12 g/kg/day) and CHO 
intake during endurance events (30-110 g/h) can enhance performance at 
individually tolerable intake rates (Costa et al., 2018). Carbohydrate intake 
recommendations depend on the duration of exercise (Figure 36) and also the CHO 
type to ingest can improve the performance delaying the fatigue. For example, 
there’s an increased oxidation rate of these exogenous CHO with 2 glucose:1 
fructose than with glucose alone because different transporters are used 
(Jeukendrup, 2014).  
Before a competition, it is necessary to take into account an overcompensation of 
glycogen and a pre-race meal 4 h before improves performance up to 2-3% (Hawley 
et al., 1997). There are studies, therefore, that say that with 24-36 hours of rest 
before a race and an intake of 8-12 g/kg/day, you can also fill the stores (Bussau et 
al., 2002). After the race, recovery from exhaustive muscle glycogen depletion is not 
a simple matter and often requires days, rather than hours to recover the 
phosphagen and lactic acid metabolic systems. Consuming carbohydrates 
immediately post-exercise to coincide with the initial rapid phase of glycogen 
synthesis has been used as a strategy to maximize rates of muscle glycogen 
synthesis, especially if there is another bout of exercise within 8 h after (otherwise 
normal meals will replace glycogen stores) (Beck et al., 2015). 
Many recreational runners don’t have access to professional nutrition advice, rather 
they utilize anecdotal evidence and rely on popular media to deliver nutrition 
information and recommendations. For example, in the past several years, some 
winners of major ultramarathon races have reported the use of low-carbohydrate 
diets, high-fat diets (LCHF), keto diets,… and thus, interest in these diets is 
increasing among recreational ultra-endurance athletes (Mahoney et al., 2016). 
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When exercise duration is long enough (more than 10 h) and exercise intensity low 
enough (for example 45–60% of VO2max, section 2.1.1), it is bio energetically 
plausible that ketogenic adaptation (the body uses primarily fat for energy) may 
enhance ultra-endurance performance (Costa et al., 2018). It seems that these diets 
facilitate the use of fat by the muscle, but do not allow the muscle to adapt quickly to 
changing substrate, for example, glucose. This makes the athletes less efficient in 
the sprints or changes of rhythm, common in competition. However, more research 
must be done. 
               
Figure 36. Carbohydrate intake guidelines. CHO intake recommendations increase 
with increasing duration of exercise and also the CHO type and nutritional training 
vary. Retrieved from Jeukendrup (2014). 
5.2.2 Fats 
Fat is of particular interest among macronutrients for endurance athletes, as it 
provides energy, fat-soluble vitamins, and essential fatty acids, which are associated 
with a lower risk of cardiovascular disease and mortality (Dehghan et al., 2017). Fats 
are used as a primary energy source when carbohydrate availability is low or when 
the intensity in endurance events is low/medium; in fact, endurance training 
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improves an athlete's ability to oxidize fat during exercise. Fat, in the form of free 
fatty acids in plasma (associated with albumin), intramuscular triglycerides, and 
adipose tissue, provides a relatively abundant fuel substrate for muscle, especially 
when endurance training is done (Thomas et al., 2016). In particular, medium-chain 
fatty acids are preferred for oxidation, since they enter circulation faster and are 
primarily absorbed by the liver. The use of fat during exercise improves 
cardiovascular health profiles because it reduces the resting levels of total 
cholesterol and triglycerides. Some types of fat in addition to providing energy, also 
play an important role in recovery (Lee at al., 2017). 
Exercise intensity affects fatty acid oxidation (FAox), which is optimal between 45 
and 65% VO2max (maximal fat oxidation). At higher intensities FAox is reduced due to 
limitations within fatty acid transport across the cell and mitochondrial membranes. 
The point at which FAox reaches a maximum and begins to decline is referred to as 
the crossover point (Figure 37). When the exercise intensities exceed the crossover 
point (~65% VO2max), the body utilizes CHO as the predominant fuel source for 
energy supply (Purdom et al., 2018). 
                      
Figure 37. The crossover concept: when exercise intensity increases, there is a 
decrease in energy derived from fat and an increase in CHO. The crossover point 
describes when the CHO contribution to substrate oxidation supersedes that of fat. 
MFO: maximal fat oxidation. Retrieved from Purdom et al. (2018). 
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Long-chain omega-3 polyunsaturated fatty acids for example, eicosapentaenoic acid 
(EPA), and docosahexaenoic acid (DHA), reduce inflammation, muscle soreness, 
perception of pain from exercise (Lee et al., 2017), and their blood levels are 
inversely related to risk for all-cause mortality and fatal cardiovascular disease 
events (Jackson and Harris, 2018). 
When a high-carbohydrate diet is consumed, the intake of fats is similar to that 
recommended for the general population of 20 to 35%. In this way, it is possible to 
maintain performance and health, but it is recommended that the consumption of 
saturated fats does not exceed 10% and include sources of essential fatty acids 
(Williamson, 2016).  
There is another metabolic state in which some of the body's energy supply comes 
from ketone bodies in the blood, in contrast to a glycolysis state in which blood 
glucose provides energy. This ketosis state occurs when the body is metabolizing fat 
at a high rate and converting fatty acids into ketones. It has been seen how this state 
improves physical endurance by altering fuel competition for oxidative respiration, 
decreases muscle glycolysis and plasma lactate concentrations while providing an 
alternative substrate for oxidative phosphorylation. Ketosis also increases 
intramuscular triacylglycerol oxidation during exercise, even in the presence of 
normal muscle glycogen, co-ingested carbohydrate and elevated insulin (Cox et al., 
2016). 
In consequence, fat oxidation rates can be improved with dietary strategies such as 
fasting, acute fat intake before exercise, and chronic exposure to diets high in fat and 
low in carbohydrates (low-carbohydrate high-fat diets, LCHF). Although there has 
been a recently revived interest in chronic adaptation to LCHF diets, there are 
divergences in their effect. There is evidence to suggest that improved rates of fat 
oxidation can only match the exercise performance achieved with diets or strategies 
that promote a high availability of CHO at moderate levels or intensities (Thomas et 
al., 2016).  
On the other hand, LCHF diets consistently improve markers of cardiovascular risk, 
lowering elevated blood glucose, insulin, triglyceride, ApoB, and saturated fat 
(especially palmitoleic acid) concentrations, reducing small dense LDL particle 
numbers, glycated hemoglobin levels, blood pressure, and body weight, while 
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increasing low HDL-cholesterol concentrations and reversing non-alcoholic fatty liver 
disease (Noakes and Windt, 2017). This LCHF provides athletes with several 
ketosis-induced adaptations that reduce oxidative stress and might influence rates of 
recovery from demanding exercise. Some highly adapted runners consuming less 
than 10% of energy from carbohydrates are able to oxidize fat at greater than 1.5 g/
min during progressive intensity exercise and consistently sustain rates of fat 
oxidation exceeding 1.2 g/min during exercise at ∼65% VO2max. The remaining 
energy that is needed is derived from the oxidation of blood lactate, ketone bodies 
and glucose derived from gluconeogenesis, without them needing to ingest 
exogenous fuels, specifically carbohydrate during a long endurance race (Noakes et 
al., 2014). 
5.2.3 Proteins 
Proteins serve as building blocks of hormones and enzymes used in all cells and 
tissues of the body, such as muscles. Protein is a critical nutrient that requires 
considerable attention on the part of the athlete to ensure adequate recovery of 
exercise and to promote optimal adaptation between training sessions (Williamson, 
2016). Marathoners, for example, when participating in endurance training and 
races, have higher needs than those required for the general population due to the 
need to repair damaged muscles and synthesize new muscle proteins. In general, 
athlete protein intakes of 1.3 to 2.0 g/kg/day are recommended (unlike 0.8 g/kg/day 
recommended by WHO to sedentary people), because they need more synthesis of 
muscle proteins, facilitate training adaptations and prevent the loss of lean muscle 
mass (Lee et al., 2017). In addition, the advisable thing is not to use the body weight 
to establish the amount of proteins that each person needs, but the one in lean 
weight (body weight-body fat = fat-free mass or lean weight in kg). The requirements 
may vary depending on the trained person (experienced athletes require less), the 
training (sessions with higher frequency and intensity require more protein), the 
availability of CHO and, above all, the availability of energy (Thomas et al., 2016). 
Endurance exercise implies maintenance of skeletal muscle integrity specifically 
important in the early post-exercise recovery period. This integrity can be associated, 
for example, with an increase in myofibrillar and/or mitochondrial protein, with 
synthesis and breakdown that depends on the protein’s half-life, and is controlled by 
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several intracellular systems. These systems require intracellular energy coming 
specifically from macronutrient intake like proteins (Smiles et al., 2016). 
It has been shown that body protein reserves provide up to 10% of the total energy 
used during endurance exercises and their contribution is influenced by many factors 
such as the intensity, duration or level of glycogen available in the body. Due to 
running, a loss of muscle mass occurs, taking place in all muscle groups, specifically 
in the lower region of the leg or calf. This loss is mainly due to eccentric contractions. 
This endogenous protein lost can be reduced by ensuring adequate reserves of 
glycogen before the activity and by consuming adequate energy during the 
prolonged activity, while promoting post-activity recovery. The rate of muscle 
degradation is accelerated when the oxidation of muscle proteins exceeds the 
synthesis, this occurs in intense and long-lasting exercises such as a marathon. 
Also, the immediacy of protein intake in the diet after exercise is essential for optimal 
recovery, suggesting a minimum of 20 g of protein within 30 to 60 minutes after 
exercise to optimally stimulate muscle protein synthesis and mitigate any existing 
decomposition that is occurring as a result of prolonged exercise (Williamson, 2016). 
5.3 Micronutrients 
Macronutrients provide sources of energy needed to fuel the body, maintain cellular 
hydration, and provide the body structure to perform work. Micronutrients enable the 
use of macronutrients for all physiologic processes. In Table 4 the main 
micronutrients are listed and they differ from macronutrients in their key 
characteristics, being regulators of health, function, and work performance. Water, 
proteins, carbohydrates, and fat are consumed in large amounts (around 100 grams 
per day), whereas vitamins and minerals are ingested in much smaller amounts 
(milligrams to micrograms per day), reflecting the turnover rates in the body and 
specific functions (Lukaski, 2004). 
Many of the metabolic pathways involved in running require micronutrients. 
Endurance training increases the demand for micronutrients because there is a 
biochemical muscle adaptation that needs them. When a runner restricts energy 
consumption, wants to lose weight or his diet is unbalanced, he will surely be 
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consuming sub-optimal amounts of micronutrients and will have to supplement them 
(most crucially with calcium, vitamin D, iron and some antioxidants ) (Thomas et al., 
2016). 
Table 4. List of the main micronutrients. 
The biological processes directly related to performance are supported by a variety 
of vitamins and minerals. Low levels of calcium, iron, B vitamins, and vitamin D for 
example, are associated with an increased risk of injuries such as stress fractures in 
Vitamins Trace Minerals Antioxidants
    Vitamin B complex     Boron
        Vitamin B1 (thiamin)     Cobalt (as a component of vitamin B12)
        Vitamin B2 (riboflavin)     Chromium
        Vitamin B3 (niacin)     Copper
        Vitamin B5 (pantothenic acid)     Iodine
        Vitamin B6 group (Pyridoxine, Pyridoxal-5-
Phosphate, Pyridoxamine)     Iron
        Vitamin B7 (biotin)     Manganese
        Vitamin B9 (folate)
        Vitamin B12 (cobalamin)
        Choline
    Vitamin A (e.g. retinol)
    Vitamin C (Ascorbic acid)
    Vitamin D
        Ergocalciferol
        Cholecalciferol
    Vitamin E (tocopherols and tocotrienols)
    Vitamin K
        Vitamin K2 (menaquinone)
    Carotenoids
        Alpha carotene
        Beta carotene
        Cryptoxanthin
        Lutein
        Lycopene
        Zeaxanthin
        Vitamin K1 (phylloquinone)
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the lower extremities. Some of the micronutrients that can most affect a runner are 
(Lee et al., 2017): 
• Vitamin D: its levels correlate with aerobic performance. 
• B complex vitamins (thiamin, riboflavin, niacin, pyridoxine, folate, biotin, 
pantothenic acid and choline): regulate energy metabolism and therefore sports 
performance because they modulate the synthesis and degradation of 
carbohydrates, fats, proteins, and bioactive compounds. 
• Vitamin E: plays an important secondary role in the recovery process, being an 
antioxidant in cell membranes and in subcellular structures. 
• Beta-carotene (precursor of vitamin A): acts as an antioxidant to reduce muscle 
damage and improve recovery after exercise. 
• Magnesium: important for energy metabolism, as well as for nerve and muscle 
function. Its deficiencies can lead to muscle weakness, muscle spasms, and 
impaired CK and lactate response to exercise. 
• Iron: directly affects the physical performance and its impairment in muscle 
function, limiting work capacity. 
• Zinc: required for a variety of functions including protein synthesis, cell function, 
glucose use, hormonal metabolism, immunity, and wound healing. 
• Chromium: is a provisionally essential mineral that intervenes in the regulation of 
glucose, lipid, and protein metabolism by enhancing the action of insulin at the 
cellular level. In athletes, there may be a greater need to consume it because they 
excrete it more than sedentary. 
5.4 Hydration 
Water is the most essential nutrient of the body and plays a critical role in 
thermoregulatory and overall function. Water is undergoing continuous recycling, 
functioning as a solvent and regulating cell volume. Water balance is controlled by 
thirst and renal function (with vasopressin, the antidiuretic hormone) (Lee et al., 
2017). Muscular work generates heat that can be aggravated by environmental 
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conditions, but sweat allows its dissipation maintaining the body temperature within 
the acceptable ranges. Being appropriately hydrated contributes to optimal health 
and exercise performance. In addition to the usual daily water losses from 
respiration, gastrointestinal, renal, and sweat sources, athletes need to replace 
sweat losses more frequently that sedentary. Sweat contains substantial but variable 
amounts of electrolytes like sodium, with lesser amounts of potassium, calcium, and 
magnesium. Runners should strive to undertake fluid management strategies before, 
during and after exercise that maintain hydration and thus preserve homeostasis, 
optimal body function, performance and perception of well-being (Thomas et al., 
2016). 
The strenuous physical exertion that is a marathon with the possibility to suffer heat 
stress, results in an increase in blood flow to the skeletal muscles and skin, 
consequently renal blood flow decrease to 25% of levels at rest. This reduction in 
blood supply leads to ischemic tubular damage (Mansour et al., 2017). 
Consequently, severe dehydration after a marathon can be a precursor to acute 
kidney injury (AKI). One of the blood biomarkers that can detect AKI is creatinine. 
This protein is a breakdown product of creatine phosphate in muscle (Figure 12a), 
and is usually produced at a fairly constant rate by the body and it is muscle mass 
depending. Creatinine can be elevated to some degree because of skeletal muscle 
size and activity, but it has been a direct indicator together with glomerular filtration 
rate (GFR), of a transient reduction in renal filtration function (McCullough et al., 
2011). Mansour et al. (2017) found significant increases in serum creatinine after the 
marathon and more than 80% of the runners developed at least stage 1 AKI (defined 
as a 1.5- to 2-fold increase or 0.3-mg/dL increase in serum creatinine level from pre-
race value). 
The daily contribution of electrolytes is very important for a runner, because they are 
capable of conducting an electrical current in solution and this property is critical in 
transmitting nerve impulses and prompting muscle contraction (skeletal and cardiac). 
Sodium (Na+), calcium, and potassium (K+) must be closely regulated, because a 
failure of potassium regulation, for example, can have serious consequences on 
nerve conduction, skeletal muscle function, and most significantly, on cardiac muscle 
contraction and rhythm (Figure 38) (Betts et al., 2017). The Na+︎-K+︎ pump (located in 
the sarcolemma and a large fraction in the t-tubular membranes, see Figure 11b) is a 
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regulator of the transport and distribution of Na+︎ and K+︎ across cell membranes with 
the main role in the excitability and contractile performance in skeletal muscle. 
Training upregulates and inactivity downregulates the content of Na+︎-K+︎ pumps in 
skeletal muscle (Clausen, 2003). 
Figure 38. Diagram of intra and extracellular electrolyte distribution (a). The sodium-
potassium pump powered by ATP to transfer sodium out of the cytoplasm and 
potassium into the cell (b). Retrieved from Betts et al. and OpenStax, Anatomy and 
Physiology: Fluid, Electrolyte, and Acid-Base Balance (2017). 
As little as a 2% reduction in body mass due to dehydration (refers to the process of 
losing body water and leads to hypohydration) has been said to result in 
performance decrements as well as hemorheology, metabolic dysregulation, 
cognitive function, mood, heat intolerance, and cardiovascular strain (Williamson, 
2016). To evaluate the degree of dehydration with both cutaneous (sweating) or 
renal (urination) water losses, acute decrease in body weight has been used as the 
gold standard, because it reflects mainly a decrease in total body water and not 
energy substrates like fat or protein (Lee et al., 2017). Also the urine color, due to its 
concentration, is an indicator of hydration status, this concentration rises 
substantially throughout the race and increasingly becomes less reliable with 
duration (Williamson, 2016). 
Other studies defend weight changes before and after an endurance exercise do not 
provide an accurate indication of hydration status specially for endurance athletes, 
because the change can be attributed to substantial breakdown of body tissues such 
as adipose and muscle and increases in weight can result from reduced diuresis (by 
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activation of vasopressin secretion and the angiotensin–renin–aldosterone 
mechanism), as well as decreases in intracellular osmolytes including glycogen, 
proteins, and triglycerides. And also weight loss greater than 2% does not 
necessarily have serious adverse consequences on performance (Williamson, 
2016). There are findings in which athletes regularly lose 5–6% of their body mass 
during ultra-endurance exercise lasting 5 to 24 h, whilst maintaining proper fluid 
allostasis and without developing any medical complications. In addition, it has been 
assessed that the best performing athletes are usually the most ‘dehydrated’, with 
some body mass losses of >6% (Tam and Noakes, 2013). 
Prolonged strenuous endurance exercise can alter physiological processes 
associated with the fluid imbalance and electrolyte levels that with proper nutrition 
can help mitigate the majority of the associated problems (Manore et al., 2000). But 
hydration during endurance events is not easy and hyperhydration has become 
increasingly common, being the most reported medical complication in ultradistance 
races. Hyperhydration can lead to life-threatening hyponatremia by altering the 
proportion of sodium in the blood and provoke brain swelling due to the entrance of 
excess water transported through osmosis. In order to prevent this, current research 
suggests that the most appropriate strategy to maintain hydration and avoid 
hyponatremia associated with exercise (EAH), during and immediately following 
exercise, is "drink up thirst" (Williamson, 2016). 
EAH can occur during or up to 24 h after a prolonged exercise with large volumes of 
water consumed. Symptoms usually appear when serum sodium levels are below 
135 mmol/L regardless of the presence or absence of signs and symptoms. The 
normal sodium range either during or outside of exercise is 135-145 mmol/L. Most of 
the clinical manifestations are related to headaches, nausea and vomiting, in the 
early phase, and with disorientation, confusion, coma, seizures, and signs of 
pulmonary edema, in the later phase. Also, EAH may lead to rhabdomyolysis (see 
section 2.2.1) through changes in the skeletal muscle membrane by osmotic shock 
and activation of reactive oxygen species (ROS) along with increases in intracellular 
calcium that activate intracellular proteases and lead to a cellular breakdown. There 
is a relationship between rhabdomyolysis and hyponatremia because 
rhabdomyolysis can lower sodium and low sodium can induce rhabdomyolysis 
(Hoffman et al., 2015). Rhabdomyolysis leads to local and systemic inflammation 
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and release of interleukin-6 (IL-6), which may increase arginine vasopressin (AVP) 
levels that further reduce serum sodium. Anti-inflammatories (NSAIDs) use may also 
contribute to excess AVP release (Figure 39) (Hew-Butler et al., 2017). Also, NSAIDs 
consumption before or during endurance races could contribute to the alteration of 
renal function aggravated by dehydration, and lead to the race abandon (more than 
60.5% who finish and 46.4% who do not finish an ultradistance race have consumed 
NSAIDs) (Hoffman and Fogard, 2011). 
                               
Figure 39. Possible bidirectional relationship between exercise-associated 
hyponatremia (EAH) and rhabdomyolysis. Retrieved from Hew-Butler et al. (2017). 
5.5 Nutrition and hydration status biomarkers 
Athletic performance and recovery from exercise are enhanced by optimal nutrition 
as it is explained in this chapter. When nutritional intake is inadequate or there is 
disordered eating in athletes, functional performance is impaired. Individual 
nutritional needs depend largely on exercise specific bioenergetic demands as well 
as on an athlete’s metabolic tolerance, needs, and preferences. A way to identify 
individual deficiencies and track changes, is the frequent monitoring of macronutrient 
and micronutrient intake, especially as runners' training volume and nutritional 
demands increase. Some examples of options for well-studied biomarkers in each 
category are (Lee et al., 2017): 
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Macronutrient metabolism: glucose, triglycerides, free fatty acids, cholesterol, 
lipids, total protein, albumin, globulin, blood urea nitrogen, amino acid, etc. 
Micronutrient metabolism: vitamin D, B vitamins, vitamin E, magnesium, iron, zinc, 
chromium, etc. 
Hydratation status: body mass, plasma/serum osmolality, plasma sodium, blood 
creatinine, arginine vasopressin, urine osmolality, urine color, salivary and tear 
osmolality, thirst, etc. Because sweat is hypotonic, exercise-induced dehydration 
leads mainly to a decrease of extracellular fluid volume (hypertonic hypovolemia due 
to water loss from the plasma). Blood biomarkers of hemoconcentration have thus 
been widely used as indexes of dehydration also (Tam and Noakes, 2013). 
Being able to find in the non-elite runners a relationship between blood biomarkers, 
nutrient intake and performance in a marathon can serve to develop the best and 
healthiest nutritional strategy, specifically when there are so many possibilities on the 
table. 
5.6 Whole-body bioimpedance measurements 
The BIA measurements phase-sensitive at 50 kHz in the BIVA model are extensively 
used in the evaluation of hydration status (Lukaski and Piccoli, 2012). After an 
intervention like an endurance running such as a marathon, the change in hydration 
with a gain or loss of fluids can be evaluated by BIVA (Lukaski et al., 2019). This 
method detects little changes in the fluid distribution before and after the marathon.  
The evaluation of the state of hydration, nutrition and training procedures, among 
others, can give very valuable information to be able to establish the homeostasis of 
the runner without incurring unwanted adverse effects. 
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6. Hypothesis 
Strenuous exercise such as a marathon in amateur or non-elite runners can cause 
changes in biomarkers associated with the pathology of several tissues such as 
skeletal and cardiac muscle, as well as impairing renal function and immunity. 
Concentration and activity of creatine kinase, C-reactive protein, creatinine, urea, 
sodium, mineral and lipid profile, cardiac high-sensitive troponin T, amino-terminal 
pro-B type natriuretic peptide and ST2 in blood, or IgA, antimicrobial proteins, anti-
inflammatory proteins and chemokines in saliva, are all altered in response to a bout 
of prolonged exercise. Such changes are transient and in most cases, full recovery 
occurs within 48 h, without any apparent long-term adverse consequences. But a 
sum of acute effects can become chronic, especially when you do not run a single 
marathon a year. 
We hypothesized that non-elite marathon runners, who experienced changes in 
these biomarkers would be more prone to tissue damage, injury, inflammation, 
cardiac, and renal impairment, infection and depressed performance, especially 
caused by inappropriate body weight and a poor training plan, recovery time, and 
diet. 
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7. Objectives 
Main objective 
The main objective of this doctoral thesis is to analyze the impact of running in non-
elite runners over different metabolic systems, and how this is affected by previous 
training hours, race time, recovery time, body weight, diet, and specific 
supplementation.  
Specific objectives 
Through a diet, health and anthropometry questionnaire, an analysis of 
bioimpedance vectors and saliva, blood and urine samples were taken at different 
time intervals (pre-race, post-race and 48 h post-race), evaluate the changes related 
to: 
1. Muscle damage and inflammation: by quantifying creatine kinase (CK), and C-
reactive protein (CRP), and analyzing the bioelectrical impedance vector (BIVA). 
2. Cardiovascular health: by quantifying high-sensitivity cardiac troponin T (Hs-
TnT), amino-terminal pro-B type natriuretic peptide (NT-proBNP), suppression of 
tumorigenicity 2 (ST2), and lipid profile (triglycerides, low density lipoprotein, high 
density lipoprotein and cholesterol). 
3. Immunity and infection: by quantifying salivary immunoglobulin A (sIgA), anti-
inflammatory proteins (angiogenin, adipokine, sialic acid-binding Ig-like lectin 5), 
pro-inflammatory chemokines (growth-regulated oncogene-alpha, growth-
regulated oncogene-beta, monocyte chemoattractant protein 1), and 
antimicrobial proteins (lactoferrin, lysozyme). 
4. Renal health: by quantifying creatinine, urea, and sodium, and analyzing the 
bioelectrical impedance vector (BIVA). 
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Abstract The number of recreational/non-elite athletes partic-
ipating in marathons is increasing, but data regarding impact of
endurance exercise on cardiovascular health are conflicting.
This study evaluated 79 recreational athletes of the 2016
Barcelona Marathon (72% men; mean age 39 ± 6 years; 71%
!35 years). Blood samples were collected at baseline (24–48 h
before the race), immediately after the race (1–2 h after the race),
and 48-h post-race. Amino-terminal pro-B type natriuretic pep-
tide (NT-proBNP, a marker of myocardial strain), ST2 (a marker
of extracellular matrix remodeling and fibrosis, inflammation,
and myocardial strain), and high-sensitivity troponin T (hs-TnT,
a marker of myocyte stress/injury) were assayed. The median
(interquartile range, IQR) years of training was 7 (5–11) years
and median (IQR) weekly training hours was 6 (5–8) h/week,
respectively. The median (IQR) race time (h:min:s) was 3:32:44
(3:18:50–3:51:46). Echocardiographic indices were within nor-
mal ranges. Immediately after the race, blood concentration of
the three cardiac biomarkers increased significantly, with 1.3-,
1.6-, and 16-fold increases in NT-proBNP, ST2, and hs-TnT,
respectively. We found an inverse relationship between weekly
training hours and increased ST2 (p = 0.007), and a direct rela-
tionship between race time and increased hs-TnT (p < 0.001)
and ST2 (p = 0.05). Our findings indicate that preparation for
and participation in marathon running may affect multiple path-
ways affecting the cardiovascular system. More data and long-
term follow-up studies in non-elite and elite athletes are needed.
Keywords Biomarkers .Marathon . ST2 . Hs-TnT .
NT-proBNP . Sports
The number of recreational/non-elite athletes participating in
marathons is increasing, but data regarding impact of endurance
exercise on cardiovascular health are conflicting [1]. Strenuous
exercise may increase the circulating concentrations of cardiac
biomarkers that are used to monitor heart health and disease.
Here, we examined dynamics of a panel of cardiac biomarkers
in non-elite athletes completing the BarcelonaMarathon in 2016.
The local ethics committee approved the study, and all partic-
ipants provided written informed consent. The study sample in-
cluded 79 recreational athletes (72%men;mean age 39 ± 6 years;
71% ! 35 years) who responded to a call for volunteers (http://
www.emmaroca.com/es/forms/estudi-cientific-perfil-de-
lultrafondista/). Blood samples were collected at baseline (24–
48 h before the race), immediately after the race (1–2 h after the
race), and 48-h post-race. Biomarkers weremeasured using com-
mercially available assays for amino-terminal pro-B type natri-
uretic peptide (NT-proBNP, a marker of myocardial strain), ST2
(amarker of extracellular matrix remodeling and fibrosis, inflam-
mation, and myocardial strain) [2], and high-sensitivity troponin
T (hs-TnT, a marker of myocyte stress/injury).
The median (interquartile range, IQR) years of training was 7
(5–11) years andmedian (IQR)weekly training hourswas 6 (5–8)
h/week, respectively. Themedian (IQR) race time (hours:min:sec)
was 3:32:44 (3:18:50–3:51:46). Echocardiographic indices mea-
sured after the race were within normal ranges (left ventricular
(LV) ejection fraction 62 ± 5%; LV end diastolic diameter
50 ± 5 mm; indexed LV mass 94 ± 20 g/body surface area;
tricuspid annular plane systolic excursion 26 ± 3 mm).
Although not the focus of the present report, we also measured
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creatinine phosphokinase (CK) as a marker of skeletal muscle
breakdown. CK increased from a baseline level of 165 U/L
(125–239 U/L) to 518 U/L (377–709 U/L) immediately post-
race and 692 U/L (462–1032) at 48 h (both p < 0.001 relative
to pre-race values). CK dynamics were not associated with age,
years of training, weekly hours of training, or performance of the
athletes.
Table 1 shows biomarker values. A significant number of
runners had ST2 (48.7%) and hs-TnT (10.4%) concentrations
above accepted cutoff point for individuals without cardiac
disease at baseline and 48-h post-race. Baseline hs-TnT corre-
lated directly with weekly training hours (p = 0.01) and cor-
related inversely with race completion time (p = 0.009). None
of the biomarkers at baseline correlated with years of training
or weekly training hours.
Immediately after the race, blood concentration of the three
cardiac biomarkers increased significantly, with 1.3-, 1.6-, and
16-fold increases in NT-proBNP, ST2, and hs-TnT, respectively
(Table 1; all p < 0.001). NT-proBNP and ST2 concentrations
returned to baseline 48 h after the race, while hs-TnT concen-
trations remained 60% higher than baseline levels (Table 1,
p < 0.001). Age and years of training showed no significant
relationships with the dynamics of the biomarkers. However,
we found an inverse relationship between weekly training hours
and increased ST2 (p = 0.007), and a direct relationship between
race time and increased hs-TnT (p < 0.001) and ST2 (p = 0.05).
In multivariable linear regression analyses that included age,
sex, and variables with a p value !0.10 in correlation analyses,
race time remained independently associated with elevations in
ST2 (p = 0.03) and hs-TnT (p < 0.001) levels.
Our findings indicate preparation for and participation in
marathon running may affect multiple physiological path-
ways, and further studies using a larger panel of biomarkers
are required in order to define the role of biomarkers in these
non-elite athletes. The mechanism of release and prognostic
meaning of abnormal concentration of these biomarkers re-
mains uncertain. In athletes completing the Boston
Marathon, increase in NT-proBNP and TnT (non-highly
sensitive) correlated with post-race diastolic dysfunction,
increased pulmonary pressures, and right ventricular dysfunc-
tion [3]. On the other hand, in non-marathon settings, these
biomarkers confer long-term increased risk for myocardial
infarction and cardiovascular death in individuals without
symptoms of cardiovascular disease [4]. Among our trained
recreational athletes, NT-proBNP concentrations modestly
rose and fell; however, the substantial percentage of those with
elevated ST2 concentrations together with huge release of hs-
TnT during the race (along with persistently high circulating
levels post-race) is noteworthy and could indicate exercise-
induced myocyte injury, possibly due to mechanisms such as
volume or pressure overload, myocardial strain, or direct
myocyte toxicity. To our knowledge, our data are pioneer
regarding endurance sports-driven ST2 increases in amateur
runners; whether such release might be responsible for long-
term extracellular matrix remodeling and, ultimately, adverse
ventricular remodeling remains unclear. Ultimately, ST2 ori-
gin in endurance sports is unclear. Besides the heart, ST2 may
have arisen from the microvasculature as endothelial cells are
known to release ST2, or the lungs, as pulmonary sources of
ST2 are also possible, or healing skeletal muscle may also be a
source in marathon runners. Further research is needed to
better understand ST2 pathobiology in endurance sports.
Marathon running and other endurance sports are increas-
ingly popular, raising concerns about sports-driven adverse
cardiac injury. More data and long-term follow-up studies in
non-elite and elite athletes are needed. Nevertheless, excessive
elaboration of cardiac biomarkers may emerge as Philippides
surrogates, named for the Greek messenger who experienced
sudden death after running more than 175 miles in 2 days.
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Table 1 Cardiovascular biomarker dynamics in recreational marathon runners
Biomarker Baseline Immediately post-race 48-h post-race p value* p value**
NT-proBNP, ng/L 70 (70–70) 92 (70–147) 70 (70–70) <0.001 0.29
ST2, ng/mL 34.2 (24.7–40.9) 54.2 (38.2–72.4) 33.7 (28.9–42.3) <0.001 0.53
hs-TnT, ng/L 2.9 (1.7–7) 46.9 (24.1–91.1) 4.7 (2.4–8.85) <0.001 <0.001
"Cut-off point
NT-proBNP, "125 ng/L (%) 0 30.7 1.4 <0.001 1.00
ST2, "35 ng/mL (%) 48.7 86.7 48.6 <0.001 1.00
hs-TnT, "14 ng/L (%) 10.4 88.3 17.9 <0.001 0.03
Values are reported as median (IQR); * 1–2-h post-race vs. baseline; ** 48-h post-race vs. baseline. Wilcoxon paired data test was used for continuous
variables; McNemar test was used for categorical variables
J. of Cardiovasc. Trans. Res.
Ethical Approval All procedures performed in studies involving hu-
man participants were in accordance with the ethical standards of the
institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards.
References
1. Lee, D. C., Pate, R. R., Lavie, C. J., Sui, X., Church, T. S., & Blair, S.
N. (2014). Leisure-time running reduces all-cause and cardiovascular
mortality risk. Journal of the American College of Cardiology, 64,
472–481.
2. Bayes-Genis, A., Januzzi, J. L., Gaggin, H. K., de Antonio, M.,
Motiwala, S. R., Zamora, E., Galán, A., Domingo, M., Urrutia, A.,
& Lupón, J. (2015). ST2 pathogenetic profile in ambulatory heart
failure patients. Journal of Cardiac Failure, 21, 355–361.
3. Neilan, T. G., Januzzi, J. L., Lee-Lewandrowski, E., et al. (2006).
Myocardial injury and ventricular dysfunction related to training
levels among nonelite participants in the Boston marathon.
Circulation, 114, 2325–2333.
4. Ford, I., Shah, A. S., Zhang, R., et al. (2016). High-sensitivity cardiac
troponin, statin therapy, and risk of coronary heart disease. Journal of
the American College of Cardiology, 68, 2719–2728.
J. of Cardiovasc. Trans. Res.

Chapter 3 93
Chapter 3: Salivary immunity and lower respiratory tract 
infections in non-elite marathon runners     
http://doi.org/10.1371/journal.pone.0206059 
 
Title: Salivary immunity and lower respiratory tract infections in non-elite marathon 
runners 

Authors: Cantó E, Roca E, Perea L, Rodrigo-Troyano A, Suarez-Cuartin G, Giner 
J, Feliu A, Soria JM, Nescolarde L, Vidal S, Sibila O 
Journal: PloS One
IF: 2.766 / Q1 

Quartil area: Multidisciplinary Science
94
RESEARCH ARTICLE
Salivary immunity and lower respiratory tract
infections in non-elite marathon runners
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Abstract
Rationale
Respiratory infections are common after strenuous exercise, when salivary immunity may
be altered. We aim to investigate changes in salivary immunity after a marathon and its rela-
tionship with lower respiratory tract infections (LRTI) in healthy non-elite marathon runners.
Methods
Forty seven healthy marathon runners (28 males and 19 females) who completed the
42.195 km of the 2016 Barcelona marathon were studied. Saliva and blood samples were
collected the day before the marathon and two days after the end of the race. Salivary IgA,
antimicrobial proteins (lactoferrin, lysozyme) and chemokines (GroĮ, Groȕ, MCP-1) were
determined using ELISA kits in saliva supernatant. Blood biochemistry and haemogram
were analyzed in all participants. The presence of LRTI was considered in those runners
who reported infectious lower respiratory tract symptoms during a minimum of 3 consecutive
days in the 2 weeks after the race.
Results
Eight participants (17%) presented a LRTI during the 2 weeks of follow-up. Higher lysozyme
levels were detected after the race in runners with LRTI when compared with those without
infection. A decrease in salivary lysozyme, GroĮ and Groȕ levels after the race were
observed in those runners who did not develop a LRTI when compared to basal levels. Sali-
vary GroĮ levels correlated with basophil blood counts, and salivary lysozyme levels corre-
lated with leukocyte blood counts.
Conclusions
LRTI are common after a marathon race in non-elite healthy runners. Changes in salivary
antimicrobial proteins and chemokines are related to the presence of LRTI and correlate
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with systemic defense cells, which suggest an important role of salivary immunity in the
development of LRTI in non-elite marathon runners.
Introduction
The number of non-elite runners participating in marathons had increased dramatically in the
last ten years [1]. Several studies have demonstrated that marathons and ultramarathons may
alter immune function and increase the risk of respiratory tract infections [2–4]. Within two
weeks of completing such strenuous exercise, the risk of infection increased 100% to 500% [5]
and around 25% of finishers reported respiratory symptoms [3].
Salivary Immunoglobulin A (sIgA) is the most common antibody on the mucosal surface.
Different studies have analyzed changes in sIgA following strenuous exercises and their poten-
tial relationship with respiratory symptoms, with conflicting results [6–8]. Other studies have
suggested that immune factors present in mucosal secretion, including antimicrobial peptides
(AMPs) and immune mediators such as chemokines, changed after prolonged running. An
increase in salivary lactoferrin, one of the most abundant AMPs, has been described in partici-
pants in a 50 km ultramarathon [9]. Furthermore, chemokines such as Growth-Regulated
Oncogene-alpha (Groċ or CXCL1), growth-Regulated Oncogene-beta (GroČ) and monocyte
chemoattractant protein 1 (MCP-1) have demonstrated an important role in the regulation of
local immunity against infections by contributing to the tissue infiltration of leukocytes [10].
Experimental studies showed that serum levels of these inflammatory mediators increased
markedly in response to exercise in mice [11]. However, limited data regarding salivary IgA,
AMPs, chemokines and the presence of lower respiratory tract infections (LRTI) in marathon
runners are available.
We hypothesized that non-elite marathon runner who experienced changes in their salivary
immunity would be more prone to developing a respiratory infection. Therefore, our aim was
to determine salivary levels of IgA, AMP and inflammatory markers before and after a mara-
thon and their relationship with the development of LRTI.
Materials and methods
Subjects
Forty seven healthy non-elite marathon runners (28 males and 19 females) completed the
42.195 km of the 2016 Barcelona Marathon. Mean finishing time was 3 hours and 38 min (±41
min). Study participants were recruited using an announcement in the marathon newsletter
that all marathon runners received two weeks prior to the race. Participation was voluntary in
all cases. The study was approved by the local ethics committee “Comité Étic de Investigació
Clı́nica de la Fundació de Gestió Sanitaria del Hospital de la Santa Creu i Sant Pau de Barce-
lona”, project number IIBSP-SUMMIT-2016-02. All participants gave signed informed
consent.
All runners were asked to report any incidence of respiratory symptoms 2 weeks before and
after the race. Runners who reported respiratory symptoms 2 weeks before marathon were
excluded from the study. LRTI was defined according the clinical definition proposed by the
European Respiratory Society and European Society for Clinical Microbiology and Infections
disease [12]: acute illness (present for 21 days or less) characterized by cough as the main
symptom, with at least one other respiratory tract symptom (sputum production, dyspnea,
wheeze or chest discomfort/pain) and no alternative explanation. In addition, all runners had
Salivary immunity in runners
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to report at least one determination of fever ( 38˚C) and duration of symptoms must be
higher than 3 days in order to exclude those symptoms induced only by strenuous exercise. All
runners with suspected LRTI were follow-up until a breakdown of symptoms was reported.
Saliva and blood collection
Saliva and blood samples were collected one day before the marathon and two days after the
end of the race. Saliva was collected into clean, sterile tub, maintained at 4˚C before centrifuga-
tion at 9500xg for 10 minutes at 4˚C. Supernatant was aspirated and 3 different aliquots were
frozen at -20˚C until use. Three 10 mL blood samples were obtained from the antecubital vein
and were transferred immediately (in less than 2 hours) to the laboratory for analysis.
Saliva analysis
The saliva samples were then thawed and total protein saliva was quantified using the Qubit
protein Assay Kit (Thermofisher Scientific). Salivary IgA (Human IgA Platinum ELISA,
ebioscience, Affymetrix, Santa Clare, CA), lactoferrin, lysozyme (AssayPro, St. Charles, MO,
USA), Groċ, GroČ and MCP-1 (Elabscience, Houston, Texas) were measured by ELISA
according to the manufacturer’s instructions. The limit of detection for IgA was: 1.6 ng/ml;
lactoferrin: 0.625 ng/ml; lysozyme: 0.0781 ng/ml; Groċ: 15.63 pg/ml, GroČ: 15.63 pg/ml and
MCP-1: 15.63 pg/ml. Data were expressed as the concentration of each molecule relative to
total saliva protein concentration [13]. Those determinations of relative salivary IgA concen-
tration with a ratio higher than 1 were excluded of the study due to possible contaminations
[14]. All determinations were performed in triplicate.
Blood analysis
Blood samples were centrifuged at 800xg at 4˚C for 10 min in a bench centrifuge. Super-
natant (plasma) was aliquoted and stored on dry ice until all samples were frozen at
-80˚C. Sodium and potassium plasma concentrations were determined using ion selective
electrodes with an ionized sodium/potassium analyzer KNA1 (Radiometer, Copenhagen,
Denmark). Creatinine and urea were measured using an AU5800 analyzer (Beckman
Coulter, Hospitalet de Llobregat, Spain). C-reactive protein was determined using the
AU-5800 Chemistry Analyzer (Bekman Coulter, Miami, FL, USA). Complete blood
counts were performed with the Unicel DxH800 automated hematology analyzer (Beck-
man Coulter, Miami, FL, USA).
Statistical analysis
Statistical analyses were performed using Graph Pad Prism 5 software. The Kolmogorov-
Smirnov test was applied to test the normal distribution of the data. All variables with a
normal distribution were reported as mean ± standard deviation (sd). T-test and paired t-
test respectively were used for the comparison of independent and related variables with
Gaussian distribution. The Wilcoxon test and Mann Whitney test were used for the com-
parison of related variables and for the comparison of independent variables respectively
with non-normally distributed data. Pearson’s and Spearman’s coefficients respectively
were used to correlate changes between normal and non-normal distributed variables.
Chi-square tests were used for the comparison of frequencies. P values less than 0.05 were
considered significant.
Salivary immunity in runners
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Results
Study participants
Table 1 shows demographic and laboratory test results prior to the marathon for all partici-
pants. Median age was 30 years old, median years of training were around 10 and training
hours per week were around 6. All laboratory tests performed were in the normal range.
No differences between males and females were found in baseline characteristics (data not
shown), except for Body Mass Index (BMI), which was higher in males than in females (23.6
±2.1 vs 20.7 ± 1.4, p = 0.01).
Lower respiratory tract infections
Eight participants (17%) reported a LRTI during follow-up. No differences in demographics
and laboratory findings between infected and non-infected participants were found prior to
the marathon (Table 1). All runners with LRTI experienced a breakdown of the symptoms
before 14 days of their onset and were fully recovered within one month after the race.
Salivary IgA
No differences before and after the marathon were found in total salivary protein concentra-
tion (2.34±1.16 mg/ml vs 2.37±0.97 mg/ml, respectively) nor in salivary IgA levels normalized
to total salivary protein (0.39±0.25 vs 0.35±0.24) (Fig 1A). In addition, no differences in IgA
levels before and after the race were found between infected and non-infected runners (Fig
1B), and no differences were observed between male and females before marathon in salivary
IgA/protein.
Table 1. Demographic and biochemical charcateristics from marathon runners.
All runners Non LRTI LRTI p value
Sex (M/F) 28/19 21/18 7/1 NS
Age 39.0±7.1 39.1±7.4 38.6±5.6 NS
BMI 22.6±2.4 22.3±2.3 23.8±2.8 NS
Years training 9.7±9.3 10.2±10.0 7.4±4.0 NS
Hours training/week 6.5±3.7 6.5±3.9 6.6±2.6 NS
Glucose (mg/dl) 84.7±14.4 85.5±15.4 81.0±7.9 NS
Na (mEq/l) 139.3±1.6 139.2±1.4 139.8±2.5 NS
K (mEq/l) 4.0±1.6 4.0±0.2 4.0±0.3 NS
Leukocytes % 6.9±1.6 6.8±1.4 7.6±2.2 NS
% Lymphocytes 34.7±7.5 34.8±6.5 34.1±11.9 NS
% Monocytes 8.3±2.7 8.5±2.9 7.7±1.3 NS
% Neutrophils 53.9±8.5 53.5±7.5 55.8±12.6 NS
% Eosinophils 2.3±1.7 2.4±1.7 1.7±1.5 NS
% Basophils 0.6±0.4 0.7±0.4 0.4±0.1 NS
Hb (g/dl) 14.1±1.1 14.5±0.9 14.0±1.2 NS
Hematocrit (%) 41.8±3.3 41.6±3.4 42.8±2.9 NS
Platelets (x109/l) 215.8±50.3 214±48 220±62 NS
CRP (mg/dl) 1.3±2.2 1.4±2.4 1.0±0.5 NS
BMI, Body Mass Index; Hb, hemoglobin; CRP, C-reactive protein.
LRTI: Lower Respiratory Tract Infection
NS, non significant
https://doi.org/10.1371/journal.pone.0206059.t001
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Salivary antimicrobial proteins
No differences before and after the race were observed in salivary lactoferrin (0.013±0.01 vs
0.010±0.007) and salivary lysozyme levels (0.0094±0.007 vs 0.0078±0.007). Furthermore, no
differences between the sexes were observed before the marathon.
When runners with and without LRTI were compared, we observed no differences in sali-
vary lactoferrin levels before and after the race. However, those runners who developed a LRTI
showed higher levels of salivary lysozyme after the race compared to those who did not develop
it (0.012±0.01 vs 0.006±0.004, p = 0.02). In addition, a decrease in lysozyme levels was
observed in runners who did not develop LRTI when levels before and after the race were com-
pared (0.010±0.007 vs 0.006±0.004, p = 0.003) (Fig 2).
Salivary chemokines
No differences before and after the race were observed regarding salivary Groċ GroČ and
MCP-1. However, runners who did not develop LRTI showed a significant decrease in salivary
Groċ and GroČ levels after the race (Groċ, 0.37±0.15 vs 0.30±0.14, p = 0.02; GroČ 0.47±0.17 vs
0.37±0.18, p = 0.03) (Fig 3A and 3B). No differences in MCP-1 levels were found.
Systemic correlations
Before the race, salivary lactoferrin levels had a weak but statistical significant negative rela-
tionship with blood lymphocyte counts (r = -0.13, p = 0.04) and salivary Groċ had a weak posi-
tive correlation with the percentage of blood basophils (r = 0.22, p = 0.03) (Fig 4A and 4B).
After the race, salivary lysozyme correlated positively with the absolute number of blood
leukocytes (r = 0.26, p = 0.006) (Fig 4C).
Discussion
In our study we observed that LRTI is common in non-elite runners following a marathon and
we demonstrated that runners who developed a LRTI had different immunological profile in
their saliva. Specifically, a decrease in salivary lysozyme, Groċ and GroČ levels was observed in
those runners who did not develop a LRTI when levels before and after the race were com-
pared. In addition, higher levels of lysozyme were detected after the race in runners with LRTI
Fig 1. Salivary sIgA from marathon non-elite runners. Salivary sIgA was determined by ELISA as described in
Materials and Methods. (A) sIgA content before and after marathon. (B) sIgA content before and after marathon based
on the development of LRTI after marathon. Results were showed as the concentration of sIgA relative to total protein
content. P values were determined by paired non parametric Wilcoxon t-test.
https://doi.org/10.1371/journal.pone.0206059.g001
Salivary immunity in runners
PLOS ONE | https://doi.org/10.1371/journal.pone.0206059 November 21, 2018 5 / 11
compared with those without infection. These findings suggest that immunological status may
be important for the development of a LRTI after a marathon.
Fig 2. Salivary lysozyme from marathon non-elite runners before and after the marathon. Results were showed as
the concentration of lysozyme relative to total protein content. P values were determined by unpaired t-test and paired
Wilcoxon test.
https://doi.org/10.1371/journal.pone.0206059.g002
Fig 3. Salivary Groċ and GroČ. Salivary (A) Groċ and (B) GroČ were determined by ELISA as described in Materials and Methods before and after marathon. P values
were determined by unpaired Mann Whitney t-test and paired Wilcoxon test.
https://doi.org/10.1371/journal.pone.0206059.g003
Salivary immunity in runners
PLOS ONE | https://doi.org/10.1371/journal.pone.0206059 November 21, 2018 6 / 11
Several data have been reported reflecting the importance of the immune system in the
development of LRTI after strenuous exercise. We observed that 17% of marathon runners
develop LRTI symptoms within 2 weeks after marathon, which is concordant to other studies
[7,15]. Although the effect of close proximity between runners during the race cannot be ruled
out, extreme effort has been shown to alter immune defenses by increasing inflammation in
the respiratory tract [16]. Different studies have postulated that a combination of several
immune, biochemical and hematological parameters participate in the severe stress on the
body resulting from such exercise and that they may be associated with an increased suscepti-
bility to developing infections [17]. Salivary IgA (sIgA) is one of the most widely-studied
parameters [7]. Some studies have pointed to the usefulness of sIgA as a noninvasive bio-
marker of mucosal immunity and LRTI risk [18,19]. However, other studies have suggested
that reductions in sIgA cannot be solely responsible for the decline in immune function that
may lead to LRTI [20]. In our cohort of runners, we did not observe differences in sIgA as
other authors previously showed [21]. We observed that sIgA represented about 40–60% of
total salivary protein, which is concordant with previous studies [22,23] but higher than other
ones [24]. Most of the studies were carried out few hours after exercise [25,26] and we wanted
to evaluate two days after finishing the marathon, since few data regarding the recovery period
and its influence on the development of LRTI are available [7].
Salivary antimicrobial proteins (sAMPs) such as lysozyme and lactoferrin protect the respi-
ratory tract from invading microorganisms and have been linked with an increased infection
risk in athletes [27]. In our cohort of runners, we observed no differences in the levels of saliva
lysozyme before the race. However, runners who did not develop LRTI showed a decrease in
lysozyme after the marathon. In contrast, those runners who developed a LRTI showed higher
Fig 4. Correlation of salivary lactoferrin, Groċ and lysozyme with systemic haematological parameters. (A)
Negative correlation between salivary lactoferrin with blood lymphocytes, (B) positive correlation between salivary
Groċ and blood basophils and (C) positive correlation between salivary lysozyme and blood leukocytes, were found.
Pearson’s and Spearman’s coefficients were respectively used to correlate changes between normal and between non-
normal distributed variables.
https://doi.org/10.1371/journal.pone.0206059.g004
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levels of salivary lysozyme after the race compared to those runners who did not develop
LRTI. Our findings are in line with other studies showing a decrease in salivary lysozyme
immediately after an ultra-marathon, though this decrease was not related to the presence of
LRTI [5]. However, other studies did not observe differences in salivary lysozyme levels after a
50 km race [25]. These discrepancies could be the consequence of different levels of effort dur-
ing exercise. Interestingly we observed an inverse relation between salivary lactoferrin and
blood lymphocyte counts before the race, which may be explained by the mobilization of neu-
trophils to maintain blood homeostasis. Previously, Inoue H et al. [28] described an immediate
increase in serum lactoferrin concentrations immediately after running exercise and serum
lactoferrin may play an antibacterial role in host defenses before the mobilization of neutro-
phils into the circulating pool. We also observed a positive correlation between blood leuko-
cyte counts and the content of saliva lysozyme after the marathon. It has been observed that
exercise sessions in both humans and animal models resulted in the stimulation of neutrophil
degranulation releasing lysozyme from blood neutrophils [29]. All of these findings suggested
that systemic alterations may affect the content of saliva lactoferrin and lysozyme in runners
and may contribute to the development of LRTI after races. Nevertheless, we cannot exclude a
process of dehydration during the marathon, since it has been demonstrated that dehydration
decreases saliva antimicrobial proteins [30,31]. Dehydration can therefore affect the content of
saliva AMPs, and further studies are needed to better elucidate its importance, though we did
not observe differences in protein content before and after the race.
Different chemokines have demonstrated a potential role in the regulation of immune
response during exercise [32]. We also found that Groċ and GroČ, which are key components
in the attraction of neutrophils to the site of inflammation, decreased after the race in runners
who did not develop a LRTI. It has been described that daily moderate exercise suppressed
Groċ [33] and, in experimental models, exercise down regulated multiple inflammatory cyto-
kines and chemokines including Groċ and MCP-1 [34,35] and had a systemic anti-inflamma-
tory effect, reducing Groċ, GroČ and MCP-1 [36,37]. These findings were observed in runners
who did not develop LRTI, suggesting that they had a better inflammatory regulation response
that may protect against infection. Therefore, athletic performance is both a stress factor and
an adaptive response to exercise that can be modulated by training, reduce inflammation and
help to prevent disease. Further studies are needed to better understand the relationship
between salivary immunity and systemic inflammation as a key factor in the development of
LRTI after exercise.
Interestingly, we observed a positive correlation between blood basophils and salivary Groċ
level before the race. Sastre B et al, identified basophils as a new player in the status of bron-
chial inflammation in athletes [38]. We observed that non LRTI runners had a higher percent-
age of systemic basophils, although differences were not statistically significant.
Our study has several limitations. First, due to the small number of runners included, the
results should be validated in other studies before generalizing them. Second, since some data
reported the effect of feeding in post exercise saliva AMPs proteins [39] we cannot exclude
feeding related affectations in the determinations of AMPs in our cohort of runners. Third,
levels of leukocyte subpopulations after the race were measured 48 hours after the marathon
and other determinations at 7 or 14 days would be helpful to better characterize systemic
response in marathon runners, and it should be an important point to be taken into account in
further studies. And fourth, infectious agents that caused LRTI are not described due to the
absence of microbiological studies. Further studies including bacterial and viral determina-
tions would be very helpful to clarify this important issue.
In conclusion, non-elite runners who developed a LRTI after a marathon showed a differ-
ential profile of saliva IgA, AMPs and chemokines compared to those runners who did not
Salivary immunity in runners
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develop infection. Therefore, exercise training and post-marathon recovery would be impor-
tant in the immunological profile and the risk of developing a LRTI. Further studies are
needed to better understand the underlying mechanisms and the impact of salivary immunity
and its regulation in the prevention and development of LRTI in non-elite marathon runners.
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Abstract
Background: Extreme exercise may alter the innate immune system. Glycans are involved in several biological
processes including immune system regulation. However, limited data regarding the impact of glycan
supplementation on immunological parameters after strenuous exercise are available. We aimed to determine the
impact of a standardized polysaccharide-based multi-ingredient supplement, Advanced Ambrotose© complex
powder (AA) on salivary secretory Immunoglobulin A (sIgA) and pro- and anti-inflammatory protein levels before
and after a marathon in non-elite runners.
Methods: Forty-one male marathon runners who completed the 42.195 km of the 2016 Barcelona marathon were
randomly assigned to two study groups. Of them, n = 20 (48%) received the AA supplement for 15 days prior the
race (AA group) and n = 21 (52%) did not receive any AA supplement (non-AA group). Saliva and blood samples
were collected the day before the marathon and two days after the end of the race. Salivary IgA, pro-inflammatory
chemokines (Gro-alpha, Gro-beta, MCP-1) and anti-inflammatory proteins (Angiogenin, ACRP, Siglec 5) were
determined using commercially ELISA kits in saliva supernatant. Biochemical parameters, including C-reactive
protein, cardiac biomarkers, and blood hemogram were also evaluated.
Results: Marathon runners who did not receive the AA supplement experienced a decrease of salivary sIgA and
pro-inflammatory chemokines (Gro-alpha and Gro-beta) after the race, while runners with AA supplementation
showed lower levels of anti-inflammatory chemokines (Angiogenin). Gro-alpha and Gro-beta salivary levels were
lower before the race in the AA group and correlated with blood leukocytes and platelets.
Conclusions: Changes in salivary sIgA and inflammatory chemokines, especially Gro-alfa and Gro-beta, were
observed in marathon runners supplemented with AA prior to the race. These findings suggested that AA may
have a positive effect on immune response after a strenuous exercise.
Keywords: Glycans, Dietary plant-derived polydisperse polysaccharide supplementation, Salivary sIgA, Inflammatory
chemokines, Marathon, Strenuous exercise
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Background
In recent years, there has been a significant increase of
participants in ultra-endurance races such as marathons
and ultramarathons. In the United States alone, mara-
thon runners have increased from 25,000 in 1976 to al-
most 503,000 in 2010 [18]. Competing in very strenuous
events imposes severe metabolic stress and causes acute
responses that may negatively alter the immune system
[17]. A high level of physical demand during such events
induces a wide range of metabolic changes and causes
micro-injuries in the muscles and other tissues. This
physical demand increases the migration of white blood
cells to the sites of injury, and induces acute phase in-
flammatory reactions [5, 16, 28]. The local response to
tissue injury involves the production of a large number
of acute phase proteins and cytokines related to innate
immunity such as secretory Immunoglobulin A (sIgA)
or inflammatory chemokines [9, 30]. Secretory Immuno-
globulin A (sIgA) is a first line of defense against exter-
nal agents, serving as a noninvasive biomarker of
mucosal immunity [10]. Several studies have shown
significant sIgA changes following strenuous exercise
[3, 19, 24]. Other important immune factors present
in mucosal secretion also change after prolonged running
[6, 20, 24]. These changes include: pro-inflammatory che-
mokines, such as Gro-alpha (neutrophil-activating protein
3 and melanoma growth stimulating activity), Gro-beta
(macrophage inflammatory protein, secreted by mono-
cytes and macrophages and chemotactic for polymorpho-
nuclear leukocytes and hematopoietic stem cells) and
MCP-1 (to recruit monocytes, memory T cells, and den-
dritic cells to the sites of inflammation produced by either
tissue injury or infection); anti-inflammatory proteins such
as Angiogenin (associated with altered normality through
angiogenesis and through activating gene expression that
suppresses apoptosis), Adipokine ACRP30 (cell signaling
protein secreted by adipose tissue involved in regulating
glucose levels as well as fatty acid breakdown) and Siglec5
(Sialic acid-binding Ig-like lectin 5).
Glycans (a generic term for any sugar or assembly of
sugars, in free form or attached to another molecule) are
directly involved in physiology [31]. Glycans are involved
in inflammation and immune system activation [11]. A
standardized polysaccharide-based multi-ingredient sup-
plement including glycans (Advanced Ambrotose© com-
plex powder (AA)) may produce a significant overall
shift towards an increased sialylation of serum glycopro-
teins. Sialylation changes can have a key role in many as-
pects of the immune response [2]. It is therefore not
surprising that one of the physiological effects of these
polysaccharides is the immunomodulation through the
glycosylation of proteins [15]. AA is a saccharide supple-
ment containing a standardized combination of plant
polysaccharides (a source of mannose, galactose, fucose,
xylose, glucose, n-acetyl-glucosamine, n-acetyl-neuraminic
acid, and n-acetyl-galactosamine) that may regulate im-
munity. In controlled human trials, polysaccharide intake
enhanced the immune system biomarkers in the blood of
healthy adults [22]. The effect of dietary supplements with
polysaccharides on retired professional football players
supported and optimized their quality of life [25]. How-
ever, no data regarding the impact of AA supplementation
on healthy marathon runners performing strenuous phys-
ical activity is available.
Our hypothesis is that glycan supplementations before
strenuous physical activity enhances immune function
and balances pro-inflammatory and anti-inflammatory
proteins. Therefore, the aim of this study is to determine
the impact of AA in the levels of sIgA, pro-inflammatory
chemokines and anti-inflammatory proteins before and
after running a marathon in non-elite marathoners.
Methods
Participants
This study is a part of the SUMMIT project (Health in
Ultra-Marathons and their Limits), whose objective is to
evaluate the behavior of certain clinical parameters in
different races and was approved by an institutional re-
view board (IIBSP-SUMMIT-2016-02). In this study, 41
male non-elite runners of the Barcelona Marathon 2016
participated and they gave signed informed consent.
All runners were weighed on race morning within 2 h
of race start in racing attire with running shoes and im-
mediately after completing the race using the same scale
Jata 565 model. Later the body mass index (BMI) was
calculated using the formula BMI = weight (kg) / height
(m2). The mean age was 39.3 ± 9.2 years old.
Study groups
Twenty participants (48%) received AA supplementation
prior to the race (AA group), while 21 participants (52%)
did not receive the AA supplement prior to the race
(non-AA group). AA was administrated at dose of 8 g/
day (with Arabinolactan, Aloe Vera extract, rice starch,
ghatti gum, gum Tragacanth, Glucosamine HCl, Wak-
ame algae extract) for 15 days before the marathon. The
41 athletes were selected for being homogeneous in age,
weekly training hours, years of training, weight and
height (Table 1), and were randomly assigned into the
two study groups.
Saliva and blood collection
Saliva samples were collected 48 h before the marathon
(d0 samples) and two days after the end of the race (d2
samples). Saliva was collected into clean, sterile tubes,
maintained at 4 °C before centrifugation at 9500!g 10
min at 4 °C. Supernatant was aspirated and 3 different
aliquots were frozen at ! 20 °C, until evaluated.
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Three 10mL blood samples were obtained from the
antecubital vein 48 h before the marathon (d0 samples), at
completion (d1 samples), and 48 h after the race (d2 sam-
ples). After the marathon, samples (d1) and weights were
obtained within the 10min interval after completing the
race and before drinking any fluid or emptying the bladder.
Saliva analysis
Saliva samples were thawed and total saliva protein was
quantified using Qubit protein Assay Kit (molecular
probes Life Technologies). Salivary IgA (Human IgA,
Platinum ELISA, ebioscience, Affymetrix, Santa Clare,
CA), Lactoferrin, Lysozyme (AssayPro, St, Charles, MO,
USA), Gro-alpha/CXCL1, Gro-beta/CXCL2 and MCP-1
(Elabscience, Houston, Texas) were measured by ELISA
according to manufacturer’s instructions. Limits of detec-
tion were for IgA: 1.6 ng/ml; lactoferrin: 0.625 ng/ml; lyso-
zyme: 0.0781 ng/ml; Gro-alpha/CXCL1: 15.63 pg/ml,
Gro-beta/CXCL2: 15.63 pg/ml, MCP-1: 15.63 pg/ml,
Angiogenin: 1.64 pg/ml, ARCP30: 24.69 pg/ml and Siglec
5: 6.86 pg/ml. The data was expressed as concentration of
each protein relative to total saliva protein concentration.
Blood analysis
The complete blood counts were performed on the Uni-
cel DxH800 automated hematology analyzer (Beckman
Coulter, Miami, FL, USA). N-terminal pro-B-type natri-
uretic peptide (NT-proBNP) was quantified in whole
EDTA blood using the AQT90 FLEX immunoassay
(Radiometer Medical, Copenhagen, Denmark). Serum
creatine kinase (CK) and C-reactive protein (CRP) were
determined using the AU-5800 Chemistry Analyzer
(Beckman Coulter). Troponin T was measured from
serum, using a High Sensitive Troponin-T assay in a
Cobas e601 platform (Roche Diagnostics, Barcelona,
Spain). ST2 was measured from serum samples using a
high-sensitivity sandwich monoclonal immunoassay
(Pressage® ST2 assay, Critical Diagnostics, San Diego,
CA, USA).
Statistical analysis
The Kolmogorov-Smirnov test was applied to test the nor-
mal distribution of the data. All variables, with a normal
distribution, were reported as mean ± standard deviation
(SD). The rest of the variables were reported as median
(interquartile rank) (IQR). T-test and paired t-test were re-
spectively used for the comparison of independent and re-
lated variables with normal distribution. Wilcoxon test
was used for the comparison of related variables with
non-normally distributed data. Pearson’s and Spearman’s
coefficients were respectively used to correlate changes
between normal and between non-normal distributed var-
iables. ANOVA and Kruskal-Wallis test were respectively
used for comparative analyses of multiple normal and
non-normal distributed data. Chi-square tests were used
for the comparison of frequencies. P values less than 0.05
were considered significant.
Results
Study participants
Forty-one male non-elite marathon runners completed
the 42.195 km of the 2016 Barcelona Marathon. Mean
finishing time was 3 h and 28min ± 0. 41 h. Median
(interquartile range) age was 39 ± 9 years old, with a
weight of 77 ± 11 kg, height of 178 ± 8 cm and Body
Mass Index (BMI) of 24.1 ± 3.4. Median training years
were 8 ± 8, with a median of 7 ± 5 h per week.
No significant differences in age, weight, height, and
training were found between runners who received AA
supplementation and those who did not (Table 1).
Plasma and blood measurements
C-reactive protein increased significantly 48 h after the
marathon (d2), although no significant differences
Table 1 Participant characteristics, anthropometric and training data before the marathon
Baseline characteristics Total cohort Non-AA group AA group p-value
Number of runners 41 21 20
Age (years) 39.3 ± 9.2 39.3 ± 12.8 39.2 ± 4.9 0.717
Weight (Kg) 77.0 ± 11.0 74.0 ± 12.0 78.5 ± 12.0 0.208
Height (cm) 178.0 ± 8.0 178.0 ± 7.0 179.5 ± 8.0 0.142
BMI (kg/m2) 24.1 ± 3.4 23.8 ± 3.0 24.2 ± 3.7 0.696
Training (years) 8.0 ± 8.5 7.0 ± 6.5 9.0 ± 12.3 0.537
Training (hours/week) 7.0 ± 5.3 6.0 ± 4.5 7.0 ± 4.9 0.106
Loss weight (%) 3.1 ± 1.8 3.1 ± 2.9 3.1 ± 1.7 0.276
Race time 3.5 ± 0.5 3.4 ± 0.6 3.6 ± 0.5 0.265
AA group: Participants received Advanced Ambrotose Complex Powder (AA) supplementation prior the race
Non-AA group: Participants did not received any AA supplement prior the race
BMI: body mass index
Values are reported as mean ± SD for the quantitative and in percentage for the categorical. ANOVA test was used for parametric variables; Kruskal Wallis test was
used for non parametric variables; Chi-Square Pearson for categorical variables
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between AA and non-AA groups were found. Similarly,
all evaluated cardiac (Hs-TnT, St2 and NTproBNP) and
muscle damage (CK) biomarkers increased after the
race, but no significant differences between participants
in either group were found (Table 2).
Hemoglobin, hematocrit, erythrocytes and platelets
counts did not change after the race (d1), with no differ-
ences between groups. However, a marked increase in
leukocyte counts per L was found in both groups after the
race (d1) and participants who received AA supplementa-
tion for 15 days prior to the race experienced a lower in-
crease compared to those without the AA
supplementation (13.2 ± 4.6 vs 16.1 ± 4.4 ! 109/L, p = 0.03)
(Table 2).
Salivary IgA
No differences in salivary IgA levels normalized to total
salivary protein before (d0) and 48 h after the race (d2)
were found (0.47 ± 0.44 vs 0.37 ± 0.29, p = 0.6). How-
ever, when participants with and without AA supple-
mentation were compared, a decrease of sIgA 48 h after
the race (d2) was observed in the non-AA group (0.55
± 0.37 vs 0.31 ± 0.35, p = 0.01), while no differences
Table 2 Plasma and blood measurements before, after and 48 h after the marathon in 41 runners
Biochemical values Total cohort Non-AA group AA group p-value
CRP_d0 (mg/dL) 0.85 ± 1.18 0.60 ± 1.28 1.00 ± 1.23 0.683
CRP_d1 (mg/dL) 0.55 ± 0.85 0.45 ± 2.91 0.95 ± 2.48 0.606
CRP_d2 (mg/dL) 7.6 ± 4.65 6.80 ± 5.00 8.95 ± 4.25 0.359
CK_d0 (U/L) 170.5 ± 123.8 188.5 ± 172.3 136.0 ± 125.3 0.633
CK_d1 (U/L) 566.0 ± 282.3 566.0 ± 251.5 567.5 ± 396.3 0.958
CK_d2 (U/L) 764.5 ± 540.8 788.5 ± 787.8 650.0 ± 513.8 0.368
Hs-TnT_d0 (ng/L) 3.1 ± 2.7 2.9 ± 2.0 3.4 ± 5.0 0.407
Hs-TnT_d1 (ng/L) 49.6 ± 68.1 48.9 ± 68.8 49.9 ± 68.8 0.449
Hs-TnT_d2 (ng/L) 4.8 ± 6.3 4.9 ± 7.2 4.6 ± 3.7 0.334
St2_d0 (ng/mL) 34.0 ± 14.8 34.7 ± 16.2 28.6 ± 16.0 0.394
St2_d1 (ng/mL) 54.9 ± 30.3 59.0 ± 40.5 43.3 ± 30.4 0.256
St2_d2 (ng/mL) 32.9 ± 20.5 37.7 ± 19.3 29.4 ± 17.1 0.059
NTproBNP_d0 (ng/L) 70.0 ± 0 70.0 ± 0 70.0 ± 0 0.336
NTproBNP_d1 (ng/L) 94.5 ± 70.5 100.5 ± 50.3 85.5 ± 221.3 0.392
NTproBNP_d2 (ng/L) 70.0 ± 0 70.0 ± 0 70.0 ± 0.5 0.845
Hemoglobin_d0 (g/L) 14.8 ± 1.3 14.8 ± 1.1 14.7 ± 1.6 0.350
Hemoglobin_d1 (g/L) 14.7 ± 1.1 14.8 ± 1.0 14.5 ± 0.3 0.173
Hemoglobin_d2 (g/L) 14.3 ± 0.7 14.4 ± 0.7 14.2 ± 0.9 0.170
Hematocrit_d0 43.7 ± 3.0 43.7 ± 3.1 43.8 ± 3.1 0.327
Hematocrit_d1 44.0 ± 4.2 44.3 ± 3.2 43.3 ± 3.4 0.132
Hematocrit_d2 42.7 ± 2.2 42.8 ± 1.8 42.2 ± 3.7 0.114
Erythrocytes_d0 (10Exp12/L) 4.9 ± 0.6 4.9 ± 0.4 5.1 ± 0.7 0.903
Erythrocytes_d1 (10Exp12/L) 5.0 ± 0.5 5.0 ± 0.4 5.0 ± 0.8 0.586
Erythrocytes_d2 (10Exp12/L) 4.8 ± 0.4 4.8 ± 0.3 4.9 ± 0.5 0.532
Platelets_d0 (10Exp9/L) 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.063
Platelets_d1 (10Exp9/L) 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 0.852
Platelets_d2 (10Exp9/L) 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.555
Leukocyte_d0 (109/L) 6.5 ± 1.9 6.4 ± 1.3 6.5 ± 3.2 0.860
Leukocyte_d1 (109/L) 12.2 ± 5.3 16.1 ± 4.4 13.2 ± 4.6 0.032
Leukocyte_d2 (109/L) 6.6 ± 1.3 6.6 ± 1.4 6.6 ± 1.8 0.217
AA group: Participants received Advanced Ambrotose Complex Powder (AA) supplementation prior the race
Non-AA group: Participants did not received any AA supplement prior the race
CK creatine kinase, CRP C-reactive protein, HGB hemoglobin, Hs-TnT high-sensitivity troponin T, NT-proBNP N-terminal pro-B-type natriuretic peptide
Values are reported as mean ± SD for the quantitative and in percentage for the categorical. ANOVA test was used for parametric variables; Kruskal Wallis test
was used for non parametric variables; Chi-Square Pearson for categorical variables
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before (d0) and 48 h after the race (d2) in the AA group
were found (0.25 ± 0.33 vs 0.24 ± 0.32, p = 0.5) (Fig. 1).
Salivary pro inflammatory proteins
A decrease of pro-inflammatory salivary proteins such
as Gro-alfa, Gro-beta and MCP-1 after the race was
observed in all participants, although differences were
not statistically significant (data not shown). Neverthe-
less, the decline in Gro-alpha (Fig. 2a) and Gro-beta
(Fig. 2b) was statistically significant in those runners who
did not receive the AA supplement (0.38 ± 0.20 vs
0.24 ± 0.18, p = 0.02 and 0.47 ± 0.26 vs 0.32 ± 0.26, p =
0.03), while differences were not observed in the AA
group. Furthermore, basal levels of Gro-alpha and
Gro-beta were significantly lower (p = 0.03) in the AA
group at baseline before the marathon (d0) compared
to the non-AA group (Fig. 2).
Salivary anti-inflammatory proteins
No statistically significant differences of salivary
anti-inflammatory proteins such as ACRP, angiotensin,
and Siglec 5 were observed before (d0) and 48 h after
the marathon (d2) (data not shown). However, in those
runners of the AA group, a significant decrease of
Angiogenin 48 h after the race (d2) was observed (0.18
± 0.08 vs 0.14 ± 0.07, p = 0.04), while differences were
not observed in the non-AA group (0.3 ± 0.13 vs 0.17 ±
0.10, p = 0.7) (Fig. 3).
Systemic correlations
After the race, those runners who received the AA supple-
ment (AA group) showed positive correlations be-
tween salivary Gro-alpha levels with leukocyte counts per
L (r = 0.38, p = 0.02) and a tendency between Gro-beta sal-
ivary levels and blood platelet counts (r = 0.27, p = 0.06).
These systemic correlations were not observed in the
non-AA group (Fig. 4).
Discussion
In our study, we demonstrated significant changes in sal-
ivary biomarkers of immune function in healthy,
non-elite athletes before and after a strenuous exercise
like an asphalt marathon, after consuming a
polysaccharide-based multi-ingredient supplement, AA,
for 15 days prior to exercise. Specifically, a decrease in
salivary sIgA, Gro-alfa and Gro-beta were observed after
the marathon in those runners who did not receive AA
supplement prior the race, while those runners who re-
ceived the AA supplement showed a decrease in a saliv-
ary Angiogenin. Gro-alpha and Gro-beta salivary levels
were lower before the race in the AA group and corre-
lated with the counts of blood leukocytes and platelets.
These findings suggest that AA supplementation pro-
duces changes in salivary immunity that may have a
positive effect on immunity before and after a marathon.
sIgA is a key component of innate immunity and pro-
vides a first line of defense against pathogens at mucosal
surfaces [8]. Numerous studies have assessed the saliva
sIgA response to prolonged strenuous exercise to ex-
plore whether immunity may be temporarily compro-
mised after the exercise. Most of the studies described a
post-exercise decrease in sIgA, including Nordic skiers
after a 50 km race [29] or trained cyclists cycling for
more than 2 h on a stationary ergometer [32]. In mara-
thon runners, a significant decrease of sIgA following a
marathon race has been described [19], which was inde-
pendent of gender, age or carbohydrate ingestion. In our
study, runners with AA supplementation did not experi-
ence a significant decrease in sIgA after the marathon,
which was observed in runners without the AA. These
findings suggested that AA supplement enhanced immun-
ity by avoiding the sIgA decrease after the race. Different
studies have postulated that glycosylation plays an import-
ant role in the biosynthesis and biological activity of the
proteins involved in antigen recognition, such as sIgA
[23]. Further studies are needed to explore this pathway,
which may be crucial in order to better understand the ef-
fect of strenuous exercise on mucosal immunity.
Supplementation with glycans can also result in salivary
glycol-modifications of proteins. These modifications can
regulate the synthesis and/or degradation of pro- and
anti-inflammatory molecules participating in the immune
response of runners to strenuous effort. Several inflamma-
tory chemokines have demonstrated a potential role in the
regulation of immune response during exercise [27]. In
our study, we demonstrated that Gro-alfa and Gro-beta,
two pro-inflammatory chemokines, involved in the attrac-
tion of neutrophils to the site of inflammation, decreased
in saliva after the race in those runners who did not
Fig. 1 Salivary IgA levels before (d0) and 48 h after the marathon
(d2) between groups
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receive AA. It has been described that moderate exercise
suppressed Gro-alfa [4] and, in experimental models, exer-
cise down-regulates multiple inflammatory cytokines [26],
including Gro-alfa and Gro-beta, that results in a systemic
anti-inflammatory effect [1, 13]. These findings were not
observed in runners who received the AA supplement,
suggesting that they had better immunoregulation. Run-
ners with AA supplementation have also showed a de-
crease in salivary Angiogenin levels, which was not
detected in runners without AA. It suggests that salivary
pro-inflammatory proteins can be buffered with
anti-inflammatory ones, especially those produced by run-
ners supplemented with AA. In addition, it is important to
note that after 15 days on AA, the baseline levels of
Gro-alfa, Gro-beta and Angiogenin were different in run-
ners with and without AA. Interpretations of all these sal-
ivary inflammatory changes are complex and require
further more detailed studies.
The systemic effect of glycans has been described in
several studies [15]. Interestingly, it is postulated that
glycans may regulate leukocyte activity [21]. In our
study, runners who received the AA supplement experi-
enced a lower increase in total blood leukocyte counts
after the race compared to those runners without the
AA supplement. Furthermore, a correlation between sal-
ivary levels of Gro-alpha with blood leukocyte counts
and salivary Gro-beta levels with blood platelet counts
were observed in the AA group. All in all, these findings
suggested a relationship between salivary and systemic
immunity, especially in those runners who received the
AA supplement prior to the race. The association be-
tween high dietary protein during high-intensity training
and reduction in respiratory symptoms in elite cyclists
by restoring impairments in leukocyte trafficking has
also been reported [35] The influence of ingredients
other than glycans on the immune system has been re-
ported. For example, brown seaweed [33], Aloe vera [12]
and glucosamine [14] have antioxidant activity and
anti-inflammatory effects. Arabinogalactan decreases the
incidence of infectious episodes by improving serum-
antigen specific IgG and IgE response to Streptococcus
pneumonia [7]. Starch supplementation promotes the
growth of commensal bacteria that may improve bowel
health [34]. However, more work is needed to clarify the
mechanism that may explain these important results.
Our study has limitations. First, we only have studied
men, and we cannot exclude the effect of glycans in sal-
ivary immunity based on sex. Second, due to the small
sample size of runners included, the results should be
validated in further studies before generalizing them.
Third, runners received the AA supplement for 15 days
prior the race, and the effect of taking this supplement
for a longer time may be different. Fourth, the influence
of ingredients included in the AA supplements which
are not glycans such as glucosamine and Aloe Vera on
Fig. 2 Salivary pro inflammatory proteins, gro alpha (a) and gro beta (b) before (d0) and 48 h after the marathon (d2) between groups
Fig. 3 Salivary anti-inflammatory protein Angiogenin before (d0)
and 48 h after the marathon (d2) between groups
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the immune system cannot be ruled out, and further
studies in non-elite marathon runners should be per-
formed to better clarify this important point.
Conclusion
In conclusion, our study documented significant changes
in salivary and systemic immunological biomarkers in
marathon runners after consuming a polysaccharide-based
multi-ingredient supplement AA, before and after the race.
Further research using randomized, double-blind,
placebo-controlled design will extend knowledge of the
potential benefits nutritional dietary supplementation with
polysaccharides may have in marathon runners.
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Chapter 5: Conclusions 
The increasing popularity in such strenuous events such as a marathon can have 
consequences in several health parameters that have to be considered. The acute 
changes that happen, have to be understood and every runner has to act in kind. 
The impact of a marathon in the healthy state of a non-elite runner is more serious 
than expected and either training hours, race time, recovery time, body weight, diet, 
and supplements, can significantly affect the performance and increase myocardial 
inflammation and strain, myocyte stress/injury, infection, body inflammation, acute 
kidney injury and muscle damage. 
More specifically, analyzing blood and saliva biomarkers together with global 
bioimpedance measurements and nutritional intake in Barcelona marathoners pre-
race, at the end and 48 h post-race, results in the different areas were obtained.  
The following main conclusions have been drawn from the published articles and 
articles under revision included in this thesis: 
Cardiovascular health 
Cardiac biomarkers significantly increased during the marathon in all runners. This 
increase reached abnormal values for hs-TnT and ST2, and was significantly 
associated with worse running performance and less training hours. We don’t know if 
these elevated biomarkers values confer long-term increased risk in cardiovascular 
health (myocardial infarction, cardiovascular death, adverse ventricular remodeling, 
diastolic dysfunction, right ventricular dysfunction, among others) or are a cardiac 
sport-driven adaptation (Chapter 2). 
In addition, the marathoners that consumed adequate amounts of unsaturated fat, 
potassium, and magnesium, performed better and presented better cardiovascular 
health (Appendix 3).  
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Immunity and infection 
Analyzing all the marathoners before and after the race, changes in salivary 
antimicrobial proteins and chemokines were found. They were related to respiratory 
tract infections (upper and lower ones) and correlated with systemic defense cells, 
suggesting an important role of salivary immunity in strenuous exercise. Therefore, 
adequate exercise training and post-marathon recovery can be important to maintain 
a proper immunological profile and prevent the risk of developing a respiratory tract 
infection (Chapter 3). 
Some types of supplements, like polysaccharide-based multi-ingredient supplements 
(glycan based), can have a positive effect on immune response after a marathon. 
Significant changes in salivary and systemic immunological biomarkers were found 
in those marathoners that took supplements. Thus, adequate supplementation 
before a marathon can bring benefits to an affected immune system after strenuous 
exercise (Chapter 4). 
Renal health 
There was a direct relationship between a marathon race in non-elite runners and 
serum biomarkers of kidney function and inflammation, with a high percentage of AKI 
stage 1 after finishing the race, but mostly recovered to baseline levels of serum 
creatinine and urea 48 h post-race. This transient reduction in renal filtration function 
was more related to inflammatory factors rather than muscle damage. Phase-
sensitive measurements at 50 kHz with BIVA, could be a non-invasive method to 
assess kidney function in runners through the Xc/H 48 h post-race value with a 
decrease >3% with respect to the baseline value (Appendix 2). 
Muscle damage and inflammation 
The highest elevations of biomarkers associated with muscle damage and 
inflammation have occurred in those runners with the worst performance in a 
marathon. In addition, these runners have been the ones who have done less 
previous training. Some of the consequences of these biomarker elevations are an 
increased risk of injury and a longer recovery time (Appendix 3). 
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Nutrition 
Marathoners with higher BMI values had worse performance and running economy 
in a marathon. An inappropriate weight to run a marathon involves problems beyond 
a poor performance. In addition, the consumption of mono- and poly-unsaturated 
fatty acids and correct intake of potassium and magnesium, result in a better 
performance (shorter race times) in marathoners, without compromising the health 
status assessed by a correct circulating lipid profile (Appendix 3). 
Figure 40 shows a graphic summary of the results obtained from the articles 
published in this thesis (Chapter 2 to 4) and from the two articles submitted 
(Appendix 2 and 3). 
 
Figure 40. Graphic summary of the results obtained in this thesis. 
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Chapter 6: Perspectives 
Despite Philippides, the Greek messenger who experienced sudden death after 
running more than 175 miles in 2 days, most of the ultra-distance racers have 
minimal risk running such distances, but scientific research can elucidate helpful 
data to avoid fatal consequences like Philippides. 
More data and long-term follow-up studies in much more non-elite and elite athletes 
are needed. Also, the analysis of the race technique, specific muscle injury 
biomarkers, and monitoring at 7 or 14 days after a marathon or ultramarathon are 
needed to better understand the underlying mechanisms. 
Concerning practical implications before a marathon, the non-elite runners should 
improve their personal performance through specific training. Localized 
bioimpedance (L-BIA) assessments and specific circulating biomarkers of muscle 
damage like CK-MM will be introduced in future marathons to evaluate muscle 
condition pre-race, immediately upon completion, and 48 h post-race. 
In addition, diet and hydration guidelines for recreational runners need to be 
improved with certain macronutrients and electrolytes, in order to preserve healthy 
recreational runners. Related to supplement effect, further research using 
randomized, double-blind, placebo-controlled experimentation will extend knowledge 
of the potential benefits nutritional dietary supplementation with polysaccharides may 
have in marathon runners. 
Thus, this thesis provides the first data related to the healthy state of amateur 
runners during a marathon; however more complementary, objective, and 
quantitative information about the impact of endurance running is needed. We must 
be able to provide data that allows us to make running an activity that is as healthy 
as possible, even in longer distances and over years of training and racing. After all 
what really kills us is a sedentary lifestyle, causing 6% of deaths worldwide. 
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ABSTRACT 
PURPOSE: This study investigates the relationship between whole-body bioimpedance vector 
displacement, using bioelectrical impedance vector analysis and renal function, through serum 
biomarkers (creatinine, urea, sodium, C-reactive protein, creatine kinase) and urine biomarkers after a 
marathon. 
METHODS: Nineteen non-elite runners were measured 24 h pre-race, immediately post-race and 48 
h post-race. The bioimpedance measurements were analysed by BIVA using the Hotelling’s T2 test. 
Runners were divided according to a cut-off of serum creatinine level immediately post-race in G1 
(<1.2 mg/dL of serum creatinine level) and G2 (≥1.2 mg/dL of serum creatinine level). The increase 
of serum creatinine levels in 83% of G2 runners was related to acute kidney injury (AKI) stage 1.  
RESULTS: Neither G1 nor G2 showed a creatinine clearance rate (CCr) lower than 60 mL/min. G2 
showed a significant increase in CRP values 48 h post-race compared to baseline than G1 (P<0.05) 
over 5 mg/L (6.8 ~ 15.2) in 92% of the runners and CK values over 215 U/L (282 ~ 1882) 48 h post-
race in 100% of the runners. By BIVA, the 95% confidence ellipses of G2 showed shorter 
bioimpedance vectors than G1 with a noticeable minor Xc/H (P < 0.01), indicating an expansion on 
extracellular water and inflammation. The runners with Xc/H 48 h post-race values ≤ 30.5Ω with a 
decrease from -3% to -12% respect to Xc/H value 24 h pre-race, indicated AKI stage 1 with 85.7% 
sensitivity and 91.7% specificity, with a direct correlation between AKI stage 1 with greater CRP 
values 48 h post-race and bioimpedance vector displacement but not with CK values 48 h post-race.  
CONCLUSION: In non-elite runners, with transient AKI stage 1, a follow-up of kidney function by 
serum biomarkers along with the BIVA can avoid noticeable renal functional impairments in future 
races. 
Keywords: marathon race, BIVA, serum creatinine, C-reactive protein, serum creatine kinase, AKI 
stage 1. 
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APPENDIX 3 
Macronutrient and mineral intake effect on racing time and cardiovascular 
health in non-elite marathon runners (NUT-D-19-01000) 
Emma Roca1, Lexa Nescolarde1, Daniel Brotons2, Antoni Bayes-Genis3,4,5,, Enrique Roche6,7 
1. Department of Electronic, Universitat Politècnica de Catalunya, Barcelona, Spain.  
2. Catalan Sports Council, Generalitat de Catalunya, Barcelona, Spain.  
3. Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n 08916 Badalona, Barcelona, Spain. 
4. Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, Campus UAB, 08913 Bellaterra, Barcelona, Spain. 
5. Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Carretera del Canyet s/n 08916 Badalona, 
Barcelona, Spain. 
6. Department of Applied Biology-Nutrition, Institute of Bioengineering, University Miguel Hernandez. Alicante Institute for Health and 
Biomedical Research (ISABIAL-FISABIO Foundation), Alicante (Spain). 
7. CIBERobn (Fisiopatología de la Obesidad y la Nutrición CB12/03/30038) Instituto de Salud Carlos III (Spain). 
ABSTRACT  
Objective: The aim of this study was to analyze, in recreational marathon runners, the intake of 
specific macronutrients and minerals that could influence cardiovascular health. 
Methods: 37 males were grouped in two groups according to their 50% percentile race time (3.39 h), 
dividing into fast (G1: 3.18 ± 0.18 h) and slow runners (G2: 3.84 ± 0.42). Anthropometric parameters, 
macronutrients and mineral records were collected before the race. Minerals (Na+, K+ and Mg2+), 
lipid profile (triglycerides, LDL, HDL and cholesterol), inflammation (C-reactive protein), muscle 
damage (creatine kinase) and cardiovascular health (high-sensitive troponin-T, N-terminal pro-B-type 
natriuretic peptide and ST2) were analyzed in blood 24h before, immediately after, and 48h post-race.  
Results: Weight (G1: 72.60 ± 7.38 kg, G2: 76.92 ± 6.51 kg; p < 0.05) and body mass index (G1: 
22.34 ± 1.64 kg/m2, G2: 24.50 ± 1.99 kg/m2; p < 0.01) were significantly different between the 
groups. Moreover, G1 consumed significantly (p < 0.01) more mono- and poly-unsaturated fatty acids 
than G2, and presented higher iron, potassium, and magnesium intake. Regarding blood lipid profile, 
G2 presented significantly higher triglyceride values and lower levels of high-density lipoprotein (p < 
0.01). The Hs-TnT marker of myocyte stress/injury was significantly higher (p < 0.05) in G2 reaching 
values above 250 ng/L, and 81% of the runners (30 from 37) presented above cut-off ≥ 14 ng/L post-
race values. 
Conclusions: Marathon runners consuming adequate amounts of unsaturated fat, potassium and 
magnesium, performed better and presented better cardiovascular health. 
Keywords: macronutrients; minerals; marathoners; performance; cardiovascular health. 
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APPENDIX 5: Races/events analyzed 2012-19
Races or events analyzed km men elite men women
elite 
women Total
Pre 
thesis 
period
2012 Cavalls del Vent (Berguedà, Catalunya) 84 9 4 2 3 18
2013
Volta Cerdanya Ultra Fons (Cerdanya) (pre/post) 14 17 2 8 0 27
Volta Cerdanya Ultra Fons (Cerdanya) (pre/post/
24/48) 35 25 5 17 3 50
Volta Cerdanya Ultra Fons (Cerdanya) (pre/post/
24/48) 55 17 0 17 0 34
Moderate altitude study with STAPS-Perpignan Univ - 20 20
2014
Ultra Trail Barcelona (pre/post/24) 100 1 1 0 1 3
Ultra Trail Barcelona (pre/post/24) 69 6 0 0 0 6
Ultra Trail Barcelona (pre/post/24) 42 1 0 0 0 1
Transvulcania (Canary Islands) (pre/post/24) 74 8 0 0 1 9
Zegama (Basque Country) (pre/post) 42 11 0 0 1 12
Volta Cerdanya Ultra Fons (Cerdanya) (pre/post) 88 10 0 2 0 12
Volta Cerdanya Ultra Fons (Cerdanya) (pre/post) 35 11 0 0 1 12
Transalpine (Germany, Italy) (pre/post) 293 7 1 7 1 16
2015
Trail Menorca (pre/post/24) 100 7 0 0 0 7
Trail Menorca (pre/post) 185 9 2 0 0 11
Thesis 
period
2016
Metabolomic study with STAPS-Perpignan Univ - 24 24
Barcelona marathon (runners) 42 57 24 81
2017
Barcelona marathon (runners) 42 29 6 35
Barcelona marathon (no racing this year) - 12 9 21
Altitude & perfomance study with STAPS-
Perpignan Univ - 30 30
Sherpa Everest altitude study with Ferran Latorre - 40 3 43
Ultra Trail Pirineus (Berguedà) 45 16 7 2 25
Marnaton (Barcelona, Sant Feliu and Begur) 5 3 8
2018
Barcelona marathon (runners) 42 23 5 28
Barcelona marathon (no racing this year) - 13 4 17
K2 altitude study with Alex Txikon - 12 4 16
Ultra Trail Pirineus (Berguedà) 45 38 6 44
Ultra Trail Naut Aran (Vall d’Aran) 54 11 1 12
2019
Barcelona marathon (runners) 42 26 4 30
Barcelona marathon (no racing this year) - 14 8 22
TOTAL 30 509 22 132 11 674
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APPENDIX 6: Races done as an endurance athlete 
Year Pos. Race km Year Pos. Race km
2019
1 Trail Vall de  Ribes (2 stages) 65
2012
3 Ultra Trail Mont Blanc, Chamonix, France  (37th overall) 110
3 Ultra Trail Australia 100 4 Ultramarathon Cavalls del Vent, Bagà 85
2018
2 Run Rabbit Run, Colorado 170
2011
2 Marathon des Sables, Morocco (23th overall) 380
7 Ultra Trail Lavaredo (Ultra Trail World Cup) (1st veteran) 110 3 Ultramarathon Cavalls del Vent, Bagà 90
2 Ultra Trail Penyagolosa (Ultra Trail World Cup) 110 2 Triatlhon sprint La Molina, Cerdanya 5
1 Costa Brava Stage Run (3 stages) 85 3 Verticalp La Molina, Cerdanya 15
2017
2 Run Rabbit Run, Colorado 170
2010
9 Ironman Nice, 1st age group, classified to Hawaii 42
23 Comrades marathon, South Africa 89 10 Zarautz Triathlon, Basque Country (Half Ironman distance) 21
1 Half marathon Coll de Pal 20 6 Half Challenge Maresme (half Ironman distance) 21
1 Half marathon Tossa de Mar 21 2 B-distance triathlon, Banyoles, Pla de l’Estany 21
2 Half marathon Montornès del Vallès 21 1 Winter Triathlon Championship, Tuixén, Alt Urgell 10
2016
3 Diagonale des Fous (Ultra Trail World Cup) in Reunion Island 170 4 Winter Triathlon Spanish Championship, Ansó, Huesca 10
2 Hardrock, Colorado, USA (9th overall) 160 1 Mountain Duathlon Championship, Folgueroles, Osona 10
1 Emmona mountain marathon 42 1 Mountain Duathlon St. Joan of Abadesses, Ripollès 10
1 Romanic extrem mountain marathon 42 1 Road Duathlon Castellfollit de la Roca, Garrotxa 10
1 Estels del Sud ultra marathon 65 2 Road Duathlon Catalonia Championship, St. Joan Ab., Ripollès 10
2015
1 TCN Camí de Cavalls, Menorca 33 2 Road Duathlon Vic, Osona 10
5 Western States, California, USA 160
2009
1 Triathlon Puigcerdà, Cerdanya 10
1 Run Rabbit Run, Colorado, USA 166 1 Half mountain Marathon Vic, Osona 22
1 Otter Trail Run, South Africa 42 12 Maresme Challenge (Ironman distance with a time of 10h30min) 42
2014
1 Transalpine Run, Germany, Italy (8 stages) 293
2004
1 Half Marathon La Molina, Cerdanya 25
1 Leadvile, Colorado, USA (8th overall) 161 1 Mountain Duathlon Puigmal 10
1 Cruce de los Andes, Chile-Argentina (3 stages) 120
2002
4 SkySki Trophées Mont-Blanc. 30
1 K42 Mallorca 47 3 World Cup mountain marathon, Kima, Italy 65
1 Ultra Trail Barcelona 100
2001
1 European Championship Mountain Marathon, Viella, Vall d’Aran 42
4 Transvulcania, Canary Islands 74 2 Mountain Marathon, Madrid 42
2013
2 Cruce de los Andes, Chile-Argentina (3 stages) 120 1 Mountain race, Molina, Cerdanya 25
1 K42 Mallorca 42 1 Catalonia Championship mountain Duathlon, Mataró, Barcelona 10
1 Magaluf Marathon, Mallorca 42
2000
7 Championships mountain Marathon, Cervinia, Italy 42
1 Ultra Trail Barcelona 114 2 Mountain Marathon, Kima, Val Masino, Italy 65
2 Kilian's Classic, Font Romeu, France 45 1 Catalonia  Championship  mountain  Duathlon,  Cerdanyola, Barcelona 10
4 Speedgoat, Utah, USA 50 5 Spanish Championship Winter Triathlon, Reinosa, Cantàbria 10
3 Ultra Trail Mont Blanc, Chamonix, France (21th overall) 169
1999
2 Spanish Championships Duathlon, Córdoba 10
1 Collserola Marathon, Barcelona 43 2 X-Treme Aneto Nike Marathon, Benasque, Huesca 42
1 K42 Tenerife 44
1998
1 Catalonia Championships mountain Duathlon 10
2012
dsf TransGranCanaria, Canary Islands 123 3 Catalonia Championships Duathlon, Reus, Tarragona 10
1 Highland Fling Race, Scottish Ultra Trail Champs, Scotland 85 1 X-Treme Aneto Nike Marathon, Benasque, Huesca 42
1 Q50 Madrid 50 1 Spanish Championships long distance Duathlon 22
1 Volta Cerdanya 35 TOTAL Km         5044

